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Abstract
Despite their growing use, there is limited literature on the design and analysis
of stepped-wedge trials (SWTs). The design is characterised by some or all
clusters experiencing the control condition follow by the intervention condition.
This enables within-cluster comparisons, but confounds the intervention effect
with secular trends.
In this thesis, I aim to use statistical methodology to improve the design effi-
ciency and identify robust methods of analysis.
I provide a new formulation of a design effect for an SWT. From this, I identify
that it is more efficient for a trial to begin after the first clusters switch to the
intervention, and end before the final clusters switch to the intervention.
SWTs are commonly analysed using a mixed-effect model with a random effect
for cluster and fixed effects for periods and the intervention. Through a wide-
ranging simulation study, I found that this “standard” model is sensitive to
deviations from model assumptions and suggest adding a random effect for
period. However, this alternative model still suffered from confidence interval
under coverage in some scenarios.
I introduce a novel method of analysis that excludes the within-cluster com-
parisons. Each period of the trial is analysed separately to give within-period
intervention effect estimates. An inverse-variance weighted average provides
an overall effect and permutation tests provide a p-value and confidence inter-
vals. In a simulation study, I find that this novel method provides unbiased
inference in a range of scenarios, but had lower power than the standard model
when the standard model was correctly specified. I introduce a new Stata com-
mand I have developed to conduct this novel method in order to encourage
wider use of this new methodology.
These finding will lead to trialists using more efficient trial designs and more
robust analysis methods.
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Notation
Correlation parameters
R The cluster-mean correlation, assuming equal correlation within
clusters
R∗ The cluster mean correlation, allowing for repeated observations of
individuals and for cluster-specific period effects
ρ ICC
pi Cluster-level autocorrelation
σ2 The total variance of the outcome. Subscripts are added to denote
components of the total variance
Trial design parameters
b Number of periods before baseline
g Number of sequences. This is denoted k in chapter 6
coj, c1j Number of clusters in the control and intervention conditions re-
spectively in period j
m Total cluster size
M Total number of observations in the trial
n Number of observations in a cluster-period
Analysis model parameters
i Index for cluster i = 1, ..., I
j Index for period j = 1, ..., J
k Index for observation k = 1, ..., K. Also the number of sequences
in chapter 6
yijk Outcome of observation k in period j in cluster i
µ Mean outcome in the first period in the control condition
βj Period effect comparing period j to the first period
tj The time between period 0 and period j
Xij Indicator variable equal to 1 if cluster i receives the intervention
in period j, 0 otherwise
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Si Variable indicating the period in which cluster i switches to the
intervention
θ Intervention effect. The subscript A denotes a specific value of the
intervention effect. The subscript j a within-period intervention
effect. θˆ denotes an estimate of the intervention effect
θ′ Change in the intervention effect with longer in the intervention
condition
dik Random effect for an observation k in cluster i N (0, σ2d)
eijk Random effect for an observation in cluster i in period j for obser-
vation k N (0, σ2e)
ui Random effect for cluster i N (0, σ2u)
vij Random effect cluster-specific period effects MVN
(
0, Λvj
)
qij Random effect for cluster i in period j N
(
0, σ2q
)
zi Random effect for cluster-specific intervention effects N (0, σ2z)
Λ A covariance matrix
γi Power given to the second term of the period effect (chapter 8 only)
Within period analysis parameters
pij Probability of an outcome in cluster i in period j. p∗ij denoted the
probability after applying a heuristic adjustment for all cases or all
controls
s0j, s1j The variance of the cluster summaries in the control and interven-
tion conditions respectively in period j
wˆ Vector of estimated weights given to each period-specific interven-
tion effect
wˆj Weight given to the intervention effect in period j
Permutation test parameters
f Number of permutations out of all possible permutations that give
a parameter estimate the same or more extreme than that observed.
f ∗ denotes the number of Monte-Carlo permutations.
F Total number of permutations of clusters to sequences. F ∗ denotes
the number of Monte-Carlo permutations
General
16
α Type-one error rate. In chapter 6 this is the proportion after rollout
β Statistical power. In chapter 6 this is the proportion before rol-
lout. In chapter 7 this is the period effect since there are only two
periods, so no subscript is used
E (x) The expectation of x
V ar (x) Variance of x
Cov (x, y) Covariance of x and y
Φ (x) Cumulative standard normal distribution function at a value x
Φ−1 (x) Inverse cumulative standard normal distribution at a value x
N Number of simulation runs
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Terminology
Terms used
in this thesis
Description
Stepped-wedge
trial (SWT)
A trial where all or some clusters switch from the control
condition to the intervention condition during the trial.
Clusters only ever switch from control to intervention, never
intervention to control. Also referred to elsewhere as a
multiple baseline trial, or unidirectional crossover trial. See
figures 1.1 and 3.1.
Parallel cluster
randomised
trial (CRT)
A trial where half of the clusters are randomised to receive a
control condition for the duration of the trial and the
remaining clusters receive the intervention for the duration of
the trial. See figure 1.2a.
Parallel cluster
randomised
trial with
baseline
observations
A CRT with a period of data collection before any clusters
receive the intervention. See figure 1.2b.
Cluster
crossover trial
(CRXO)
A trial where half of the cluster are randomised to receive the
control condition followed by the intervention condition, and
the remaining cluster are randomised to receive the
intervention condition followed by the control condition. See
figure 1.2c.
Hybrid trial A type of SWT with an unequal allocation of clusters to
sequences. Some proportion of the clusters are randomised to
receive the control or intervention condition for the duration
of the trial, the remaining clusters are randomised to an SWT
with half a period before and half a period after rollout. See
figure 3.1d.
Condition Refers to whether clusters are receiving the control or the
intervention. Known elsewhere as arms, or treatments.
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Terms used
in this thesis
Description
Clusters The collections of individuals and unit of randomisation.
Indicated by the subscript i = 1, .., I. Known elsewhere as
groups.
Switch-points Describes the times at which clusters switch from the control
to the intervention condition. Known elsewhere as steps,
crossover-points, and uptake-times.
Sequences
(chapter 1-6, 8,
& 9) / Groups
(chapter 7),
Defines the randomisation of clusters. Clusters are
randomised to one of g sequences/ groups that switch from
control to intervention at different times (switch-points)
during the trial. Elsewhere, these are also known as steps or
arms.
Rollout The time between the first sequence switching to the
intervention and the final sequence switching to the
intervention. Before rollout, all clusters are in the control
condition. After rollout, all clusters are in the intervention
condition.
Periods The time between subsequent sequences switching from
control to the intervention. Indicated by the subscript
j = 1, ..., J . There may also be a period before the first
sequence switches and/or after the final sequence switches.
Elsewhere, known as epochs or steps.
Standard SWT
design
An SWT with one period before rollout and one period after
rollout. Each period contains the same number of
observations and an equal number of clusters are randomised
to each sequence. See figure 1.1.
Incomplete
SWT
An SWT with no observations collected in some clusters in
some periods. In a complete SWT, observations are collected
in all clusters for all periods.
Total cluster
size
The number of observations collected in each cluster across
the whole trial.
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Terms used
in this thesis
Description
Secular
trends/period
effect
Changes in the outcome over time.
Vertical
comparison
Comparison of outcomes from cluster in the control condition
to outcomes from clusters in the intervention condition within
a period.
Horizontal
comparison
Comparison of outcomes from periods in the control condition
to outcomes from periods in the intervention condition within
a cluster.
Hussey and
Hughes model,
(chapter 1-6, &
9) / Standard
model (chapter
7 & 8)
A mixed-effect model with a random effect for cluster and
fixed effects for the periods and intervention, as shown in
model 3.1. This is the most common analysis for SWTs.
Cluster-period
interaction
model
A mixed-effect model with a random effects for cluster and
the interaction between clusters and periods, with a fixed
effect for intervention, as shown in model 3.2.
Random-
period
model
A mixed -effect model with random effects for clusters and
periods, and a fixed effect for intervention as shown in model
3.4. The random effects have an unstructured covariance
matrix.
Random-
intervention
model
A mixed-effect model with random effects for cluster and
intervention, and a fixed effects for periods, as shown in
model 3.6. The random effects have an unstructured
covariance matrix.
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1 Introduction
Since the early beginnings of medical research, there have been concerns about
statistical methods being used inappropriately [1]. Methodological literature
aims to improve our understanding of statistical techniques, and to disseminate
this knowledge to researchers wishing to use these methods. This has been an
issue in many types of research, including randomised controlled trials (RCTs).
In an RCT, individuals are randomised to either receive a control condition,
usually the standard of care, or a new intervention condition. By random-
ising the subjects, all known and unknown factors that could confound the
intervention effect should be balanced between the two groups; this allows any
difference between the two groups to be attributed to the intervention [2]. In
the past, RCTs have been subject to poor implementation of statistical tech-
niques [1], but there have been improvements [3]. These improvements have
been reinforced by the development of the Consolidated Standards of Report-
ing Trials (CONSORT) statement in 1996 that gave guidelines for the essential
information that should be reported for a clinical trial [4, 5].
With the advent and growing use of more complex trial designs, the need for
better understanding of the statistical methods being used to analyse trials is
even greater.
In this thesis, I will provide some important contributions to the methodolo-
gical literature for stepped-wedge cluster-randomised trials (SWTs); this is a
study design that is being used more frequently but where the methodology
literature is in its infancy.
This chapter will give an overview of the SWT and related trial designs and
discuss some of the reasons for using the SWT design. First, I will introduce
cluster-randomised trials and how clustering is described mathematically. In
section 1.2, I will describe the SWT design and the terminology used in this
field. In section 1.3, I will describe related trial designs that will be referred
to in the thesis. Section 1.4 will describe why the SWT design is growing
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Chapter 1. Introduction
in popularity and some of drawbacks to using this design. The chapter will
conclude with an outline of this thesis and my contributions to the thesis.
1.1 Cluster Randomised Trials
In a cluster randomised trial, sets of individuals are randomised rather than
randomising the individuals themselves. These are usually naturally occurring
sets of individuals, such as residents in villages, patients in hospital wards,
or pupils in schools. This is sometimes done for practical reasons because
the intervention can only be introduced to an entire cluster of individuals,
for example, providing water wells to villages [6]. Alternatively, it might be
that the trialist wants to explore the effect of the intervention within a whole
community, for example, introducing vaccines to the majority of children in
an area will reduce the chance of the unvaccinated children getting infected
(known as herd immunity) [6].
In this type of setting, individuals within the same clusters are likely to be
more similar to one another than to individuals from a different clusters; by
randomising clusters, we are not getting the same amount of information about
the effect of the intervention as if we randomised individuals. The independ-
ence assumptions of most simple analysis methods are inappropriate. The
degree of clustering is characterised by the intracluster correlation coefficient
(ICC, ρ), defined as
ρ = σ
2
b
σ2w + σ2b
where σ2b is the variability between clusters, and σ2w is the variability within a
cluster [6]. The ICC is the proportion of total variability in the data that is
due to between-cluster variability. A high ICC means that observations in the
same cluster are relatively more similar to one another than to observations in
a different cluster. In health research, the ICC rarely exceeds 0.05 [7, 8].
Girling and Hemming introduced a slightly different concept to describe this
correlation that incorporates the total cluster size (the total number of ob-
servations in each cluster across the whole of the trial) [9]. Assuming equal
correlation within clusters, the cluster-mean correlation, R, is defined as:
R = mρ1 + (m− 1)ρ
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where m is the total cluster size. Rather than partitioning the total variabil-
ity, the cluster-mean correlation partitions the variability of the cluster-means
into between-cluster variability and within-cluster variability. The cluster-
mean correlation varies between 0 and 1, increasing as the ICC or cluster size
increase. A cluster-mean correlation of 0 implies all the cluster-mean variabil-
ity is within-cluster variability, whereas, a cluster-mean correlation of 1 implies
that all of the cluster-mean variability is between-cluster variability. Unlike
the ICC, which is usually small, the cluster-mean correlation can span from 0
to 1 in health research [9].
Whilst there are other measures of clustering, these are not used in this thesis.
There are many types of cluster-randomised trial study designs, but in this
thesis, I will focus on the SWT design.
1.2 Stepped-Wedge Trials
In an SWT, sometimes referred to as a multiple baseline design [10] or uni-
directional crossover design [11], clusters are randomised into sequences. The
trial consists of a number of periods, and clusters in each sequence are exposed
to the control condition for a different number of periods then spend the re-
maining periods exposed to the intervention condition. For example, in a trial
with three periods a sequences could consist of two periods in the control con-
dition followed by one period in the intervention condition, or one period in the
control condition followed by two periods in the intervention condition. The
times at which clusters switch from the control to the intervention condition
are known as switch-points.
This can lead to a range of different designs, as will be described in section
3.1. An example of the most commonly used design [12], herein referred to as
the standard design, is shown in figure 1.1. In this design, the switch-points
are equally spread throughout the study and observations are collected before
the first and after the final switch-point.
A key characteristic of these trials is that the intervention effect has been
confounded with changes in the outcome over time (secular trends) because
the intervention observations are, on average, later in time than the control
observations.
The use of the SWT design is growing; the same number of protocol or trial
result articles were published in 2013 and 2014 as were published at any time
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before 2013 [12]. SWTs have been seen in many areas of research including
economics, education, and medical research, but they are most common in
health research [12, 13]. They have frequently been used to evaluate health-
education interventions [14]. They are now more commonly used in high-
income countries [12], but this was not always the case [15].
Figure 1.1: Schematic of a standard stepped-wedge trial
The broad use of this design across a range of disciplines, along with a lack of
reporting guidelines, has led to inconsistent terminology being used to describe
the characteristics of the trial [13]. In this section, the different terminology will
be outlined, highlighting the terminology used in this thesis. This terminology
is also given in the glossary in the preliminaries of this thesis.
The defining feature of an SWT is that clusters switch from control to the
intervention at more than one time-point. In this thesis, I will use the term
switch-points throughout to describe the times at which clusters switch, but
elsewhere they are sometimes referred to as steps [16], uptake times [9], or
crossover points [17].
The time between the first and final switch-point is known as rollout because
there are some clusters still in the control condition whilst others have switched
to the intervention condition [18]. There are no other common names for this
elsewhere in the literature.
The times between switch-points are referred to as periods throughout this
thesis, and this terminology is common in the literature [13, 18]. They have
also been referred to as epochs [19], or again, steps [20, 21].
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This thesis will primarily use the term sequence to describe the randomisation
of clusters, although Chapter 7 uses the term groups because it was published
earlier. Elsewhere, sequences have been called arms [22], or steps [5].
SWTs are a relatively new type of cluster randomised trial and are more com-
plex than alternative designs.
1.3 Related Cluster Randomised Designs
Often, an SWT is not the only feasible trial design. In this section, I will
describe other cluster randomised trial designs that are referred to later in this
thesis.
The simplest form of cluster randomised trial is a parallel cluster randomised
trial (CRT), where the clusters are randomised to two groups, one of which
receives a control condition for the duration of the trial, and the second receives
an intervention condition for the duration of the trial (figure 1.2a). CRTs can
be designed with observations of follow-up alone or with baseline observations
(figures 1.2a and 1.2b respectively). In a study with follow-up alone, clusters
are only observed after the intervention clusters have received the intervention.
In a CRT with baseline observations, there is an additional baseline period
before the intervention is introduced to any clusters, as well as the follow-up
period after introduction of the intervention, and the outcome is observed in
both periods of the study. The baseline period could contain the same number
of observations as the follow-up period, or it could be larger or smaller.
Like SWTs, CRTs are used in many fields of research including medical, educ-
tion, and economics [23]. They became popular in the 1980s but several re-
views noted poor methodological quality of CRTs in the following 20 years
[24, 25]. Although there are still methodological issues, there have been im-
provements in the reporting and analysis of CRTs [26], largely attributed to an
increase in methodological papers and books, and the development of CON-
SORT guidelines [26–28]. However, suboptimal reporting and use of meth-
odology remains common, highlighting that publication of methodology is not
sufficient to improve trial methodology, efforts to increase methodology uptake
are also required [26].
A lesser used design is a cluster crossover trial (CRXO, figure 1.2c) [29]. This
design consists of two periods, with the same number of observations in each.
Across these two periods, cluster are randomised to receive either the control
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Figure 1.2: Schematics of other cluster-randomised trial designs
(a) Parallel cluster randomised trial
(CRT)
(b) Parallel cluster randomised trial with
baseline observations
(c) Cluster randomised crossover trial
(CRXO)
condition in the first period followed by the intervention condition in the second
period, or the intervention condition in the first period followed by the control
condition in the second period. Like an SWT, clusters are exposed to both
the control and intervention conditions. Unlike an SWT, in the CRXO design
the intervention effect is not confounded with time effects. A CRXO is only
suitable where the intervention can be removed and the intervention effect
disappears. As an example, Johnson et al [30] conducted a CRXO to assess
the impact of parental training and support on developmental outcomes of
preterm babies at two years old . The clusters were neonatal units in the UK.
Half of the units were randomised to receive the control condition followed
by intervention condition and the remaining units received the intervention
condition followed by the control condition. This study overcame problems of
caused by removing the intervention by firstly recruiting different parents in
each period, and secondly, using different staff to implement the intervention
on top of the usual care that all parents received.
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1.4 Reasons for Choosing a Stepped-Wedge Trial
Design
Although still relatively uncommon compared to CRTs, the SWT design is be-
ing increasingly used [12]. SWTs have primarily become popular for logistical
reasons, but ethical reasons have also been given [31]. However, there is some
debate in the literature around these justifications [31–33]
Arguments that restricted resources limit the rollout of the intervention have
been countered by the suggestion of a staggered CRT that maintains the bal-
ance of calendar time between the two arms [31, 32]. Such a design also has
the logistical benefit that only half of the clusters ever receive the intervention,
so less effort is required for the intervention rollout [31]. A downside to the
staggered rollout in SWT is that they can lead to trials that take longer to
complete [18].
Using an SWT is thought to improve recruitment of clusters since all clusters
know that they will receive the intervention; this is again countered with a
modified CRT design where control clusters are given the intervention after
data collection ends if the intervention is shown to be effective [32].
Some think that an SWT is more ethical than a CRT when the intervention
is expected to have a positive effect as all clusters eventually receive the in-
tervention [34]. However, even with an SWT there will often still be many
individuals within clusters that do not receive the intervention; where it is
unethical to withhold the intervention from some clusters, it would also be
unethical to delay rollout of the intervention [31, 33].
One justification that is less criticised is conducting an SWT when the inter-
vention is going to be rolled out anyway. By randomising the process of rollout
and collecting data while the intervention is being rolled out, the intervention
can be assessed at the same time as rollout occurs [31, 35]. Randomisation will
mean this assessment is more robust than an assessment of a non-randomised
rollout [36].
Lastly, in many settings, SWTs are thought to estimate the intervention ef-
fect with a smaller variance than a CRT, meaning trials can require a smaller
sample size and maintain the same level of power [34]. This is only the case
when there is a sufficiently large correlation between individuals in the same
cluster and clusters are sufficiently large [16, 37, 38]. The reason for this
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potential increase in statistical power is that the intervention and control con-
ditions can be compared within-clusters as well as between clusters, and most
analysis methods utilise all of these comparisons [39–41]. In a CRT, the differ-
ence between the intervention and control conditions is assessed by comparing
clusters in each condition (between-cluster comparisons). In an SWT, these
comparisons are also possible. In each period of the trial, clusters in each con-
dition can be compared to provide an intervention effect; these comparisons
are known as vertical comparisons. Only allowing for vertical comparisons,
the CRT would have the most power because there are the same number of
clusters in each condition at all times [42]. For SWTs, the intervention can also
be compared within clusters; these comparison are known as horizontal com-
parisons [17, 43]. The horizontal comparisons can be estimated with greater
certainty because the between-cluster variability has been removed. However,
they are confounded with time because, in an SWT, the intervention is on
average later in time than the control condition [17]. This means that they
require assumptions about the secular trends of clusters [17, 43]. The con-
founding with time is a primary feature of SWTs, and is also the design’s main
drawback. Failing to appropriately adjust for this known confounder could
lead to a biased intervention effect [17].
Despite their growing popularity, I will show in chapter 3 that this is a poorly
understood design, with many gaps in the methodological literature. Just as
with CRTs in 1980s, the methodological literature is lagging behind the uptake
in applying this trial design. Methodological literature is required to ensure
SWTs are being designed and analysed appropriately. As also seen with CRTs,
further efforts are also required once methodology is available to encourage the
uptake of these methods.
1.5 Thesis Outline
This thesis adds to the current literature on designing and analysing SWTs,
with a focus on health research. I begin with a broad overview of the current
methodological literature for these designs, followed by my research improving
the design efficiency and the robustness of analysis.
I use three case studies of SWTs in this thesis to explore different analysis
options and to design simulation studies. These are described in chapter 2.
Chapter 3 describes the current literature on SWTs. I begin with a discussion
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of what is classed as an SWT, as the term covers a wide range of designs. I
discuss whether the most commonly used analysis methods are sufficient to
provide unbiased estimates of the intervention effect. I follow this with an
exploration of the methods for sample size calculations and how these differ to
methods for CRTs.
This review of current literature revealed many knowledge gaps. In chapter
4, I describe the gaps this thesis aims to address; efficient design and robust
analysis.
Chapter 5 provides details of the methods used in the simulation studies
presented in chapters 7 and 8. All other details of methods are presented
within the chapters of novel work.
The next four chapters each give a paper of novel work under taken during this
PhD. These are written in the “paper style” format and are either published
or ready for publication.
In Chapter 6, I identify changes to the SWT design that reduce the sample
size required for a given power. In particular, the first and last period with all
clusters in the control and intervention conditions respectively are inefficient
and designs which exclude these periods require a smaller sample size.
Chapters 7, 8, and 9 describe work exploring methods of analysis that ensure
robust adjustment for secular trends and correctly account for correlation. I
have focused on binary outcomes because these are common in practice [44].
Chapter 7 demonstrates that simply adjusting for period effects as fixed cat-
egorical variables is not always sufficient and doing so can lead to under-covered
confidence intervals. Allowing the secular trends to vary between the clusters
corrects this problem. I also identify a similar result that assuming that the
intervention effect is common to all clusters can lead to biased intervention
effect estimates and under-covered confidence intervals.
In Chapter 8, a novel analysis strategy is introduced that uses cluster-summary
analyses within each period, conditioning on time, and so removing all con-
founding with secular trends. I give an example of this analysis method in
trial data and conduct a simulation study to assess its performance against
the most commonly used analysis method.
At present, the method described in chapter 8 requires some coding knowledge
to run the analysis. In order to simplify use of this method, and improve its
uptake, I wrote a Stata command to run this analysis. In Chapter 9, I describe
this Stata command and provide a tutorial of its use.
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Lastly, Chapter 10 gives a summary of the main conclusions of this work in the
context of the broader literature. I describe the implications for SWTs going
forward and ideas for future research leading on from my findings.
1.6 Role of the Candidate
I conceived the aims and objectives in this thesis, with support from my su-
pervisors Katherine Fielding and James Hargreaves. In this section, I will
describe my role addressing these aims in the description of the current liter-
ature (chapter 3), and the four chapters of novel work (chapters 6 to 9). All
other chapters in this thesis were written by myself incorporating feedback
from Katherine Fielding and James Hargreaves. I had no role in conducting
the case studies used in this thesis.
1.6.1 Review of Current Literature (Chapter 3)
I was part of the data extraction team for a series of five articles in the Trials
Journal. The series focused on a systematic review of SWTs [14], however I
did not design this systematic review. I was involved in discussions and paper
editing for the article on SWT designs [18]. I played a large role in interpreting
the results for the article on SWT analysis [17], and contributed to editing the
text of this paper. This series formed a starting point for chapter 3.
I led the remaining contributions of chapter 3, describing the current state of
methodology literature for SWTs with guidance from Katherine Fielding and
James Hargreaves.
1.6.2 Novel Work on Efficient Design of SWTs (Chapter 6)
Chapter 6 gives a published paper providing recommendations for improving
the design efficiency of SWTs. The idea for this paper was initially identified
by Andrew Copas along with the idea of reparameterising an existing design
effect, but in a simpler form than that given in the published paper. I developed
this idea, increasing the flexibility of the design effect beyond the original
suggestions of Andrew Copas, and derived all results given in the paper. I
also wrote the first draft of the paper. Andrew Copas checked the derivations
and suggested substantial edits to the text. Katherine Fielding and James
Hargreaves suggested edits to the text.
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1.6.3 Novel Work Identifying Problems with Current
Analysis Method (Chapter 7)
Chapter 7 gives a published paper detailing the results of a simulation study
comparing bias, confidence interval coverage, and power of several analysis
models. The motivation for this work stemmed from the paper by Davey et
al [45], but I lead development and design of the simulation study, conducted
the analysis, and wrote the first draft of the paper. Richard Hayes provided
guidance in interpretation of results. All co-authors provided comments and
edits to the manuscript text.
1.6.4 Novel Work Developing a Cluster-Summary,
Within-Period Analysis (Chapter 8)
The idea for the analysis method described in chapter 8 came from the group
discussion during the development of the Trials Journal series described above.
Calum Davey and I were both keen to explore the idea of an analysis that only
includes the vertical comparisons.
The work and the ideas for this chapter were divided between myself and
Calum Davey. I led identifying the methods behind conducting a simulation
study and we both decided on the design of the simulation study. We both
looked for datasets to use as the basis for the simulation study, and I determ-
ined representation of the chosen data in terms of statistical distributions.
Coding the simulation studies was shared between us; I created a first draft of
the simulation study, whilst Calum Davey created a first draft of the code to
conduct the cluster-summary, within-period analysis, which we then combined
and finalised. The analysis and interpretation of results was divided between
us. I conducted the example analysis using the within-period analysis method
on a real SWT.
Calum Davey drafted a plan for the paper before I wrote the first draft.
Katherine Fielding, James Hargreaves, and Richard Hayes provided guidance
throughout this process and suggested edits to the text.
1.6.5 Novel Work Creating a Stata Command (Chapter 9)
I developed the idea to create a Stata command to facilitate the use of permuta-
tion tests for SWTs. Katherine Fielding, James Hargreaves, Richard Hayes
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and Calum Davey contributed ideas for functionality for the command. I then
coded the command and conducted the majority of testing. The command
was also tested by Calum Davey, James Hargreaves, and Katherine Fielding. I
wrote the first draft of the manuscript and all co-authors provided comments
on the text.
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2 Stepped-Wedge Trial Case
Studies
Throughout this thesis I will use three examples of stepped-wedge trials as
case studies. Two are completed SWTs, and one is a hypothetical SWT in a
real setting. In the four papers that make up the original contributions of my
thesis, these case studies are used as examples and as the basis of simulation
studies.
2.1 Deworming School Children Trial
In 1998 a group of researchers used an SWT to explore the impact of deworming
school children on their school attendance.
Helminths are a type of parasitic worm that includes roundworm, hookworm,
and whipworm. Helminth infections are very common, and it is estimated
that, in 2017, 1.5 billion people (24% of the worlds population) are infected
[1]. Prevalence of infection are particularly high in deprived areas with poor
sanitation [1]. In the Busia district of Kenya, where this trial was conducted,
over 90% of school children were infected with a Helminth infection in 1998
[2].
With such high prevalence of infection, an intervention to treat infections,
and so prevent onward transmission, is appealing. To this end, the World
Health Organisation (WHO) recommend periodic deworming treatment of all
at-risk people living in areas with a prevalence above 20% [1], and school based
deworming programs are now common place [3].
Whilst it is generally accepted that the use of deworming drugs and improv-
ing hygiene practices can induce a large reduction in the number of helminth
infections [4], the secondary impacts of such programs are debated. In partic-
ular, some researchers claim that these programs increase school attendance
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in children [5], but a recent Cochrane review has concluded that the evidence
is lacking [3].
In Chapter 6 of this thesis, I use data from one of the most highly cited
deworming trials investigating the impact on school attendance [6].
In 1998 and 1999, trialists ran a quasi-randomised SWT to explore the effect
of a deworming intervention on school attendance [5]. The intervention they
tested was administration of deworming drugs annually to all eligible children
in participating schools along with education on how to prevent infection, such
as hand-washing advice and advising children to wear shoes. 75 schools in the
Busia district of Kenya were quasi-randomised into 3 sequences. Schools in the
first sequence received the deworming intervention in both years, schools in the
second sequence received the intervention only in the second year, and schools
in the third sequence did not receive the deworming intervention in either year
(Figure 2.1). This is described as quasi-randomised because the allocation of
schools to sequences was determined by a list sorted alphabetically by area,
then by school size. The first school in the list was allocated to sequence 1,
the second to sequence 2, and so on down the list. While this approach has
potential limitations [7], for the purpose of this thesis I will treat the trial as
though it was randomised.
This is an example of an SWT that does not have periods before or after
rollout.
Figure 2.1: Schematic of deworming trial design
Many outcomes were collected for children enrolled at these schools, but I
will focus on school attendance. This was measured by field workers making
unannounced visits to schools: school were observed for an average of 3.8 visits
in each year. Some characteristics of the clusters, pupils, and observations are
given in Table 2.1. A median of 393 (interquartile range (IQR) 259-528) pupils
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were observed in each school across the 2 years with a median of 8 (IQR 6-9)
observations per pupil. 14328/27596 (52%) of pupils were male with a median
age of 12 (IQR 10-14) at their first observation.
Table 2.1: Deworming trial school and pupil characteristics by randomised
sequence
Sequence 1 Sequence 2 Sequence 3 Total
School level characteristics
Number of schools 25 25 25 75
Median pupils
observed per school
(IQR)
393 (281-501) 370 (380-525) 396 (247-528) 393 (259-528)
Median observations
per school (IQR)
2866
(1952-3680)
2640
(1812-3866)
2743
(1770-3375)
2743
(1774-3727)
Pupil level characteristics
Number of pupils 10,319 10,397 9,786 30,502
Median observations
per pupil (IQR)
8 (5-9) 8 (6-9) 8 (5-9) 8 (6-9)
Sex
Female 4648 (45%) 4708 (45%) 3912 (40%) 13268 (44%)
Male 5256 (51%) 4838 (47%) 4238 (43%) 14328 (47%)
Missing 415 (4%) 851 (8%) 1640 (17%) 2906 (10%)
Median age (IQR),
years
12 (10-14) 12 (9-14) 13 (10-14) 12 (10-14)
Initial Standard N (%)
0-1 2521 (24%) 2863 (28%) 2448 (25%) 7832 (26%)
2-3 2636 (26%) 2703 (26%) 2475 (25%) 7814 (26%)
4-5 2333 (23%) 2049 (20%) 2132 (22%) 6514 (21%)
6-8 2400 (23%) 2177 (21%) 2162 (22%) 6739 (22%)
Not known 429 (4%) 605 (6%) 569 (6%) 1603 (5%)
The mean and standard deviation of attendance for schools by year and ran-
domisation sequence is shown in Figure 2.2. The capped bars span one stand-
ard deviation either side of the mean school attendance. Sequence 1, which
received the intervention in both years, had slightly higher attendance than
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sequence 3, which did not receive the intervention in either year. All schools
experienced a decrease in attendance between the two years, but there does
appear to be a smaller decrease for sequence two, the sequence that switched
from the the control condition to the intervention condition. The variability
between the attendance at different schools is large relative to the difference
between sequences, and it is larger in the first year than the second year.
Figure 2.2: Graph of mean ± standard deviation of school attendance in each
year, by randomised sequence
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Overall, the original trialist concluded that the deworming interventions in-
creased school attendance by 5.1% (95% CI 0.8%, 9.4%; p=0.02) [5]. However,
a recent replication of this trial analysis identified several errors that led to
the result above changing to an increase in school attendance of 5.7% (95% CI
3.0%, 8.4%;p<0.001) [8].
The partner paper to this replication, a reanalysis of the data, identified an
intriguing result [9]. This reanalysis showed that, when analysed with both
years’ data combined into one model and adjusting for period effects, there was
strong evidence that the deworming intervention improved school attendance:
in an adjusted analysis, odds ratio (OR)=1.82 (95% CI 1.74, 1.91; p<0.001).
One would expect the effect estimate from this overall analysis to be between
the estimates from the two individual years. But, analysing each year separ-
ately with the same analysis model (excluding the time effect because we are
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stratifying by time) gave estimates in both years that were smaller than this
overall estimate: in 1998 OR=1.48 (0.88, 2.52; p=0.15) and in 1999 OR=1.23
(1.01, 1.51; p=0.04).
This counter-intuitive result motivated the research in Chapter 7. I conduct
a simulation study mimicking this trial and reanalyse the trial using different
analysis models. In line with the reanalysis of this trial [9], I will ignore
clustering within pupils and analyse the trial as though different pupils were
observed at each visit.
2.2 Tuberculosis Diagnostic Test Trial
The second case-study I will use in this thesis is an SWT conducted in Brazil
that investigated the effect of different diagnostic tests for tuberculosis (TB)
on the patient’s outcome and whether their TB diagnosis was bacterially con-
firmed [10].
WHO estimated a TB incidence in Brazil of between 72 and 97 TB notifications
per 1,000 person-years in 2015, putting Brazil in the top 20 countries with the
highest burden of TB [11]. Treatment success rate is below the global average,
despite high rates of TB treatment, and it is hypothesised that early diagnosis
of TB and detection of drug resistance could contribute to ending the country’s
TB epidemic [11].
The standard diagnostic test for TB, sputum smear-microscopy, is quick and
cheap, but it has low sensitivity, particularly in patients with human immun-
odeficiency virus (HIV) [12]. Because of this, many patients are diagnosed
with TB based on clinical symptoms alone, even if their test comes back neg-
ative [12]. A new TB diagnostic test (Xpert MTB/RIF) is known to be more
sensitive than the standard smear-microscopy method of diagnosis, and it also
provides a result for rifampicin drug resistance at the time of diagnosis [13].
Whilst the accuracy of the new diagnostic test is well established [13], the
impact of this on patient outcomes is not so clear. Several studies have found
increases in bacterial confirmation of TB, but this has had little impact on
patient outcomes [14, 15].
My second case study is an SWT in Brazil that ran in 2012 looking at this
issue.
In 2012 as part of a pilot rollout of the Xpert test in Brazil, this trial team
used an SWT to explore the impact of switching from smear microscopy to
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the Xpert test [16]. The trial enrolled 14 laboratories covering most diagnoses
in the cities of Rio de Janeiro and Manaus in Brazil. At the initiation of the
study, all laboratories were using sputum smear microscopy to diagnose TB.
Following a month of baseline data collection, the Xpert diagnostic test was
rolled out to two laboratories at random each month, so that 7 months later
all laboratories were using the Xpert diagnostic test (figure 2.3). The primary
outcomes were notification of cases to the national notification system and time
to treatment initiation [16]. A second paper (Trajman et al [10]) reported on
the secondary outcomes of (i) TB treatment outcomes and (ii) prevalence of
bacteriological confirmation of individuals diagnosed with TB.
Figure 2.3: Schematic of TB diagnosis trial design
Table 2.2 summarises the patient characteristics from individuals contributing
to the secondary outcomes. All patients who were diagnosed with TB during
the study in the participating laboratories were included in the study; a median
of 34 (IQR 21-45) patients per lab per study month. This gave a total of 3926
patients. 3148 (80%) patients were from Rio de Janeiro and more laboratories
in Rio de Janeiro switched to the Xpert test later in the trial, resulting in an
imbalance between the diagnostic tests. 2546 (65%) patients were male, most
were aged between 15 and 29 (2082, 53%) and were HIV negative (2126/2518,
84% of those with known status).
In this thesis, I focus on two secondary outcomes of the trial; patient outcomes
and bacterial confirmation of TB.
In Chapter 8, I use the impact of the diagnostic test on TB patient outcomes
as a case-study. For each patient diagnosed with TB during the study, their
TB-treatment outcome was collected 15-23 months after diagnosis. A patient’s
outcome was defined as favourable, meaning that they successfully completed
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Table 2.2: TB diagnostic trial patient characteristics by diagnostic test.
Taken from Trajman et al [10]
Sputum smear
microscopy
N(%)
Xpert
MTB/RIF
N(%)
Total
N(%)
Total 1777 2147 3924
City
Rio de
Janeiro
1618 (91%) 1528 (71%) 3146 (80%)
Manaus 159 (9%) 619 (29%) 778 (20%)
Male Sex 1140 (64%) 1405 (65%) 2545 (65%)
Age
<15 51 (3%) 40 (2%) 91 (2%)
15-29 929 (52%) 1153 (54%) 2082 (53%)
30-59 592 (33%) 697 (32%) 1289 (33%)
<60 205 (12%) 257 (12%) 462 (12%)
HIV status
Negative 975 (55%) 1151 (54%) 2126 (54%)
Positive 196 (11%) 195 (9%) 391 (10%)
Unknown 606 (34%) 801 (37%) 1407 (36%)
treatment without evidence of treatment failure, or unfavourable. An unfa-
vourable outcome included death from any cause and transfer to another clinic
(this included specialist clinics treating drug-resistant TB).
Trajman et al [10] reported that there was no evidence in this trial that the
Xpert diagnostic test reduced unfavourable patient outcome (OR=0.93 95% CI
0.79-1.08) . However, their analysis did not adjust for secular trends. Figure
2.4a shows the mean and standard deviation of the percentage of patients in
each laboratory with a favourable outcome in each study month. In most
study months, the percentage of patients with favourable outcomes is greater
for those diagnosed after their laboratory switched to the Xpert test , but the
difference appears small. There appears to be a small decrease over time in
the percentage with favourable outcomes.
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Figure 2.4: Graph of mean ± standard deviation of laboratory-level outcomes
in each study month by diagnostic test
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(a) Favourable patient outcomes
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(b) Bacterial confirmation of diagnosis
In Chapter 9, I use the impact of the diagnostic test on whether patients had
their TB diagnosis bacterially confirmed [10]. Each patient’s diagnosis was re-
corded as clinical, with either a negative test or no test done, or as bacterially
confirmed by the diagnostic test. Trajman et al [10] reported that, overall,
more patients diagnosed with the Xpert test had a bacterially confirmed dia-
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gnosis than those diagnosed using a sputum smear microscopy test (76.2% and
68.0% respectively). Figure 2.4b shows the mean and standard deviation of
the percentage of patients in each laboratory with a bacterially confirmed dia-
gnosis in each study month. The percentage of confirmed diagnoses is higher
in those diagnosed with an Xpert test in all study-months, and there are no
obvious secular trends in this outcome.
2.3 Hypothetical NHS Health-Check Trial
The final case study I will consider in this thesis is an observational dataset
from the National Health Service (NHS) in England [17]. This is an example
of a high-income setting where SWTs are commonly performed [18–20]. I will
create hypothetical trials based on this observational data for a simulation
study.
In England, the NHS offers health-checks to all adults aged 40-74 every five
years. The checks are carried out by general practices and third parties, and
they assess the patient’s risk of diabetes, heart disease, kidney disease, stroke,
and dementia [21]. The percentage of those eligible attending a health-check
increase from 5.8% between April 2009 and March 2010, to 30% between April
2012 and March 2013 [21].
Data on the uptake of health-checks are publicly available for each local author-
ity in each quarter [17]. For each local authority in England, in each quarter,
the number of patients eligible for the health-checks, offered a health-check,
and that accepted a health-check are given. Unlike the paper by Robson et al
[21], which reported the proportion of those eligible that receive a health-check,
I focused on the proportion of those offered a health-check that accepted the
offer. For this case study, I use data from January 2013 to December 2014.
Figure 2.5 shows the mean and standard deviation of the percentage of accept-
ance in each quarter. On average, 49% of patients in the first quarter of 2013
accepted the offer of a health-check; this increased to 54% in the last quarter.
At the start of 2014, this dropped to 46% before increasing to 56% in the last
quarter.
In Chapter 8, I simulate hypothetical trials that test an intervention aimed to
increase the acceptance of health-checks. Two SWT designs are considered;
in the first, local authorities are randomised to 3 sequences as shown in figure
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Figure 2.5: Graph of mean ± standard deviation of local authority level
proportion of NHS health-check acceptance over time.
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2.6a, and in the second, local authorities are randomised to 11 sequences as
shown in figure 2.6b.
Figure 2.6: Schematic of hypothetical NHS health-check SWTs
(a) 3 sequences (b) 11 sequences
2.4 Summary
In this chapter I have introduced the case studies that will be used throughout
this thesis. These case studies motivated the aims of this thesis, in particular
the counter intuitive results of the deworming trial. The designs used in these
case studies varied substantially; the deworming study and NHS hypothetical
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trials did not include periods outside rollout, while the TB diagnostic trial used
the standard design. The number of sequences varied from 3 to 11. However,
there are commonalities to these case studies; all three used binary outcomes.
This is common in SWTs more generally [19], and so will be the focus of this
PhD. I have not provided details of the analysis methods used in these case
studies, or whether these were appropriate in the setting, as this will be further
explored throughout this thesis.
In the next chapter, I will provide an overview of the literature on designing
and analysing SWTs to give a broader context for SWTs than these case studies
have been able to provide.
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3 Current Recommendations on
Design and Analysis
The literature on the methodology of SWTs is in its infancy, meaning that
many topics have yet to be explored. This is in part because SWTs cover a
large range of designs.
The first section of this chapter will introduce the breadth of designs covered
by the term “stepped-wedge trial”: the designs can vary in how clusters are
randomised and the rollout of the intervention, as well as how individuals
within clusters are observed, and in the effect of the intervention. Much of
this section is based on a series of articles that I was involved in at the start of
this PhD [1–6]. The series focused on a systematic review of SWTs published
between 1987 (when the first SWT was conducted) and 2010 [1]. My main
involvement was in exploring the designs used by the SWTs identified in the
review including issues with these designs [2], and the analyses they used high-
lighting key areas for consideration in analysis [3]. This first section primarily
focuses on the review of common designs.
The remaining sections describe the current state of the literature on SWTs.
Section 3.2 describes methodology literature on analysing SWTs, including
which methods are used in practice [3, 7–9]. Finally, section 3.3 details the
methodology literature on sample size calculations for SWTs and the implica-
tion this has for efficient trial design. These final two sections are focused on
literature identified through writing the papers in chapters 6 to 9.
3.1 The Breadth of Stepped-Wedge Trial Designs
An issue with SWT methodology is that the term covers a wide range of
designs (figure 3.1). The systematic review, which I co-authored at the start
of this PhD explored this variation [2]. In this section I will highlight the
considerations relevant to this thesis.
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There are many ways in which clusters can be randomised, for example, the
number of sequences can vary, and the time between switch-points can vary
between trials. Even once the randomisation and allocation of the intervention
has been determined, there is variability in how observations are made of the
individuals. Many of these variations exist in other cluster randomised trial
designs, but the impact is more important in SWTs because of the confounding
of the intervention effect with time. This section will describe the range of
designs possible, the impact of such design choices, and the focus of this PhD.
3.1.1 Cluster-Level Designs
The most commonly used design, which I will refer to as the standard design,
includes a period before rollout and a period after rollout (figure 1.1). The
periods of the trial are all of equal size with the same number of observations
in each, and there are the same number of clusters in each sequence. System-
atic reviews have shown that most SWTs have a median of 17 clusters [1, 7],
randomised to a median of 4 sequences (IQR 2 - 6) [1, 7, 8].
Other SWT designs include longer periods before or after rollout (figure 3.1a)
[10], and others have excluded the periods before and after rollout altogether
(figure 3.1b) [11]. Martin et al [7] found approximately 34% of SWTs included
extended periods before or after rollout.
In non-standard SWT designs, the number of observations in each period or
in each cluster may vary. Usually, this is because the number is not controlled
by the trialist, such as in the TB diagnostic case-study described in chapter 2
where the number of observations in each period was determined by the number
of patients diagnosed with TB in each laboratory and not by the trialists. This
meant that the number varied, both between periods and between laboratories.
Few studies report that their cluster size varied, but this may be due to poor
reporting rather than low prevalence of such designs [7].
In incomplete designs, there are some periods where no observations are col-
lected. Reasons to use incomplete designs include not collecting observations
in the period immediately following a cluster switching to the intervention to
allow time for the cluster to transition (figure 3.1c) [12], or improving the effi-
ciency of the design by optimising when observations are collected [13]. These
designs are unusual in practice [7].
Another way SWTs can vary is in how they allocate clusters to sequences.
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Figure 3.1: Schematics of modified stepped-wedge trials
(a) Schematic of a modified SWT with a
longer period after rollout
(b) Schematic of a modified SWT with no
observations before or after rollout
(c) Schematic of an incomplete SWT.
A white background represents periods
where no observations are made. Indi-
viduals may or may not be exposed.
(d) Schematic of SWT with an unequal
allocation of clusters to sequences (Hy-
brid design)
Rather than uniform allocation, SWTs can be designed to have more clusters
randomised to some sequences than to others. An example of such a design is
called a Hybrid design (figure 3.1d) [14]. This is an SWT with no observations
before or after rollout and with the first and final periods half the size of the
remaining periods. The number of clusters randomised to the sequences that
remain in the control or intervention for the duration of the trial is allowed
to differ to the number of clusters randomised to the other sequences of the
design. This is often described as a combination of an SWT and a CRT,
where some proportion of the clusters are randomised to an SWT with the
periods before and after rollout half the size of the remaining periods, and the
remaining clusters randomised to a CRT. To my knowledge, this design has
not yet been implemented in practice.
Because the range of SWT designs is so large, I limited the scope of designs
considered in this thesis. This thesis will only consider complete SWTs with
uniform allocation of clusters to sequences. However, I will consider designs
with no observations outside rollout as well as designs with periods before and
after rollout. SWTs comparing more than one intervention condition have also
been suggested [15, 16], but I will only consider designs with a control and
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one intervention condition. In Chapter 6, I have assumed an equal number of
observations in each cluster in each period, but in Chapters 7-9, the number
of observations varies between periods and clusters.
3.1.2 Participants and Observations
In a cluster randomised trial, each cluster consists of a population of parti-
cipants. How those participants are exposed, sampled and observed will vary
from trial to trial. In this section, I will discuss how participant sampling and
observation can vary and why this is particularly important in SWTs. Lastly,
I will describe the types of sampling and observation that this PhD will focus
on.
The data type of observations collected has implications for the analysis. The
most common are continuous outcomes such as a test score, binary outcomes
such as school attendance, and rate or time-to-event outcomes such as time to
infection [7]. The most common type for SWTs is binary [7].
SWTs require that observations of the clusters are collected during each period
of the trial (or most periods for an incomplete design). These could either be
collected from the same individuals observed multiple times during the study
(a cohort design), or from different individuals each observed only once during
the study (a repeated cross-sectional design) [17].
These two broad categories can be further refined.
Cohort designs can be divided into open and closed cohorts [2]. This distinction
is usually determined by the study setting and not by the trialist.
In a closed cohort, individuals are sampled at the start of the trial and observed
multiple time through to the end of the trial: once the sample has been selected,
no one can join it (figure 3.2a). An example is a year-long trial of the effect of
free school breakfasts on school attendance [18]. In this study, children that
joined the participating schools during the study did not have their attendance
monitored so did not join the study cohort (but were still able to receive free
school breakfasts). Only a few children were lost to follow up, so the same
children were observed in each period.
In an open cohort, participants are able to join the sample during the trial
(figure 3.2b). For example, a trial of preventive TB therapy given to people
living with HIV and attending an HIV clinic [19]. In this study, clinic patients
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joined the study when they visited the clinic and left at their final visit during
the study: this meant that the study sample changed throughout the trial. In
both types of cohort design, some individuals may leave the sample during the
study, but this would be more common in an open cohort.
Similarly, repeated cross-sectional designs can be classified based on the pop-
ulations from which the cross-sectional samples are taken: again, this will
usually be determined by the setting and not by the trialist.
In some trials, the population is largely closed to migration into and out of the
cluster and so cross-sections are from the same population of individuals in
each period (figure 3.2c). An example of repeated cross-sectional samples of a
closed population is a trial which sent postal surveys to a sample of members of
the clusters in each period of the trial, so that different residents were observed
in each period [20].
Alternatively, some populations have larger levels of migration into and out
of the cluster and so the cross-sections are from a different population of in-
dividuals in each period (figure 3.2d). An example is sampling women in a
maternity ward over a 10 month trial [21].
Figure 3.2: Diagram of trial participant exposure and observation. Back-
ground: light is control condition, darker is intervention condition. Dashed
lines represent the time a participant is exposed. Dots represent observations
of individuals
(a) Closed cohort (b) Open cohort
(c) Cross-sectional sample from
closed population
(d) Cross-sectional sample from open
population
There has been disagreement about how common each type of design is; most
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reviews have found that between 35% and 55% use cross-sectional designs [1,
8, 9], but one review only identified 16% as cross-sectional designs [7].
Whilst these forms of sampling and observation are present in all cluster ran-
domised trials, the distinction is particularly important in an SWT because of
the confounding of the intervention effect with time and because clusters are
exposed to both conditions.
Confounding with time means that changes to the sample over time could
bias the intervention effect estimate if confounding factors become imbalanced
between the control and intervention conditions [2]. In a cohort design, this
could be caused by non-random attrition of the sample. Conversely, samples
taken from a largely closed population, with few individuals joining or leaving
the clusters during the trial, are likely to be similar at the start and end of the
trial.
In trials conducted in closed populations where individuals are exposed to
both the control and intervention condition, the intervention effect could be
confounded with changes in the individuals’ health [2]. An example is a trial
aiming to improve diabetes control of a cohort of patients [22]; patients who
receive the intervention later in the trial may have been in a worse state of dia-
betes control at the time they switch than those that received the intervention
earlier, which could alter the effect of the intervention.
In this thesis, I focus on repeated cross-sectional sampling, in both open and
closed populations, because these designs are more common and are simpler
to analyse as there is only one level of clustering to account for in the analysis.
Throughout this thesis, I allow for secular trends in the outcome, but assume
that there are no other confounding factors and that changes in the clusters’
populations do not affect the intervention effect.
3.1.3 The Intervention Effect
The final aspect of trials design that is particularly important in SWTs is the
intervention effect and whether it changes over time or between clusters.
The aim of RCTs is to estimate the effect of an intervention. In most RCTs, the
outcomes under each condition are compared after a fixed amount of time and
exposure to the intervention. For example, a trial in Scotland studied the im-
pact of an education programme on sexual activity [23]. The trial randomised
25 secondary schools to either receive the programme or not and measured the
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outcome in a cohort of pupils that were surveyed 2 years after the trial began.
In most SWTs, this is not the case; instead, observations are collected with
different lengths of exposure to the intervention. Because of this, assumptions
have to be made about how the intervention effect is expected to change over
time.
One way in which the intervention effect may change over time is if there is a
lag to its effectiveness after the clusters switch, similar to the concept of carry
over in a crossover trial [2]. This could either be a lag in implementing the
intervention, or it could be that some time is needed after implementation for
it to have an effect. Trials where individuals are exposed to both control and
intervention conditions are more likely to be affected [2].
The second way in which the intervention effect may change is if the effect
wanes after some period of time. Some interventions, such as a vaccine, have
long lasting effects after an individual is exposed. Other interventions, such as
educational interventions, require ongoing exposure to have an effect and so
the effect is more likely to wane with time since exposure.
Settings where waning of the intervention effect is not an issue allow for designs
where individuals are only exposed for a short period of time [2]. Observation
of an individual can occur some time after exposure as long as the individuals
are no longer subject to the clusters’ exposure. An examples of such a design
is the Gambia trial [24] that is measuring the effect of a hepatitis vaccine (the
intervention) on incidence of liver disease in the 40 years following childhood
vaccination. Such designs appear very different to designs where individuals
are constantly exposed within the cluster and are observed within the time
frame of the intervention rollout, but in terms of analysis they are similar.
Alternatively, in setting where the effect of the intervention is only temporary,
i.e. the effect will wane very quickly, SWTs can explore the removal of an in-
tervention, with clusters moving from the intervention condition to the control
condition [25].
Lastly, the intervention may have a differing effect in each cluster. This could
be a result of differences in the clusters, leading to a greater or smaller sus-
ceptibility to the intervention, or in the implementation of the intervention.
This phenomenon has been noted in CRTs [26, 27], and it is more likely in
SWTs where the intervention is implemented at different calendar times in
each sequence of clusters [4]. This is separate to confounding of the inter-
vention effect with secular trends, which affect the control and intervention
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observation equally.
Careful consideration of the trial design can safeguard against some of these
issues. Longer periods give more time for the intervention to become effective,
but may result in a lengthier trial and so a higher chance of a waning effect [2].
The use of incomplete designs, where no observations are collected in the period
after a cluster switches, are a solution to lag. Differential intervention effects
can be controlled to some extent through a carefully designed intervention
defined by a strict protocol, although this will not be appropriate in every
setting [4].
In the remainder of this thesis, I will not consider the complexities of lag or
waning intervention effects and will instead focus on a simple case that assumes
that the intervention is fully realised immediately after implementation, and
remains the same throughout the trial. This is a common assumption in both
methodology papers and trial analysis [8]. The implications of this simplifica-
tion will be explored in the discussion. I will however explore the impact on
analysis of the intervention effect varying between clusters.
3.2 Analysis Methods
In this section I will describe the current literature on the analysis of SWTs.
In the simple case of cross-sectional designs, the analysis must consider two
main issues beyond those of other RCTs: secular trends and clustering.
In Chapter 1, I introduced the concepts of vertical and horizontal comparisons
[3, 28]. To date, the majority of analysis methods discussed in the literature
have incorporated both types of comparisons. This gives maximum power to
detect an effect, but inclusion of the horizontal comparisons means that period
effects and correlations over time must be appropriately considered.
Clustering can be accounted for in cluster randomised trials through mixed-
effect modelling, generalised estimating equations (GEE), or by analysing at
the level of the cluster [17].
Most literature for SWTs has focused on mixed-effect models, but some liter-
ature has described using GEE. Analysing at the cluster level has been less
extensively explored for SWTs. In subsection 3.2.2, I will detail the most
commonly used analysis model for SWTs and problems with this model. In
57
Chapter 3. Current Recommendations on Design and Analysis
subsections 3.2.3 and 3.2.4 I will describe modifications that have been sugges-
ted for this analysis model. Subsections 3.2.5 and 3.2.6 describe the literature
on GEE and cluster level analysis respectively. Subsection 3.2.7 described the
current literature on analyses that only utilise vertical comparisons to avoid
confounding the intervention with time. Subsection 3.2.8 will describe the ease
of implementation of all the discussed methods in commonly used software. I
have focused on literature relating to robust estimation of a singular interven-
tion effect. There are several other areas of methodological research that I
have not detailed, such as group-sequential designs [29], estimating complier
average causal effects [30], and analysis methods for trials with more than one
intervention [16].
3.2.1 Properties of Analysis Methods
Before describing the analysis methods used for SWT, I will first describe the
characteristics of an analysis which are desirable.
First, the analysis method should provide an unbiased estimate of the para-
meter of interest. That is
E
(
θˆ
)
= θA
Second, the analysis method should provide standard error estimates that
appropriately reflect the uncertainty around the estimate. This can be seen
through the confidence interval coverage and the type-one error rate.
A 95% confidence interval is defined as an interval which we would expect to
contain the true effect in 95% of repetitions of a study [31]. Therefore, we
would expect 95% of the simulated confidence intervals to contain the true
parameter effect. When this is not the case, either the parameter estimates
are biased, the parameter standard-errors are biased, or the test statistic is
being compared to an inappropriate distribution.
The type-one error rate is related to this: it is defined as the probability of a
p − value < α when the parameter effect is truly null and is 1 - the coverage
of (1− α) % confidence intervals when the parameter is simulated to have no
effect [31]. It is common to use α = 0.05.
Lastly, the analysis method should be efficient. From a choice of unbiased
estimates, the one with the smallest standard error will be preferred. The
power of the method is one way to assess the efficiency of an analysis method.
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The power is the probability of detecting an effect with p < α when there is
truly an effect present [31].
In the rest of this section I will describe the literature comparing these prop-
erties for different analysis methods for SWTs.
3.2.2 Hussey and Hughes Model
In their simplest form, mixed-effect models account for clustering by partition-
ing the error term into a cluster-level error and a within-cluster error by giving
each cluster its own intercept term and assuming that these follow a normal
distribution [17]. The error structure can be extended to account for more com-
plex correlations within the data by, for example, introducing random slopes
for covariates in the data. In general, mixed-effect models have been found to
be sensitive to the correlation structure being correctly specified [32].
Hussey and Hughes published the first paper describing the analysis of SWTs
[33]. This model is now widely used [3, 8] and is the basis of the first design
effect for an SWT (see section 3.3). They suggested using the following linear
mixed-effect model (LMM) for continuous outcomes, herein referred to as the
Hussey and Hughes model, or the standard model:
yijk = µ+ βj + θXij + ui + eijk (3.1)
where yijk is the outcome in cluster i = 1, ..., I, in period j = 1, ..., J , for
individual k = 1, ..., K, βj is a period effect comparing period j to the first
period with β1 = 0, θ is the intervention effect, Xij is 1 if cluster i received
the intervention in period j and 0 otherwise, ui ∼ N (0, σ2u) is a random effect
for cluster, and eijk ∼ N (0, σ2e) is the within-cluster, individual-level error and
σ2u + σ2e = σ2.
This can be extended to binary and count outcomes through generalised linear
mixed-effect models (GLMM). With a binary outcome and a logit link, this res-
ults in the model estimating cluster-specific estimates, not population-average
estimates [34].
The model includes a random effect for cluster to account for the correlation
of observations in the same cluster. It incorporates horizontal and vertical
comparisons [28, 35].
The horizontal comparisons are adjusted for secular trends (period effects) by
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the inclusion of a fixed, categorical variable for period. This leads to strong as-
sumptions about the correlation structure of the data. Because time is treated
as a fixed effect, the same change over time is assumed for all clusters and
all observations within a cluster are assumed to be equally correlated whether
they are from the same period or different periods (this is also known as ex-
changeability within clusters). The intervention effect is also assumed to be
common to all clusters, which again means that observations within a cluster
are equally correlated regardless of whether they are from the same or differ-
ent conditions. Although Hussey and Hughes suggest using this model, their
paper gives no limitations in the appropriate use of the model.
Matthews and Forbes [28] provide a greater insight into how this analysis
model estimates an intervention effect. The analysis model takes a weighted
average of the vertical and horizontal comparisons, with weights depending
on the cluster-mean correlation. The model gives a different weight to each
cluster-period cell of the trial, with some cluster-periods contributing very little
to the analysis.
At the start of this PhD in 2014, there was very little literature assessing
whether this widely used analysis model was appropriate, given the known
sensitivity of mixed-effect models to misspecified random effects [36]. In the
paper I co-authored with Davey et al [3], we highlighted the importance of
ensuring that there was adequate adjustment of period effects, and questioned
whether a fixed categorical variable would be sufficient in all situations.
In 2015, the Ebola outbreak gave rise to the need for pragmatic, efficient trials
to assess the efficacy of new vaccines developed in response to the outbreak.
Several groups gave strong consideration to using an SWT, but none selected
the SWT design [37, 38], and some expressed concerns about the use of SWTs
in this setting [39, 40]. Bellan et al [40] performed a simulation study to cal-
culate the power and type-one error rate of several trial designs in a simulated
Ebola vaccine trial in Sierra Leone. They found that analysis using a Cox
model with frailty resulted in inflated type-one error. This was because of
the spatial temporal trends in the outcome seen in this pandemic setting [40]:
the incidence of Ebola changed differently over time in each district because
infections spread from one place to another, violating the assumption of a com-
mon period effect. Conversely, they saw <5% bias in the intervention effect
estimate. However, a pandemic setting is not representative of the settings
that usually use SWTs, which may have less variability in the secular trends
between clusters.
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More recently, two papers have assessed this issue in other settings. Ji et al
[41] and Wang and DeGruttola [42] both assessed the results of the model 3.1
in a more common setting when the period effect varied between the clusters
through simulation studies. They found that model 3.1 gave inflated type-one
error rates when the period effects varied between the clusters [41, 42].
Even when the assumptions of this model are met, mixed-effect models are
known to to have inflated type-one error rates when the number of clusters
is small unless small sample corrections are used [43]. This has started to be
explored for SWTs; Barker et al [44] found that model 3.1 has inflated type-one
errors when used with six or fewer clusters, and Zhan et al [45] found biased
cluster-level variance estimates with a total of 11 clusters using a Poisson
GLMM.
Despite these warning, many trialists continue to pay little attention to the
period effects in their analyses with at most fixed effects for periods included
in their analysis model [8]. Alternative analysis methods are needed that
maintain an appropriate type-one error rate in the presence of period effects
that differ between clusters.
In light of these findings several adaptations of this model have been con-
sidered, but none are commonly used [8]. The next two subsections will outline
suggested adaptations to model 3.1.
3.2.3 Non-Parametric Methods
Since research to date has found that the intervention effect estimate from
model 3.1 is unbiased [40–42], and only the type-one error is affected, several
authors have suggested the use of non-parametric inference with the interven-
tion effect estimate from model 3.1 [40–42]. Two such non-parametric methods
are bootstraps and permutation tests.
Bootstraps
Bootstrapping is where p-values and confidence intervals are calculated by
repeatedly resampling with replacement from the observed data. The observed
data are taken to be representative of the population from which they are
sampled. By resampling from the observed data with replacement, one obtains
a different sample that remains representative of the population. Repeating
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this process many times will give a distribution of the intervention effect in
the population [46].
To account for clustering in cluster randomised trials when using the bootstrap,
the clusters are resampled. A second stage of resampling individuals within
clusters has been shown to improve the confidence interval coverage with a
small number of clusters [47].
Bellan et al [40] assessed the use of bootstraps with the Cox model in SWTs.
Although bootstraps are widely thought to give very robust inference [46],
Bellan et al [40] found that this method gave inflated type-one error; the
authors conclude that this is because they only had 20 clusters in the simulation
study. Bootstraps rely on asymptotic theory so require a sufficiently large
sample to maintain favourable properties [46]. Most SWTs have fewer than 20
clusters [1, 7], so this prevents bootstraps being widely useful to correct the
type-one error rate of model 3.1 unless refined methods are identified.
Permutation tests
A permutation test works on the premise that if the intervention has no effect
on the outcome, the assignment of observations to control and intervention is
arbitrary. For any assignment of observations to control and intervention, we
can calculate an intervention effect. If we repeat this many times, each time
collecting the intervention effect for that assignment, this gives a distribution
of the intervention effect under a null hypothesis that the intervention has no
effect. The proportion of assignments that gave an intervention effect the same
or more extreme than the observed intervention effect is the p-value.
The permutation test only requires that two conditions hold: exchangeability
of observations, and a strong null hypothesis [46].
Exchangeability means that any assignment of the observations to control or
intervention in equally likely. For SWTs, this means that assignment of clusters
to sequences should be permuted (reassigned), rather than simply permuting
the individual observations.
A strong null hypothesis tests that the intervention has no effect on any ob-
servations, as opposed to a weak hypothesis that tests that there is no effect
on average. This means that the intervention effect cannot vary within, or
between the clusters, which also implies that observations must be equally
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correlated regardless of whether they were from the control or intervention
condition, as is assumed by model 3.1.
Whilst sensitivity of permutation tests to the strong null hypothesis assump-
tion has not been assessed for SWTs, Gail et al [48] found that permutation
tests tends to be relatively robust under a weak null hypothesis unless there is
an imbalance in the number of clusters in each arm and the smaller arm has a
larger variance.
Several authors [40–42] have suggested the use of permutation tests with model
3.1 and found that this gave a correct type-one error rate in the scenarios they
considered.
3.2.4 Other Mixed-Effect Models
Whilst some researchers have investigated non-parametric inference, others
have considered parametric modifications to model 3.1. Hemming et al [49]
gives an overview of many of these modifications. Here, all models are writ-
ten as LMM, but can be extended to GLMM for non-normally distributed
outcomes.
Fixed period effects that vary within strata
Hemming et al [49] suggest fitting different period effects within some strata
of clusters. This relaxed the assumption of a common period effect, but still
requires that the period effects are common to all clusters within the defined
strata. This model would also still assume exchangeability of observations
within clusters. Moreover, identification of appropriate strata would be diffi-
cult it practice.
A Cluster-period interaction model
Several authors have suggested including a random effect for a cluster-period
interaction will relax the assumptions of a common period-effect and exchange-
ability of observations within clusters [12, 14, 35, 49, 50]. The suggested model
is as follows, herein referred to as the cluster-period interaction model:
yijk = µ+ βj + θXij + ui + qij + eijk (3.2)
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where ui ∼ N (0, σ2u), qij ∼ N
(
0, σ2q
)
is a random-effect for each cluster-
period, and eijk ∼ N (0, σ2e). The random effects are independent. In this
model, observations in different periods are less correlated than observations
in the same period and period effects are allowed to vary between clusters. The
total variance is fixed to be the same in all periods of the trial. The ICC is
now the correlation of two observations in the same cluster in the same period:
ρ∗ =
σ2u + σ2q
σ2u + σ2q + σ2e
and the cluster-level autocorrelation, describing the correlation between obser-
vations in the same cluster but different periods, is:
pi = σ
2
u
σ2u + σ2q
The cluster-level autocorrelation is the same for all pairs of periods, regardless
of whether they are close in time to one another, or further apart.
The model has also been extended to allow for cohort designs [14, 50]:
yijk = µ+ βj + θXij + ui + qij + dik + eijk (3.3)
where dik ∼ N (0, σ2d) is a random effect for individuals, and now eijk is a
random effect for an individual in a specific period.
Despite several papers suggesting this model [14, 35, 49, 50], no literature has
assessed whether it had better properties than model 3.1 for SWTs.
While there is a lack of advice available on whether a random effect for a
cluster-period is necessary or sufficient for the analysis of SWTs, there is a
more definitive answer for a CRXO, and a CRT with baseline observations.
For these trial designs, mixed-effect models should include a random effect for
cluster-period interactions, as well as for clusters [51, 52]. Turner et al [51]
and Morgan et al [52] ran simulation studies comparing analysis methods for
a CRXO. Morgan et al [52] directly compared model 3.1 and model 3.2, and
found that model 3.2 had a type-one error rate closer to 5% than model 3.1.
Despite advice from the the methodological literature, uptake of of the cluster-
period interaction model is poor for CRXO designs [53]. In the field of CRTs
with baseline observations, similar results have been found: Ukoumunne and
Thompson [27] found that a model similar to model 3.1 gave invalid results.
However, these designs only have 2 periods. SWTs can have many more periods
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than this, and it may be unrealistic to assume the same correlation between
all periods.
Random-period model
An alternative parameterisation fits a random effect for each period, herein
referred to as the random-period model:
yijk = µ+ βj + vij + θXij + ui + eijk (3.4)
where vij ∼ MVN (0, Λv) where Λv is a (J − 1) × (J − 1) covariance matrix
with Λv11 = 0, and vij and ui may be correlated. This is modified from a
version given by Heuvel et al [54], which treated the period effect as linear.
This is a very flexible model that allows the total variability to change in each
period, and allows the cluster-level autocorrelation to be different for each
pair of periods. However, this model will grow in complexity as the number of
periods increases, unless a linear period effect is assumed.
Heuvel et al [54] assessed this model in a simulation study, and found slightly
inflated type-one error. But, the simulation study used a specific scenario with
a small sample and assumed a linear time effect, so the results are not easily
generalisable.
Intervention effect lag and wane
Heuvel et al [54] also suggested a model that allowed the intervention effect to
increase with time in the intervention:
yijk = µ+ βtj + θXij (tj − Si) + ui + eijk (3.5)
where tj is the time from the first period to period j, Si is the time at which
cluster i switched to the intervention. The period effect is treated as con-
tinuous, and the intervention effect is assumed to increase with time in the
intervention. This is one way of dealing with the lag in the intervention dis-
cussed in section 3.1.3. A more flexible approach to modelling change to the
intervention over time, would be to have an interaction term between the in-
tervention effect and time since switch [3]:
yijk = µ+ βtj + θXij + θ
′
Xij (tj − Si) + ui + eijk
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This model now allows the intervention effect to increase or decrease with
time in the intervention, allowing for a waning of effect over time, in which
case θ′ would be negative, or an increase in the intervention with time in the
intervention, in which case θ′ would be positive. Hemming et al [49] suggest a
similar model with an interaction with period to allow the intervention effect
to vary between the periods.
Another option is to treat the intervention effect as fractional, so that in the
first period after the intervention is rolled out the intervention is assumed to
be at half efficacy and for all later periods it is at full efficacy [33], or excluding
observations from the period following a cluster switching to the intervention.
However, the intervention effect estimate might be sensitive to the proportion
of efficacy assigned to each period and this is difficult to know in advance. In
addition, excluding observations is inefficient.
Other fixed-effect parameterisations can be used to explore different aspects
of the intervention effect [49, 55].
Fixed intervention effects that vary within strata
Hemming et al [49] suggest modelling different intervention effects within spe-
cified strata of clusters. This relaxes the assumption of model 3.1 of a common
intervention effect, but continues to assume equal correlation of observations
with clusters. In addition, it may be difficult in it practice to identify strata
where the intervention effect is likely to differ. This may be useful as a sens-
itivity analysis, but may have limited use as a primary, prespecified analysis.
Random-intervention model
All analysis methods mentioned so far have assumed that the intervention effect
is common to all clusters and that observations are exchangeable between the
control and intervention conditions. An alternative model that allows the
intervention effect to vary between clusters, herein referred to as the random-
intervention model is:
yijk = µ+ βj + (θ + zi)Xij + ui + eijk (3.6)
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where zi ∼ N (0, σ2z) and zi and ui may be correlated [56]. This is a repara-
meterisation of the model suggested by Hemming et al [49]:
yijk = µ+ βj + θXij + u∗0iXij + u∗1i (1−Xij) + eijk
where u0i ∼ N
(
0, σ2u0
)
and u1i ∼ N
(
0, σ2u1
)
are random effects for clusters
while in the control and intervention conditions respectively, which may be
correlated.
In CRTs, ignoring variability in the intervention effect between clusters has
been shown to bias the intervention effect estimate and underestimate the
effect’s standard error [57].
Robust variance and fixed cluster effects
Other modifications to model 3.1 include using a robust variance estimate, and
treating cluster effects as fixed. Hussey and Hughes suggested using the jack-
knife variance estimator with their analysis [33]. Moulton et al [58] suggested
using a robust variance estimator with the Cox model instead of a random
effect for cluster: since the Cox model conditions on time, this model should
only incorporate vertical comparisons.
It should also be possible to account for clustering using fixed effects rather
than random effects because the intervention effect can be estimated within
clusters (as horizontal comparisons). This has performed well in literature to
date in terms of estimating an intervention effect and producing valid confid-
ence intervals [44]. However, this method implies that the clusters included
in the study are the only clusters relevant to the research question, and so
estimates the intervention effect with greater precision than is appropriate for
generalising the intervention effect to a larger population of clusters [59].
3.2.5 Generalised Estimating Equations
Models that utilise GEE calculate the mean effect of the covariates across all
individuals, also known as the population-average effects, treating the correl-
ation structure of the data as nuisance parameters. GEE have been shown to
be robust to misspecification of the correlation structure [60], although this
has not been assessed in the context of SWTs.
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Only 2/10 studies reporting SWT results from 2010 to 2014 used GEE [1].
This is often because SWTs have few clusters, and the robust variance estim-
ator commonly used in conjunction with GEE is anti-conservative with small
samples [44, 61]. Scott et al [61] have suggested using small sample correction
techniques or permutation tests to account for this problem; both techniques
gave appropriate type-one error rates with as few as 10 clusters.
GEE incorporate horizontal and vertical comparisons so they must adjust for
time. Scott et al [61] used the following analysis model:
yijk = µ+ βj + θXij + εijk
where εijk are the total residuals that are assumed to have zero means given a
set of covariates and follow a working correlation matrix.
There is no published advice on choosing a working correlation structure in
the setting of SWTs. Scott uses an autoregressive one structure [61], but this
may not be appropriate in other settings. The use of non-diagonal correlation
matrices can lead to biased effect estimates with time varying covariates [62].
3.2.6 Cluster-Level Analysis
Cluster-level analyses are used in CRTs as a simple, straightforward way of
accounting for clustering. They are used in trials with a small number of
clusters where mixed-effect models and GEE are inappropriate [43, 60]. They
have the additional benefit of allowing the simple calculation of the more epi-
demiologically relevant measure of the risk difference for binary outcomes [63,
64].
In the case of a CRT, the outcome is summarised at the cluster level: this
could be risks, rates, or the mean of the outcome in each cluster. These
cluster summaries can then be analysed using a standard two sample t-test to
calculate the difference between the intervention and control outcomes [17].
Concerns have been raised about whether estimates of risk ratio and odds ratios
are unbiased using this method. Ukoumunne et al [65] found that in scenarios
with a small number of observations per cluster and a high ICC the cluster-level
analysis produced biased estimates of the marginal risk ratio and odds ratio
true effects. They hypothesised that there were 2 reasons for these biases. The
bias with a small number of observations per cluster was due to the need for
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a heuristic adjustment when there were no cases (or controls for odds ratios)
in a cluster, a common adjustment is to add 0.5 to the number of cases and
controls to such clusters [26, 65, 66]. The bias with a high ICC they hypothesis
was due to the method calculating the difference in the geometric means of
the log odds or log risk, rather than the arithmetic means. However, others
have suggested that a cluster-level analysis estimates a cluster-specific effect
[67]; this could explain the observed bias for the odds ratio, since Ukoumunne
et al [65] compared the estimate to the marginal effect. The risk difference
does not seem to be affected by any of these issues [65].
In SWTs, a cluster-level analysis is more difficult. The outcome cannot be
summarised over all observations in the same cluster because some of the
clusters’ observations will be control and some will be intervention, and this
would also ignore any period effects.
The only cluster-level analyses currently available, suggested by Hussey and
Hughes [33], uses a model similar to model 3.1, but using summaries of the
outcome in each cluster-period as the outcome. This model still requires a
random effect for cluster because there are multiple cluster-period summaries
per cluster. With equal cluster sizes and a continuous outcome, this would be
equivalent to analysis with model 3.2. This method has been shown to produce
biased estimates of the risk difference when the risk in each cluster-period is
used as the outcome and the ICC is low [44]. It may also be unsuitable with
a small number of clusters because it requires random effects.
3.2.7 Within-Period Analysis
A within-period, or vertical, analysis method is one which only utilises the
vertical comparisons for estimating the intervention effect [3]. This is desir-
able because these are randomised comparisons that are not confounded with
secular trends.
There are two published within-period analysis methods for SWTs, though
methods for combining dependent effects have been explored for other longit-
udinal data contexts.
Granston explored the impact of modelling each period of the trial independ-
ently with model 3.1 (excluding the period effect) and combining the period-
specific estimates as an inverse-variance weighted average [68]. However, Gran-
ston only considered scenarios where model 3.1 is correctly specified.
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Similarly, Matthews and Forbes [28] derived algebraic formula for a vertical
analysis. They looked at optimising the weights assigned to each period in
such an analysis under different correlation structures. They found that in-
verse variance weights were optimal under the assumptions of model 3.1, and
that only marginal improvements to efficiency were possible through intro-
ducing additional imbalance in the weights of the periods when assuming an
autoregressive correlation structure between the periods, so that correlation
between observations reduced over time. All correlation structures assumed
that the total variance remained constant throughout the trial, so inverse vari-
ance weights were equivalent to weights by the imbalance in the number of
clusters in each condition.
In the broader statistical literature, others have explored methods of combining
dependent effects, mostly in the context of analysing longitudinal data with
multiple observations of individuals.
Several papers have provided methods for testing a set of dependent estimates
θˆj, j = 1, ..., J [69–71]. They were primarily concerned with the longitudinal
data where individuals are observed multiple times. They wanted to analyse
the effect of some parameter θj without specifying the correlation structure in
the data and without assuming that the parameter effect was constant over
time. In cases where θj can be assumed to be constant over time, they suggest
combining the time-specific effects as a weighted average. Assuming complete
data, they show that the weights for combining the estimates that maximise
power are as follows:
wˆ = (wˆ1, ..., wˆJ) =
(
(1, ..., 1) Λˆ−1w (1, ..., 1)
′)−1 Λˆ−1w (1, ..., 1)′
where Λˆw is the covariance matrix for the time-specific parameters. Zeger
[72] noted that the estimates θˆj and covariance matrix Λˆw are identical to
the estimates provided by GEE with an independent correlation structure and
robust variance estimate.
Using these weights, the test statistic θ
(
wˆ′Λˆwwˆ
)−1/2
asymptotically follows
a standard normal distribution. Moulton and Zeger [71] also suggest using
bootstraps to calculate confidence intervals and a p-value for the overall effect.
This method has not been explored in the context of SWT. It provides a
method of parametric inference without specifying a correlation structure for
the data. However, the efficiency gains from estimating a covariance matrix
are questionable given the results of Matthews and Forbes [28], and the as-
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sumptions of a normal distribution may be unsuitable with the small number
of clusters often seen in SWTs [1, 7].
3.2.8 Software Implementation of Analysis Methods
Despite some research warning about the suitability of model 3.1, the model
remains the most popular choice in practice [8]. This could be because the
literature on this topic is fairly recent, but a lack of available software has
also been identified as a factor limiting the uptake of new statistical methods
[73]. In this section, I will look at the availability of software to perform
the analysis methods identified in the review to see where software might be
limiting uptake.
LMM and GLMM can be implemented with relative ease in most common
statistical software (Stata© [74], R [75], SAS©). Stata provides the commands
mixed for LMM, and meglm for GLMM. Several packages are available for
R such as lme4 [76]. In SAS, procedures such as MIXED and GLIMMIX
can be used for LMM and GLMM. This wide availability of software may in
part explain the popularity of model 3.1 and makes the development of more
suitable model based alternative analyses appealing. These software can also
fit the more complex correlation structures described in section 3.2.4.
The second most common analysis method of SWTs is GEE [8], which are
also widely available in common statistical software. Since SWTs often have
a small number of clusters, the small sample corrections suggested by Scott et
al are recommended [77]. These are widely available in R [61], and SAS, but
fewer corrections are available in Stata.
Bootstraps can also be implemented in these software. Stata’s bootstrap com-
mand and the R package multivcov will perform bootstraps allowing for clus-
tering in the data [78]; however, bootstraps must be manually coded in SAS.
Bootstraps have not yet been shown to give appropriate inference for SWTs
because of the small number of clusters the designs often use and this is likely
the factor limiting their use.
Permutation tests have been shown to give robust inference when used with
the model 3.1 [41, 42], but are not widely used in practice. This may be
because they are less easily implemented. While there is an R package that
performs permutation tests that are valid for SWTs [79], in Stata and SAS, the
inbuilt commands are not suitable for use with SWTs. In both software, in-
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dividual observations are permuted between intervention conditions and so do
not maintain exchangeability for SWTs. Instead, the process must be manually
coded in these software. Improving the ease of implementing the permutation
test may increase the uptake of this more robust method, and so would be
beneficial to SWT analysis.
3.2.9 Summary
The analysis model that prevails in practice is model 3.1. At the start of this
PhD, there were few alternative methods to, and little criticism of, model 3.1
published. The intervening three years has seen developments in both of these
areas. Model 3.1 has been shown to have inflated type-one error rates in the
presence of cluster-specific period effects, consistent with findings from other
trial designs, and many alternative analyses have been suggested. However,
few of these analyses have been assessed to see if they have better performance
than model 3.1 when observations in the same cluster but different periods are
less correlated than observations in the same cluster and the same period.
Model 3.2 has performed well in other study designs with two periods (the
CRXO and CRT with baseline observations), but this may not translate to an
SWT, which can have many more than two periods, because the cluster-level
autocorrelation is fixed to be the same for all periods. Model 3.4 has had little
attention, despite its flexibility for allowing different correlation structures
within clusters.
There has been little consideration in the literature to date of the impact of
assuming a common intervention effect in mixed-effect models, despite these
causing bias in CRTs [57].
The issues with type-one error have arisen because these models use the ho-
rizontal comparisons in their estimation of the intervention effect. The most
robust analysis would be to exclude these comparisons as Granston considered
[68], and accept that this comes at the cost of lower power. There is a need
for methods that provide valid inference without requiring assumptions about
the correlation structure between periods.
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3.3 Power and Sample Size
As explained in section 3.1.1, a cluster randomised trial provides less in-
formation about the intervention effect than an individually randomised trial.
Within cluster randomised trials, the amount of information available about
the intervention effect varies by design.
In a CRT, the intervention effect can only be observed by comparisons between
clusters in each condition (vertical comparisons). Power is maximised from
these types of comparisons when there is an equal number of clusters in the
control and intervention conditions [58].
In an SWT, the intervention effect can be observed by comparing clusters in
each condition within each period (vertical comparisons), and by comparing
periods in the control and intervention conditions within each cluster (hori-
zontal comparisons). The vertical comparisons will provide less power than
they do in a CRT because of the imbalance in the number of clusters in the
control and intervention conditions. The horizontal comparisons are not avail-
able in a CRT so can increase the power of the SWT design relative to the CRT
design. The amount of information taken from the horizontal comparisons will
very much depend on the assumptions made about the period effects and the
correlation within clusters between periods. The potential for this design to
require a smaller sample size for the same power has resulted in some trials
including a very small number of clusters. This raises problems for the use of
mixed-effect models [80], and for generalisability of results [81].
Earlier sample size literature focused on model 3.1 assumptions, which include
assuming equal correlation within clusters. More recently, sample size literat-
ure has focused on models with weaker assumptions, such as model 3.2, which
assumes that observations in the same period are more correlated than obser-
vations in different periods. This model will weight the horizontal comparisons
more or less depending on how strong the correlation is between periods.
All but two papers have focused on variance formulae and design effects for
SWTs. Whilst these are simple to use, it has been noted that sometimes the
results they provide are only approximate [82], particularly for outcomes that
are not normally distributed [5]. One paper provides software to calculate the
power of a given design with a given sample size [83], and one suggested using
simulation studies [5].
As well as providing methods for calculating sample size requirements, this lit-
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erature often also provides advice on how to minimise that sample size through
design choices.
In this section, I will appraise this literature. I will begin with a description
of how variance formulae and design effects are related and how they can in-
form trial design and sample size requirements. Subsections 3.3.2 - 3.3.4 detail
literature that has provided design effects or variance formula, or used these
methods to provide advice on trial design. Subsection 3.3.5 will describe results
derived through simulation studies. Subsection 3.3.6 will describe implement-
ation of sample size methods into statistical software.
3.3.1 Background to Design Effects
Using a design effect is a simple way to calculate the required sample size of a
given trial design. A sample size is calculated assuming individual randomisa-
tion in a parallel trial, and this number is then multiplied by a design effect
to give the appropriate sample size of a different design [17]. The justification
of a design effect is as follows [84]:
Let α be the significance level, β be the statistical power, θ be an intervention
effect, and V aralt
(
θˆ
)
the variance of an estimate of the intervention effect
using an alternative trial design such as an SWT. The power of a Wald test is
as follows:
power = Φ
 θ√
V aralt
(
θˆ
) − Φ−1 (1− α/2)

where Φ (x) is the cumulative standard normal distribution function at a value
x, and Φ−1 (x) is the inverse of this function so if α = 0.05, Φ−1 (1− α/2) =
1.96.
The power to detect a difference θ for a given sample size can be directly
calculated from this formula, or the process of calculating a required sample
size for a given power can be simplified by rearranging this formula:
M =
[
Φ−1 (1− β) + Φ−1 (1− α/2)
]2 4σ2
θ2
V aralt
(
θˆ
)
V arind
(
θˆ
)
where M is the required total number of observations , σ2 is the variance of
the outcome, and V arind
(
θˆ
)
is the variance of the intervention effect estimate
of an individually randomised, parallel trial design.
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This is simply the formula for the sample size of an individually randomised
trial multiplied by the ratio of the intervention effect estimate variance under
the alternative trial design and the variance under the individually randomised
trial. So, if one can calculate how much larger the variance of a given trial
design will be compared to the variance of an individually randomised trial,
called the design effect, one can use this ratio to calculate the sample size.
The design effect for a CRT depends on the ICC and the total cluster size [84]:
DECRT = 1 + (m− 1)ρ
where m is the total cluster size and ρ is the ICC.
The design effect for a CRT with 50% of observations at baseline is [85]:
DECRT B =
(
1 + (m2 − 1)ρ
)1−
 m2 ρ
1 +
(
m
2 − 1
)
ρ
2

Design effects are very simple to use and the effect of some assumptions on the
sample size, such as the ICC, can be explored through calculating the design
effect for different values.
The formula for the design effect and V aralt
(
θˆ
)
can also provide insights into
how each parameter affects the power of a given design, for example the design
effect for a CRT shows that the sample size of a CRT will increase as the ICC
increases.
Some data assumptions are fixed in order to calculate a formula for V aralt
(
θˆ
)
.
If these assumptions are not appropriate to a specific setting, the sample size
calculated by the design effect will not necessarily provide the required power.
3.3.2 Hussey and Hughes Model Assumptions
Hussey and Hughes [33] provide a formula for the variance of an intervention
effect estimate from their model 3.1. This formula provided the basis of all
early work on sample size calculations for SWTs. Calculations of sample size
based on this formula require the assumptions of model 3.1 to hold, namely
common period effects and intervention effects, and so equal correlation of all
observations within a cluster.
As described above, this formula can be directly applied to calculate the power
to detect a given intervention effect for a given design and sample size.
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Woertman et al [86] converted the variance formula into a design effect for an
SWT. While it was not clear in the original paper that the formula gave the
sample size required for each period of the trial (as opposed to the total sample
size), this was later clarified [87]. The design effect derived by Woertman et al
[86], corrected to give a total sample size requirement, is as follows:
DEW =
1 + ρ (gn+ bn− 1)
1 + ρ (0.5gn+ bn− 1)
3 (1− ρ)
2
(
g − 1
g
) (g + b) (3.7)
where ρ is the ICC, g is the number of sequences, n in the number of obser-
vations collected during each period, and b is the size of the baseline period
relative to other periods. The baseline period is allowed to be bigger or smaller
than all other periods of the design, but the final period, after the last sequence
has switched to the intervention, must be the same size as the other periods
of the design. There cannot be any cluster-periods excluded from the analysis
and each sequence must contain the same number of clusters. This means that
the total cluster size is given by m = n (g + b) and is assumed to be the same
for all clusters.
Assuming equal cluster size when in fact cluster size varies can cause under
estimation of the required sample size in CRTs [67]. Initial investigations
suggest that the SWT design is less sensitive to deviations from this assumption
[88].
The availability of this design effect, and the variance formula derived by
Hussey and Hughes have improved sample size calculations for SWTs: before
these were published many trials ignored the SWT design altogether in their
calculations and only accounted for the clustering [7]. Since this design effect
has been published, it has become the most common method for sample size
calculation [7].
The greater understanding of SWT sample size and power requirements led to
comparisons with the power of other designs, in particular a CRT and CRT
with baseline observations.
Some early comparisons of a CRT and SWT did not keep the total cluster size
the same for the two designs, instead they compared an SWT with a CRT that
had clusters the same size as one period of the SWT [86]. Later comparisons
of these designs kept cluster size equal for each design and a general consensus
emerged that the SWT is more powerful than a CRT when the ICC is high
and the cluster sizes are large, but with low ICC or small cluster size, the
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CRT is most powerful [87, 89, 90]. Hemming et al found that an SWT with
4 sequences was always more powerful than a CRT with baseline observations
where 50% of observations were collected at baseline [85, 91].
There have also been many papers discussing improvements to the SWT design
to increase its power. Numerical calculations have consistently shown that for
the standard design SWT, the power increases with the number of sequences [5,
33, 86]. Here again, some comparisons increased the number of observations
as they increased the number of sequences [5, 33], but even when the total
number of observations was held constant, this pattern of increasing power
persisted [86].
Lawrie et al [92] algebraically explored the impact of relaxing the assumption
that each sequence contains an equal number of clusters. They found that it
was optimal to have more clusters randomised to the first and final sequences
to switch to the intervention than in the intermediary sequences.
3.3.3 Cluster-Period Interaction Model Assumptions
More recently, several researchers have developed design effects for an SWT as-
suming analysis with the cluster-period interaction model (model 3.2 or model
3.3) [14, 35, 50]. The design effect of Girling and Hemming for the standard
SWT is:
DEgirling =
m
g+1
σ2q
σ2 +
σ2e
σ2
2
3
(
1− 1
g
)
− 13
(
1− 2
g+1
)
R∗
where R∗ is the cluster-mean correlation incorporating the additional random
effects of model 3.3. R∗ now has the interpretation of partitioning the cluster-
means into time-dependent and time-independent variability:
R∗ =
σ2u +
σ2d
n
σ2u +
σ2q
g+1 +
σ2
d
n
+ σ2e
m
For a repeated cross-sectional design, σ2d = 0. Under the assumptions of model
3.1, Girling and Hemmings’ design effect simplifies to the design effect 3.7 and
R∗ = R [14].
These methods have only recently been published so their uptake in practice
has not yet been assessed.
Girling and Hemming used their variance formula to identify the SWT design
with minimal variance, and so a minimal sample size, allowing an unequal
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allocation of clusters to sequences: the answer is the Hybrid design (figure
1.1d) [14]. The sample size of this design is minimised when the proportion
of clusters randomised to the SWT was equal to the cluster-mean correlation.
For example, if R∗ = 0.75, 75% of the clusters should be randomised to the
SWT and the remaining clusters randomised to the CRT [14].
Girling and Hemming also identified that an SWT with the periods before and
after rollout half the size of the periods within rollout always had a smaller
variance than the standard SWT design [14].
Hooper et al [50] derived a similar design effect and used it to explore the
sensitivity of the sample size to changes in the design effect parameters. They
found that sample size calculations were sensitive to changes in the cluster-level
autocorrelation, with sample size increasing as the cluster-level autocorrelation
reduced from one. This is concordant with the inflated type-one errors seen
by others when this assumption is violated in analysis [40–42].
3.3.4 Within-Period Analysis
The additional power an SWT has compared to a CRT when the ICC or cluster
size is large is because models 3.1 and 3.2 incorporate horizontal comparisons.
In terms of vertical comparisons, the CRT should have the most power because
this design has an equal number of clusters in each condition at all times.
Moulton et al [58] have quantified the drop in power due to this imbalance,
though only for their specific design. They found that their SWT, asuming no
clustering and independent periods with 14 sequences and a long period follow-
ing rollout, would require 1.44 times the sample size of a CRT and found that
this would to increase to a limit of 1.5 as the number of sequences increased.
Others have explored the difference in efficiency comparing within-period ana-
lyses to model 3.1.
Both Granston [68] and Matthews and Forbes [28] compared the variance
of their respective within-period methods with model 3.1 under the assump-
tions of model 3.1, and both found that the within-period methods resulted
in a larger intervention effect variance than model 3.1. Matthews and Forbes
show that the difference increased as the cluster-mean correlation R∗ increased,
driven by an increasing variance for the within-period method.
However, both of these studies have only compared the variance of the within-
period method with model 3.1 under the assumptions of model 3.1 [28, 68]. As
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shown in subsection 3.2.2, these assumptions are not always appropriate. The
cluster-mean correlation will be lower where there is cluster-level autocorrela-
tion, as defined for model 3.2, so the variance of a within-period method will
be smaller. Conversely, Hooper et al [50] showed that the variance of model 3.2
is greater when there is cluster-level autocorrelation. This suggests that the
difference between these methods will be smaller in practice than the current
literature suggests.
3.3.5 Sample Size under Other Assumptions
Given the complexities of analysis that I described in section 3.2, design effects
are not available for all potential chosen analysis models. For example, all pre-
viously described design effects assume that the intervention effect is common
to all clusters, so would not be appropriate for analysis model 3.6. In such
cases, simulation studies can be used to calculate the power of a particular
study.
Baio et al [5] and Hughes [56] identified that ignoring period effects in the
sample size calculation inflates the apparent power, so period effects must be
considered from the start of planning a trial. This also means that all sample
size methodology should incorporate period effects, however there are examples
of methodology that have ignored this important confounder [93].
Baio et al [5] also found that when the intervention effect varied between the
clusters this reduced the study’s power to detect an effect, and showed that
changes to the ICC affect cross-sectional designs more than cohort designs.
3.3.6 Software Implementation of Sample Size Calculations
As with analysis methods, the uptake of sample size calculation methods is
dependent on their availability in commonly used software. There are two
main software implementations available for SWT sample size calculations.
Calculation of power under the assumption of model 3.1 is available in several
ways.
Hemming and Girling implemented the variance formula derived by Hussey
and Hughes [33] as a command for the statistical software Stata [74, 83]. In
their Stata command, they allow users to enter the design of their trial as a
“design-pattern matrix” of 0,1, and “.” for control periods, intervention periods,
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or periods that are excluded respectively. An example of a design-pattern
matrix for an incomplete SWT is given in figure 3.3. This allows trialists to
explore a wide range of designs, for example excluding certain cluster-periods,
or extending one particular period of the trial to twice as long. However, the
assumptions of model 3.1 must apply for the resulting power to be valid.
Figure 3.3: Diagram of a design-pattern matrix
0 0 0 0 0 . 1
0 0 0 0 . 1 1
0 0 0 . 1 1 1
0 0 . 1 1 1 1
0 . 1 1 1 1 1
Hughes has also has developed a spreadsheet for calculating the power using
the Hussey and Hughes variance formula of a given design [33, 94].
The wide availability of software implementing methods making the assump-
tions of model 3.1 may explain their wide uptake [7].
Baio et al [95] has written an R package to simplify the process of using
simulation studies to calculate the sample size of an SWT.
3.3.7 Summary
At the start of this PhD, the only literature available on the sample size of
SWTs made the assumptions of model 3.1. These methods have since be-
come popular [7]. The literature on designing SWTs focused on the impact of
increasing the number of sequences on the trial power [86].
More recently, the sample size literature has relaxed the assumption of equal
correlation within clusters and has been extended for cohort studies [14, 50].
These have yet to be implemented in any software to my knowledge.
Literature on making SWTs more efficient has looked at the effect of allowing
an unequal allocation of clusters to sequences.
3.4 Summary
Much of the literature in this review has been published after I started this
PhD; at the start of my PhD, literature on both design and analysis still
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focused on model 3.1. Literature on analysis of SWTs to date, has largely
focused on repeated cross-sectional designs. The design literature is starting
to explore cohort designs, although many gaps remain in our understanding
of the simpler repeated cross-sectional design. Therefore, this thesis will focus
on furthering our understanding of the analysis of complete, cross-sectional
designs.
Chapter 6 will explore improvements to the efficiency of the SWT design under
the assumption of model 3.1. The finding of Girling and Hemming [14] and
Lawrie et al [92] that it was optimal to have more clusters randomised to the
sequences that remain in one condition for the longest time may provide some
insight into how to improve SWT designs with an equal allocation of clusters
to all sequences. A very simple modification that has not been explored is
whether it is optimal to include the first period of the standard SWT design,
before any clusters have switched to the intervention, and the last period, after
all clusters have switched. This would lead to a design similar to the Hybrid
design but with equal allocation. Equal allocation of clusters to sequences may
be preferable where resources limit the rollout of the intervention, for example
if a limited number of teams are available to introduce the intervention.
Chapters 7, 8 and 9 of this thesis will explore alternative analysis options.
In Chapter 7, I conduct a simulation study comparing model 3.1 to models
with additional random effects for either period effects (model 3.4) or the
intervention effect (model 3.6) in a range of different data scenarios. I extend
the existing literature by exploring the deworming case-study in which the
total variability of the outcome reduces in the second year. It is also novel to
look at the impact of the intervention effect varying between clusters on the
intervention effect estimate.
In Chapter 8, I describe an analysis method that only uses the vertical compar-
isons, similar to that of Granston [68] and Matthews and Forbes [28], but using
cluster-period summaries and the permutation test. There are several advant-
ages to my method, over the those proposed by Granston, and Matthews and
Forbes: the use of cluster-summaries allows the simple calculation of risk dif-
ferences as recommended by the CONSORT statement [96], and are easier to
interpret than odds ratios. Secondly, because a cluster-level summary is used,
there is no question over the number of clusters required for valid inference, as
there is with mixed-effect models [17]. Lastly, using permutation tests should
give valid inference without requiring assumptions about the correlation of
81
Bibliography
observations between periods, making this a much more robust analysis.
In Chapter 9, I address the need for software that computes permutation tests
for SWTs and demonstrate a Stata command I have developed for this purpose.
The command conducts the cluster-summary analysis described in Chapter 8,
as well as enabling the methods described by Ji et al [41] and Wang and
DeGruttola [42].
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4 Aims and objectives
At the start of my PhD, there were many gaps in the SWT methodology
literature. For this thesis, I aimed to address the gaps that I felt would have
a large impact on improving the use of the SWT design.
The first aim, addressed ways to improve the design of SWTs. This was
achieved through the following objective:
1. To identify a more efficient complete SWT design maintaining equal al-
location of clusters to sequences through varying the size of the periods
before the first and after the final periods switch to the intervention. To
identify how this optimised design compares to other designs, namely a
CRT, a CRT with baseline observations, and a hybrid design.
The rest of this thesis will be used to address the second aim, to identify
improvements to the analysis of SWTs. At the start of my PhD, there was
little literature exploring whether the Hussey and Hughes model (model 3.1)
was appropriate. To address this aim, I will answer the following objectives:
1. To investigate the effect of misspecifying the correlation structure of a
mixed-effect model used to analyse an SWT.
2. To propose an analysis method for SWTs using only the vertical compar-
isons. In particular, I will propose an analysis using a cluster-summary
analysis in each period, combining within-period estimates of the inter-
vention effect using a weighted average. I will assess the use of permuta-
tion tests for inference.
3. To develop a Stata command to facilitate the use of permutation tests,
and the cluster-summary, within-period analysis described above for
SWTs.
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Simulation Studies
In chapters 7 and 8 of this thesis I use simulation studies to address the aims
of each chapter. The aim of chapter 7 was to explore the performance of
model 3.1 when the random effects are misspecified, and to compare this to
other potential mixed-effect models. The aim of chapter 8 was to assess the
performance of a novel cluster-summary, within-period analysis method and
compare this to model 3.1. In this chapter I will provide some details of the
simulation studies that I conducted.
Simulation studies aim to replicate the process of conducting a study. When
conducting an RCT, a sample is taken from a population. This sample is then
randomised to determine whether, or in the case of an SWT when, they receive
the intervention. After exposure, an outcome or outcomes are collected from
the sampled individuals and the outcomes are then analysed. The principle
of a simulation study is that all aspects of this process can be imitated under
assumptions about what will happen in the trial. This can be informative
about the properties of the trial analysis, such as its accuracy in estimating
the intervention effect, the confidence interval coverage, or the power.
The steps in this process are (1) define the study design and generate a set
of observations mimicking the process for sampling observations (2) analyse
the data (3) repeat steps (1) and (2) many times, and (4) analyse simulation
study. The following sections will describe how I implemented these steps in
chapters 7 and 8 in more detail.
Chapter 7 simulations were run in R version 3.2, and chapter 8 simulations
were run in R version 3.3 [1].
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5.1 Data Generation
The first step of a simulation study is to generate some data mimicking data
from a particular study. For an SWT, this means deciding on the following
design features: selecting a number of clusters, a number of sequences, how
many observations are collected in each period and before and after rollout
in each cluster. From this, a dataset can be created with a row for each
observation within each cluster and columns indicating the cluster that the
observation belongs to, the period that the observation was collected in, and
whether the observations was made under the control or intervention condition.
The outcomes of each individual will depend on the population from which
the individuals have been sampled [2]. The population can be based on gen-
eral characteristics representing a population where the study is likely to take
place. An example is the simulation study by Barker et al [3] where a system-
atic review was used to determine likely values for the ICC and SWT designs.
Alternatively, the population can be simulated to represent a specific popula-
tion in which a study is likely to take place. This was the approach I took in
chapters 7 and 8. Any results from a simulation study can only be general-
ised to the scenarios generated, so it is important that these are well thought
through and reflect common situations [4].
In chapter 7, the data were simulated to mimic the deworming trial case study.
The simulated study had two periods and three sequences as described in
section 2.1. To understand the general population characteristics, without
the introduction of the deworming intervention, I studied clusters in the third
sequence of the trial, which did not receive the intervention in either year.
Using a GLMM version of the random-period model (model 3.4) with a logit
link, I determined the odds of school attendance in each year and the covariance
matrix relating to these using:
logit {P (yijk = 1 | tj, ui, vij)} = µ+ (β + vi) tj + ui
where tj is zero in the first year and 1 in the sencond year of the study and ui
vi
 ∼ N
 0
0
,
σ2u σ
2
u,v
σ2u,v σ
2
v

I then substituted these parameters into model 3.4 with a logit link, adding
an intervention effect to generate samples of data for the simulated trial.
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In chapter 8 I used a similar process. I analysed the NHS health check data
to determine the underlying trends in health check acceptance and correlation
structure across the two years. Here, I again used a GLMM form of model
3.4 with a logit link. For this data I treated time as continuous and used
fractional polynomials [5] to determine the shape of the trends within each
year and included a binary covariate for year:
logit {P (yijk = 1 | t1j, t2j, ui, v1i, v2i)} = µ+ (β1 + v1i) t1j + (β2 + v2i) t32j + ui
where t1j indicates the year, 0 and 1 in the first year and second year respect-
ively, and t2j indiciates the quarter within each year as 0,1,2, or 3.
ui
v1i
v2i
 ∼ N

0
0
0
,
σ2u σ
2
u,v1 σ
2
u,v2
σ2u,v1 σ
2
v1 σ
2
v1,v2
σ2u,v2 σ
2
v1,v2 σ
2
v2

Again, I then substituted the determined values into an identical model with
the addition of an intervention effect to generate samples of data for the sim-
ulated trial. This generated samples with a specified cluster-specific interven-
tion effect. Other methods are available to generate samples with a specific
marginal intervention effect [6].
To widen the generalisability of the results, the simulation study can be re-
peated using different data generating processes that make different data as-
sumptions. This could include different correlation assumptions, missing data
mechanisms, and the size of clusters. When using simulation studies for sample
size calculations, it can be useful to explore the spread of power estimates un-
der different assumptions because the form of the data produced during a trial
is difficult to predict in advance [2]. When using simulation studies for meth-
odology this gives a wider applicability and understanding of study results.
In Chapter 7, I also generated data with σ2u,v = σ2v = 0, and I generated data
with a varying intervention effect by adding a random effect zi ∼ N (0, σ2z),
independent of ui and vi to the data generating model. This allowed me
to assess the impact of different correlation structures on the analysis model
performance. I also repeated the simulation study with a larger intervention
effect in the second sequence of the trial than in the first sequence of the trial
(see figure 2.1 for the trial design). This allowed me to demonstrate the weight
given to horizontal and vertical comparisons as only sequence two contributed
horizontal comparisons in this design. Further details are given in chapter 7.
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In Chapter 8, I generated data with σ2v1 = σ2v2 = σ2u,v1 = σ2u,v2 = σ2v1,v2 = 0,
and generated data with less variability, by dividing the covariance matrix
by a factor of 0.2. This allowed me to assess the performance of the novel
analysis in the presence of different correlation structures and different degrees
of clustering.
5.2 Analysing Simulated Data
These generated datasets can then be analysed using a chosen analysis model,
or several different analysis models can be compared. The results of each
analysis model, such as the intervention effect estimate and its standard error,
are collected and saved. The extracted results can be used to investigate the
properties of the analysis model/s under the data assumptions simulated [4].
Comparing the performance of different analysis models under different data
generating processes can help to identify when problems with analysis models
occur and when one analysis method may be preferable to another [4].
In Chapter 7, I compared models 3.1, 3.4, and 3.6. For each of these mod-
els, there were data scenarios where they were correctly specified (making
appropriate assumptions about the data), and incorrectly specified (making
incorrect assumptions about the data). Comparing the correctly specified to
the incorrectly specified models also helped interpretation of results.
In Chapter 8, I analyse the data using model 3.1 because this the most com-
monly used analysis method in practice [7]. I compare this to my novel cluster-
summary, within-period analysis method.
5.3 Number of Simulations
Using one generated dataset gives very little information about the properties
of the analysis model/s because the random variability in the data gives rise to
error, known as Monte-Carlo error [8, 9]. Instead, we repeat this process many
times. Each time taking a different sample from the statistical distributions to
get a different sample of outcomes within the same population, and applying
the analysis models. To allow the simulations to be replicable, a random
number seed should be provided at the start of the study; this means that the
same values are sampled from the distributions each time the simulation study
is rerun [4].
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The number of repetitions required will depend on how certain one wants to be
of a particular property of an analysis model. More details of these properties
were given in section 3.2.1. For example, when simulation studies are used as
part of a sample size calculation, the power will be of most interest.
In Chapter 7, the primary interest was identifying biased estimation of the
intervention effect, so the number of simulations was selected so that an in-
tervention effect odds ratio of 1.5 would be estimated with 5% accuracy in
scenarios with the most variance (assumed to be a variance of 0.05). This lead
to a requirement of 500 simulations, calculated by [4]:
N =
(
(Φ−1 (1− α/2) + Φ−1 (1− β))V ar (θ)
θ ∗ accuracy
)2
where N is the number of simulations, Φ−1 (x) is the inverse cumulative stand-
ard normal distribution function, α is the type-one error rate, β is the required
power to detect a a difference at the required level of accuracy, θ is the inter-
vention effect with an expected variance of V ar (θ).
In chapter 8, the primary interest was maintaining 95% confidence interval
coverage. The coverage will follow a binomial distribution, and so we can use
the normal approximation to the binomial distribution to decide the required
width of the confidence interval for the confidence interval coverage using [10]:
CI width = 1.96 ∗
√
0.95 (1− 0.95)
N
Using this formula, 1000 simulations will estimate the confidence interval cov-
erage to within 1.4%.
5.4 Analysing the Simulation Study
Simulation studies can be used to evaluate all of the properties described in
subsection 3.2.1.
5.4.1 Bias
Burton et al [4] describe the different measures of bias in a simulation study.
The parameter estimates generated for each simulated dataset will vary, giving
a distribution of estimates with a mean θˆ and variance var
(
θˆ
)
. In this context,
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the square root of the variance is the empirical standard error of the estimates,
and should be similar to the model estimate of the standard error.
The simplest measure of bias is the difference between the mean of the estim-
ates and the true intervention effect (θA):
absolute bias = θˆ − θA
Bias should be considered in relation to the Monte-Carlo error around the para-
meter estimates. A small absolute bias in an estimate that has large variability
is less important than the same absolute bias in an estimate with a small vari-
ability. Mean parameter estimates more than 1/2 a standard deviation away
from the true parameter effect have been found have an impact on type 1 error
rate and so this is sometimes used to indicate practically important bias [4].
However, this value is dependent on the parameter effect size and the variance
of the estimates. The percentage bias removes the dependence on the effect
size, but is still dependent on the variance of the estimates:
percentage bias = θˆ − θA
θA
∗ 100
Some have used a percentage bias greater than 10% to indicate a concerning
amount of bias [11].
Standardised bias removes the dependence on the variance:
standardised percentage bias = θˆ − θA√
V ar
(
θˆ
) ∗ 100
A standardised bias of more than 40% has been shown to impact the method’s
error rates [12].
In Chapter 7, I calculated absolute and the percentage bias, to improve the
interpretability of results. In chapter 8, I calculated only absolute bias, but
interpreted the results considering the variability of the estimates.
5.4.2 Confidence Interval Coverage and Type-one Error
In a simulation study, we can calculate the percentage of repetitions in which
a parameter’s confidence interval contains the true effect. If the percentage
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is less than 95%, the confidence interval is under covered, if the percentage is
greater than 95%, the confidence interval is over covered. Under coverage is
of greater concern than over coverage [4].
Both chapters 7 and 8 explored the coverage of all the analysis methods con-
sidered. In chapter 7 I also calculated the type-one error rate.
5.4.3 Power
The power is calculated by simulating datasets with an intervention of θA
and calculating the percentage which have an intervention-effect estimate with
p < α. For example, a trialist may want to know the power to detect an
intervention-effect of θA at a significance level of 0.05. If data is simulated
to have a true intervention effect of θA and 80% of the intervention-effect
estimates had p < 0.05, the analysis has 80% power to detect an intervention-
effect of θA at a significance-level of 0.05 under the assumptions made in the
data generating process.
When using a simulation study for sample size calculations and when compar-
ing the efficiency of analysis models, the power to detect an effect of size is the
property of primary interest. Power calculated in this way is only interpretable
if the method has correct confidence interval coverage.
Chapters 7 does not report the power of the analysis models as the simulation
study focused on identifying bias and under coverage of confidence intervals.
Chapter 8 explored the power of the analysis methods considered, although this
was not possible in all scenarios because of under covered confidence intervals.
5.4.4 Presentation of Results
In many previously published simulation studies, the Monte-Carlo error of ana-
lysis method properties has not been well reported [9]. This can lead to over
interpretation of random variation in each property. To avoid this, in both
papers, the parameter mean estimates are displayed with a measure of the
spread of the estimates (chapter 7 reports the interquartile range of the estim-
ates, chapter 8 reports the standard deviation of the estimates). Confidence
intervals are given to estimates of confidence interval coverage in both chapters,
and absolute bias in chapter 7. The variance of each property was calculated
assuming normal approximations, which has been shown to be appropriate in
most situations [8].
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5.5 Summary
Simulation studies are a very flexible tool for exploring the properties of an
analysis in a given set of circumstances, and advances in computing power
have made simulation studies more feasible. They enable consideration of
all aspects of inference, Burton et al [4] encourages consideration of several
aspects to improve interpretability of results, for example, only investigating
power could fail to identify that the analysis is producing biased estimates.
However, the results they provide are only as generalisable as the breadth of
data-generating processes explored.
In Chapters 7 and 8, I have used simulation studies to explore the properties of
several analysis methods. The data generating processes in both chapters were
informed by real setting where either an SWT had been conducted, or would
be likely to be conducted (the deworming case study and NHS health-check
case study respectively). Bias, and confidence interval coverage were explored
in both simulations studies. Power was also considered in chapter 8. Careful
thought was given to presenting results.
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6 Paper A: The Optimal Design of
the Stepped-Wedge Trials with
Equal Allocation to Sequences,
and a Comparison to Other Trial
Designs
In research paper A, I address the first aim of this thesis: to improve the
efficiency of the SWT design.
My review of the literature on SWT design suggested that the periods before
and after rollout may be inefficient. In this paper I explore this question. I
derive a design effect that assumes that data follow model 3.1 (in this chapter
referred to as the Hussey and Hughes model). I use differentiation of this new
formulation of the design effect to identify the proportion before and after
rollout and the number of sequences that minimises the design effect and so
gives the most efficient SWT design. I then compare this most efficient SWT
design to other cluster randomised designs.
In this paper, k denotes the number of sequences (all other chapters of this
thesis have used the letter g). The appendix given here differs to the published
version to improve consistency of terminology and format with the rest of this
thesis.
The paper has been peer reviewed and is published in Clinical Trials, titled
“The optimal design of the stepped-wedge trials with equal allocation to se-
quences, and a comparison to other trial designs” by myself, Katherine Field-
ing, James Hargreaves, and Andrew Copas. The paper is licensed under CC
BY 2.0. It did not require ethics approval because no real data are used.
Evidence of retention of copyright is given in Appendix A.
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The optimal design of stepped wedge
trials with equal allocation to
sequences and a comparison to other
trial designs
Jennifer AThompson1,2, Katherine Fielding1, James Hargreaves3 and
Andrew Copas2
Abstract
Background/Aims: We sought to optimise the design of stepped wedge trials with an equal allocation of clusters to
sequences and explored sample size comparisons with alternative trial designs.
Methods: We developed a new expression for the design effect for a stepped wedge trial, assuming that observations
are equally correlated within clusters and an equal number of observations in each period between sequences switching
to the intervention. We minimised the design effect with respect to (1) the fraction of observations before the first and
after the final sequence switches (the periods with all clusters in the control or intervention condition, respectively) and
(2) the number of sequences. We compared the design effect of this optimised stepped wedge trial to the design effects
of a parallel cluster-randomised trial, a cluster-randomised trial with baseline observations, and a hybrid trial design (a
mixture of cluster-randomised trial and stepped wedge trial) with the same total cluster size for all designs.
Results:We found that a stepped wedge trial with an equal allocation to sequences is optimised by obtaining all observa-
tions after the first sequence switches and before the final sequence switches to the intervention; this means that the first
sequence remains in the control condition and the last sequence remains in the intervention condition for the duration of
the trial. With this design, the optimal number of sequences is 1=(1 ﬃﬃﬃRp ), where R= rm=(1+ r(m 1)) is the
cluster-mean correlation, r is the intracluster correlation coefficient, and m is the total cluster size. The optimal number
of sequences is small when the intracluster correlation coefficient and cluster size are small and large when the intraclus-
ter correlation coefficient or cluster size is large. A cluster-randomised trial remains more efficient than the optimised
stepped wedge trial when the intracluster correlation coefficient or cluster size is small. A cluster-randomised trial with
baseline observations always requires a larger sample size than the optimised stepped wedge trial. The hybrid design can
always give an equally or more efficient design, but will be at most 5% more efficient. We provide a strategy for selecting
a design if the optimal number of sequences is unfeasible. For a non-optimal number of sequences, the sample size may be
reduced by allowing a proportion of observations before the first or after the final sequence has switched.
Conclusion: The standard stepped wedge trial is inefficient. To reduce sample sizes when a hybrid design is unfeasible,
stepped wedge trial designs should have no observations before the first sequence switches or after the final sequence
switches.
Keywords
Stepped wedge trial, cluster randomised trial, hybrid trial, sample size, design effect, power, study design
Introduction
Stepped wedge trials (SWTs) are growing in popularity,
but modification of the design to minimise their sample
size have not been fully explored.
In an SWT, clusters are randomised into allocation
sequences. Sequences consist of a different number of
periods in the control condition, followed by the
remaining periods of the trial in the intervention
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condition. At the beginning of each period, one of the
sequences switches to the intervention, as shown in
Figure 1(a). This means that a design with k sequences
has k 2 1 periods between the first sequence switching
and the final sequence switching to the intervention
condition. We will call this section of the trial ‘rollout’
because the intervention has been introduced to some
but not all the clusters.
Before and after rollout, that is, before the first
sequence switches to the intervention and after the final
sequence switches to the intervention, there can be
additional periods of data collection that may be longer
or shorter than the periods during rollout (Figure 1(b)
and (d)). In a standard SWT design (Figure 1(a)), these
periods are the same length as the periods between roll-
out. Variations of the SWT design could include only
the rollout period (Figure 1(c)), a period before rollout
but not after or after rollout but not before.
There are many further possible variations but in this
article, we only consider designs where the same num-
ber of observations is collected in each of the periods
during rollout and that the same number of clusters is
randomised to each sequence. This implies that the roll-
out will occur at an even pace, that is, equal numbers of
clusters implement the intervention at each time, which
we feel is a natural constraint when there are limited
resources to conduct the implementation. We focus on
data with equal correlation within each cluster.1
There are several approaches to sample size calcula-
tion for SWTs;2–5 the simplest is the design effect
approach. Here, a sample size is calculated assuming
individual randomisation and is then multiplied by a
design effect to increase the sample size appropriately
for a different design. Woertman et al. developed what
they termed a design effect for an SWT, but this must
be multiplied by the number of periods in the trial to
give what we define here as the design effect.2,6 While
their design effect has been a useful contribution to the
literature, it is difficult to untangle the effects of each
design component on the sample size to examine how
to improve the efficiency of SWTs.
One such component which cannot be examined by
the design effect of Woertman et al. is the number of
periods before and after rollout; changing the number
of periods before rollout increases the total cluster size
so it is difficult to examine the impact of this change
holding the total cluster size constant.2 Girling and
Hemming found that having half a period before roll-
out and half a period after rollout produced greater
efficiency than the standard design when the total clus-
ter size was held constant,7 but it is not known whether
even fewer observations before and after rollout would
Figure 1. Diagrammatic illustrations of trial designs. Each has the same number of clusters and the same total cluster size. (a)–(d)
Stepped wedge cluster-randomised trials (SWTs) with four sequences varying the amount of data before and after rollout. (a)
Standard design: the same number of observations before and after rollout and between sequences switching, (b) number of
observations before and after rollout is half the number between sequences switching, (c) optimised design: no observations before
or after rollout, (d) no observations before rollout, 50% after rollout. (e)–(g) Other designs: (e) parallel cluster-randomised trial:
CRT, (f) parallel cluster-randomised trial with baseline observations, (g) hybrid design with 50% CRT, 50% SWTwith four sequences
and the number of observations before and after rollout equal to half the number between sequences switching.
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be more efficient. In addition, although there is a con-
sensus through empirical evidence that the power of a
standard SWT increases with an increase in the number
of sequences,2,3 this has not been explored for varia-
tions of the SWT design.
Researchers often cite increased statistical power as
a reason for choosing SWTs over other trial designs.8
Designs where clusters act as their own control can be
more powerful,7 but they also require assumptions
about changes in the outcome over time. Comparisons
have been made between SWTs and parallel cluster-
randomised trials (CRTs; Figure 1(e)), CRTs with
baseline observations where half of the total cluster size
are baseline observations (Figure 1(f)), and more
recently with the hybrid design described by Girling
and Hemming.7 The hybrid design includes sequences
that are in the control or intervention conditions for
the entire study and allows allocation to those two
sequences to differ from allocation to the remaining
sequences which form an SWT design, as shown in
Figure 1(g). Standard SWT designs have been found to
be more efficient than CRTs when the intracluster cor-
relation coefficient (ICC) is high and when the total
cluster sizes are large, and a standard SWT with four
or more sequences always has more power than a CRT
with baseline observations.6,9–11 The hybrid design
appears to have the highest power as it is most flexible,7
but the degree of efficiency gain from allowing unequal
allocation has not been established.
In this article, we give a new design effect expression
for an SWT that allows the number of observations
before and after rollout to vary without increasing the
total cluster size but maintains the requirement com-
mon to the standard SWT of equal-sized periods
between sequences switching to the intervention and the
same number of clusters randomised to each sequence.
This allowed us to identify the optimal number of
sequences and the optimal number of observations
before and after rollout to minimise the required num-
ber of clusters for a given power, ICC, and total cluster
size. We compare the efficiency of our optimised SWT
designs to several other common trial designs for a
given power, ICC, and total cluster size, and we provide
guidance in choosing a trial design. An example is then
used to demonstrate the difference in sample size
between possible designs.
Methods
SWT
Woertman et al. developed a design effect for an SWT
under the assumptions of the Hussey and Hughes anal-
ysis model.2,3,6 We rewrite this design effect based on
similar methodology to that used by Woertman et al.2
In our new design effect, the number of observations
before and after rollout is specified as proportions of
the total cluster size. For example, one could have half
of all observations after rollout and none before roll-
out, as shown in Figure 1(d).
For simplicity, we assumed that the outcome is nor-
mally distributed, clusters are of equal size, and obser-
vations are equally correlated within clusters regardless
of time or whether from the control or intervention
condition. We assume that the intervention effect is
constant over time, is fully realised by the first observa-
tion after the intervention is implemented, and is com-
mon across all clusters. We also require that secular
trends are common to all clusters, the same number of
clusters is randomised to each sequence, and that there
is the same number of observations in all periods
between sequences switching to the intervention.
This new design effect will be used to find the combi-
nation of number of sequences and proportion of
observations before and after rollout that minimise the
sample size (number of clusters) for a given power,
total cluster size, and ICC. This SWT, derived under
the constraint of equal allocation to sequences, will be
referred to as an ‘optimised’ SWT.
This optimised SWT will then be compared to other
trial designs. We will consider a CRT, a CRT with base-
line observations and the hybrid design.7 Throughout
these comparisons, we fix the power, total cluster size,
and ICC.
Parallel CRT
A CRT (Figure 1(e)) is an attractive design because the
intervention effect is not confounded with time and so
it does not require assumptions about secular trends.
The published design effect for a CRT is as follows
DECRT = 1+ m 1ð Þr ð1Þ
where m is the total cluster size, and r is the ICC.12
Parallel CRT with baseline observations
A CRT with baseline observations (Figure 1(f)) is
equivalent to an SWT with two sequences, some pro-
portion of observations before rollout and no observa-
tions after rollout.13 Making the same assumptions as
the SWT, such a design can be analysed with the same
model as an SWT,3 and so, the new design effect can
also be applied. We used our design effect to find the
optimum proportion of observations to have at base-
line to minimise the sample size of this design before
comparing the required sample size to the optimised
SWT.
Hybrid design trial
Girling and Hemming described a trial design where
some of the clusters were randomised to a parallel
Thompson et al. 3
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CRT, while the remaining clusters were randomised to
an SWT with half a period before rollout and half a
period after rollout (Figure 1(g)).7 This hybrid trial
design makes the same assumptions as the SWT and
can be analysed with the Hussey and Hughes analysis
model.3 They found that the optimal proportion of
clusters to randomise to the SWT was the cluster-mean
correlation defined as follows7
R=
mr
1+ m 1ð Þr
where 0R 1 increases as the ICC or total cluster size
increases. So, when the ICC or cluster size increases,
the optimal proportion of clusters randomised to the
SWT increases and the proportion randomised to the
CRT reduces.
The hybrid design is flexible enough that it can sim-
plify to a parallel CRT, it can simplify to a design simi-
lar to a standard SWT but with half a period before
and half a period after rollout (Figure 1(b)), and it can
simplify to a modified SWT design with no period
before and after rollout, and the first and final periods
are half the size of the other periods, similar to the
design considered later in this article. The first two of
these simplifications are straightforward to see; all clus-
ters are randomised to the relevant part of the trial.
The final simplification requires a proportion of 2/(k
+ 2) clusters to be randomised to the parallel CRT
and the remaining clusters to be randomised to the
SWT with k sequences. Following the recommenda-
tions of Girling and Hemming will lead to one of these
designs if it is the most efficient option or it will lead to
a hybrid design if that is most efficient.7
We compared our optimised SWT with k sequences
to an optimal hybrid design to see whether the
increased flexibility of the hybrid design gave a practi-
cally relevant decrease in sample size. The optimal
hybrid had a proportion equal to the cluster-mean cor-
relation of clusters randomised to the SWT, and the
SWT within the hybrid had as many sequences as there
were clusters.
Choosing an SWT design
Finally, we acknowledge that the optimised SWT may
not always be a practical design and provide recom-
mendations for how to design an efficient and practical
trial. We provide an example to demonstrate the differ-
ences in sample size of different designs.
Results
The design effect for an SWT
We define k as the number of sequences, b as the pro-
portion of the total cluster size that is before rollout,
and a the proportion of the total cluster size that is
after rollout. For example, in a standard SWT,
b=a= 1=(k+ 1) (Figure 1(a)), alternatively one
could have no observations before rollout, so b= 0,
but a large period after rollout, say half of the total
cluster size, so a= 0:5 (Figure 1(d)). The total cluster
size remains the same regardless of a and b, and the
remaining observations are distributed equally between
the periods within rollout.
In Appendix 1, we derive a design effect for an SWT
with these characteristics
DESWT = 1+ m 1ð Þrð Þ 3k k  1ð Þ
2 k+ 1ð Þ
1 Rð Þ
1 b+að Þ½  k 1 0:5R 1 b+að Þ½ ð Þ  1½ 
ð2Þ
The terms a and b only affect the design effect
through their sum a+b and so it is the combined pro-
portion of observations outside rollout that affects the
power, rather than the individual quantities. a and b
are also exchangeable in this equation; this means that
observations before and after rollout have the same
impact on power. This is due to the assumption of
observations being equally correlated within each
cluster.
Minimising the sample size of an SWT
In Appendix 2, we show that the optimised SWT has
no observations outside rollout (a+b= 0; Figure
1(c)) with the number of sequences depending on the
ICC and total cluster size, as shown in equation (3)
Optimal number of sequences=
1
1 ﬃﬃﬃRp ð3Þ
Equation (3) will give a non-integer number; to find
the exact optimal number of sequences, calculate the
design effect (equation (2)) for the integers either side
of the result given by equation (3), but a rule of thumb
is to round the result to the nearest integer.
The optimal number of sequences increases as the
cluster-mean correlation increases (i.e. the ICC or total
cluster size increase), but for low cluster-mean correla-
tion (low ICC or small total cluster size), a small num-
ber of sequences is optimal. For example, with 100
observations per cluster and an ICC = 0.01
(R = 0.50), it is optimal to have 3 sequences, but with
an ICC = 0.1 (R = 0.92), it is optimal to have 24
sequences. Figure 2 shows the optimal number of
sequences for different cluster-mean correlations.
Minimising the sample size of a CRT with baseline
observations
The design effect (equation (2)) can also give the opti-
mal proportion of baseline observations for a CRT. In
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Appendix 4, we show that the proportion of observa-
tions at baseline that minimises the sample size of a
CRT with baseline observations is as follows
b=
1 1
2R
if R  1
2
0 otherwise
8<
: ð4Þ
For low values of the cluster-mean correlation, it is
optimal to have no baseline observations, and for
higher values, the optimal proportion of baseline mea-
surements increases to a ceiling of 50% of observations.
Comparison of an optimised SWT to a CRT
In Appendix 3, we show that when the optimal number
of sequences from equation (3) is\2.5, this means that
a CRT would require a smaller sample size than any
SWT with no observations outside rollout. As a rule of
thumb, a CRT will require a smaller sample size when
r\
1
9
16
m+ 1
For example, with 100 observations per cluster, a
CRT will require fewer clusters than an SWT with no
observations outside rollout if ICC \ 0.005.
Alternatively, a CRT can be compared to a specific
SWT with k sequences and no observations outside roll-
out. The CRT will require a smaller sample size when
r\
1
k+ 1ð Þ
k  1ð Þ m+ 1
In Appendix 5, we show that a CRT with baseline
observations will always require the same or a larger
sample size than the optimised SWT.
Comparison to a hybrid design
Figure 3 shows the relative sample size of the SWT
with no observations outside rollout and 3, 4, 5, or 20
sequences compared to the optimised hybrid design.
The optimal SWT, with the optimal number of
sequences, is the lowest line at any value of R. For
example, at R = 0.2, two sequences are optimal, but at
R = 0.7, five sequences are optimal. While the hybrid
always has the smaller sample size of the two designs,
the differences are small when compared to the optimal
SWT, and the optimal SWT requires at most a 5%
larger sample size than the hybrid design.
Other pragmatic SWT designs: a non-optimal
number of sequences and including observations
outside rollout
It may not always be practical to use the optimal num-
ber of sequences calculated in equation (3) as this may
be a large number. The primary constraint on the num-
ber of sequences is that it cannot exceed the number of
clusters in the trial, and the number of periods in the
trial cannot exceed the total cluster size. Furthermore,
in many settings, the logistical effort to implement the
Figure 2. Optimal number of sequences by the cluster-mean
correlation. The number of sequences tends to infinity as the
cluster-mean correlation tends to 1.
Figure 3. Graph of the sample size of the SWTwith no
observations outside rollout, relative to the optimised hybrid
against the cluster-mean correlation. Darkest and dotted
line = 2 sequences, lightest and solid line = 20 sequences. The
optimal SWT is the lowest line at any given cluster-mean
correlation.
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intervention at many different time points would be too
great.
In such cases, a smaller, feasible number of sequences
could be selected and there may then be some gain from
obtaining observations outside rollout. For a fixed num-
ber of sequences, the optimal proportion of observations
outside rollout (see Appendix 2 for derivation) is a func-
tion of the number of sequences and the cluster-mean
correlation, as shown in equation (5)
a+b=
1 k  1ð Þ
k
1
R
if R  k  1ð Þ
k
0 otherwise
8<
: ð5Þ
For low values of the cluster-mean correlation, that
is, low ICC or small total cluster size, it is optimal to
have no observations outside rollout, and for higher
values, as the ICC or total cluster size increases, the
optimal proportion outside rollout increases up to a
proportion of 1/k.
This proportion varies between 0 (no observations
outside rollout) and 1/k (equivalent to the same num-
ber of observations outside rollout as in one period of
the trial). This tells us that the standard SWT, with 1/k
observations before and 1/k observations after rollout,
is inefficient.
For an SWT with the proportion of observations
outside rollout selected from equation (5), increasing
the number of sequences reduces the sample size of the
design (see Appendix 7). However, there is little gain
from increasing past five sequences, after which there is
a maximum 4% further reduction in the sample size.
This is only true while R  (k  1)=k, equivalent to
k\1=(1 R). When the number of sequences passes
this threshold, the sample size is smallest with no obser-
vations outside rollout and increasing the number of
sequences will only continue to reduce the sample size
up to the optimal number of sequences from equation
(3). Appendix 7 contains comparisons of an SWT with
this proportion of the observations outside rollout to
the other trial designs considered in this article.
Selecting an SWT design
One strategy for selecting an SWT design with an equal
number of clusters in each sequence and an equal num-
ber of observations in each period is as follows:
1. Calculate the optimal number of sequences using
equation (3).
2. If the number of sequences is feasible, then you
have the optimal SWT design by selecting this
number of sequences and collecting no observa-
tions outside of rollout.
3. If the number of sequences is unfeasibly high, select
the number closest to this value that is feasible.
Then, compare the cluster-mean correlation to the
chosen number of sequences using equation (5) to
see whether there is any gain from including obser-
vations outside rollout.
Several iterations of designs may be needed to
achieve an equal number of clusters in each sequence,
varying the numbers of clusters or sequences, so the
former is a multiple of the latter. Iterations may also be
required to achieve an equal number of observations in
each period, varying the total cluster size and number
of periods, so the former is a multiple of the latter.
Alternatively, the Stata command by Hemming et al.
can be used to calculate the power of an unbalanced
design.4 Once the most appropriate SWT design has
been identified, the sample size can be compared with
other potential designs such as the CRT and hybrid
design if these are feasible.
Example
Consider a CRT designed to yield 80% power to detect
a mean difference of 0.1 in a continuous outcome with
a total variance of 1, using a two-sided test at the 5%
significance level. The ICC is 0.04, and the total num-
ber of observations per cluster is 84. Table 1 shows the
number of clusters required to achieve 80% power by
several designs. For each design, we give the number of
clusters given by the relevant design effect and the num-
ber of clusters and power after allowing for an equal
number of clusters allocated to each sequence. For the
power of some designs, we also made small changes to
the total cluster size so that there are an equal number
of observations in each period of the trial.
The optimised SWT has eight sequences (and no
observations outside rollout). After adjusting the num-
ber of clusters to get the same number in each sequence,
this design required 88 clusters. Increasing the number
of sequences to 88 (one cluster randomised to each
sequence) resulted in the design effect giving a larger
required number of clusters; this design is an impracti-
cal design only given to show that the required number
of clusters does not decrease with more sequences.
Other SWT designs required between 96 and 99 clusters
to achieve 80% power.
A CRT requires almost twice as many clusters as the
optimised SWT (162 clusters), and a CRT with baseline
observations requires 112 clusters. As expected, the
optimised hybrid design, with 78% of clusters rando-
mised to an SWT with 17 sequences, required slightly
fewer clusters than the optimised SWT.
Discussion
We have shown that the sample size of an SWT under
equal allocation to sequences can be minimised by col-
lecting all observations within rollout. Unlike the stan-
dard SWT, in this optimised SWT, the optimal number
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of sequences depends on the cluster-mean correlation.
We have also provided advice on when to consider
other trial designs, acknowledging that a hybrid design
will be always slightly more efficient.
Our finding that the most efficient SWT design is to
have no observations outside rollout, at least if the
resulting optimal number of sequences is also feasible,
has not been suggested previously. This optimised
SWT may, however, be unacceptable because not all
the clusters will receive the intervention during the trial.
Trialists may want to include some observations after
rollout to avoid a ‘disappointment effect’ in the clusters
that would not otherwise receive the intervention.
Alternatively, the intervention could still be implemen-
ted after data collection has been completed.
We found that there were an optimal number of
sequences for minimising the sample size of the SWT
with no observations outside rollout. The number was
large when the cluster-mean correlation was high (high
ICC or large total cluster size) but small when the
cluster-mean correlation was low (small ICC and small
total cluster size). This contrasts with previous research
for the standard SWT which showed that the sample
size reduced as the number of sequences increased.2,3 It
is, however, consistent with the consensus in the litera-
ture and finding of this study that a CRT requires a
smaller sample size than an SWT when the ICC and
total cluster size are low.7,10
We examined the optimal proportion of baseline
observations in a CRT. We found that when the
cluster-mean correlation is low, there is no benefit for
the power of the study from including baseline observa-
tions. This is because when the ICC is high, the baseline
observations will explain more of the variability in the
follow-up measurements than when the ICC is low.
Our results differed to much of the current literature
that suggests that there is always a benefit to including
baseline measurements.14,15 In this literature, total clus-
ter size was not held constant – instead, baseline obser-
vations were included as additional observations
relative to a design with no baseline.
This article is the first to compare the sample size
implications of increasing the proportion of observa-
tions outside rollout versus increasing the number of
sequences. We have found that increasing the number
of sequences can have a larger impact on the sample
size than increasing the proportion of observations out-
side rollout. For example, there is a larger reduction in
sample size (providing the ICC and total cluster size
are large enough) going from a CRT to an SWT with
three sequences and no observations outside rollout
than adding baseline observations to a CRT.
We found that the optimal number of sequences
quickly increased with the ICC and total cluster size to
a number that may not be practical. In cases such as
this where a non-optimal number of sequences is cho-
sen, we found that observations outside rollout may
compensate and provide a reduction in the sample size;
however, it is never beneficial to the sample size to have
more observations outside rollout than are collected in
Table 1. Illustrative example of the number of clusters required by different designs to achieve 80% power to detect a difference of
0.1 with standard deviation of 1.
Design Calculated
number of clusters
Final design
Number of clusters
after rounding
Total cluster
sizea
Power (%)
Optimised SWT
8 sequences, no observations outside rollout 86.1 88 84 81
Other SWT designs
88 sequences, no observations outside rollout 87.7 88 87 81
8 sequences, 22% outside rollout (standard SWT) 94.0 96 81 80
3 sequences, no observations outside rollout 96.9 99 84 81
3 sequences, optimal outside rollout (14%) 94.2 96 84 81
Other designs
CRT 161.5 162 84 80
CRTwith optimal proportion of
observations at baseline (36%)
111.6 112 84 80
Hybrid: 78% 17-sequence SWTs (optimalb) 84.8 86: 68 SWTs, 18 CRTs 85 81
CRT: parallel cluster-randomised trial; SWT: stepped wedge trial.
Total cluster size = 84, intracluster correlation coefficient (ICC) = 0.04, 5% significance level and 80% power.
Difference in calculated number of clusters and final number of clusters is due to rounding up and the requirement for an equal number of clusters
per sequence.
aFor power calculations, the total cluster size had to be varied for some of these designs to allow an equal number of observations in each period of
the trial.
bThe optimal number of sequences was 68, which gave a calculated number of clusters or 84.7. For 17 sequences, the calculated number is higher,
but the final number of clusters required was the same as for 68 sequences and allowed a total cluster size similar to the other designs being
considered.
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one period of the trial, similar to the results from
Girling and Hemming.7
Some recently published SWTs included a large pro-
portion of data outside of rollout, usually with the jus-
tification of investigating the longer-term effect of the
intervention.1,16 These designs will give a larger var-
iance for the intervention effect than our optimised
SWT design with the same number of observations
would have done. Trialists should also be aware that
with no control observations after rollout, it will be dif-
ficult to assess whether changes in the outcome are due
to changes in the intervention effect or other reasons.
Our design effect assumes that the intervention effect
remains constant throughout the trial. If this is not
expected to be the case, different methods of sample
size calculation, such as simulations,5 and more com-
plex analysis methods should be used.
We found that the hybrid design was more efficient
than the optimised SWT, as expected, due to its addi-
tional flexibility to allow unequal allocation to
sequences. However, the gain in efficiency from this
flexibility was at most 5%. Therefore, where consider-
able additional resources would be required to imple-
ment the intervention in a larger number of clusters at
the start of the trial than at subsequent switches, the
hybrid design will be unattractive. This might be the
case if, for example, there is only one team available to
roll the intervention out. The optimised hybrid design
does not, however, always allocate more clusters to
implement the intervention immediately than to other
sequences, so one approach to design is to first see
whether the optimised hybrid is feasible, and if not,
then consider the optimised SWT under equal
allocation.
We have given comparisons to some alternative
designs, but there are many designs that we have not
included. We have not explored incomplete designs
such as the dog-leg design or unbalanced SWTs.17,18
We have compared trial designs fixing the total cluster
size, but a further area of research could vary the total
cluster size and fix the number of clusters or look to
minimise a combination of the two. In some settings,
there may be little or no cost associated with collecting
observations before or after rollout, for example, with
routinely collected data. If this is the case, it may be
more informative to compare trial designs for a given
cost rather than a fixed total cluster size.
As with all design effects, the assumptions made
about the data must hold for the design effect to be
valid, such as exchangeability within clusters and time
trends that are common to all clusters. If these assump-
tions do not hold, using the design effect given here
may result in an underpowered trial as the assumed
analysis model would be inappropriate. These assump-
tions have sometimes been criticised as being unrealis-
tic, and others have provided design effects where some
assumptions have been relaxed.19–21 Baio et al. found
the assumption of normality affected sample size calcu-
lations for binary outcomes.5
Power is only one consideration of many when
selecting a trial design. Caution should also be used in
designing trials with very few clusters; among other
issues, this may reduce generalisability and increase the
possibility of chance imbalances.22 The lower sample
size requirements of SWT and hybrid designs com-
pared to a CRT come at the cost of requiring assump-
tions about how the outcome is changing over time
because the intervention effect is confounded with time.
Care needs to be taken to ensure that these assump-
tions are appropriate and that the analysis takes this
into account adequately.19
We have identified SWT designs that require fewer
clusters than the standard SWT and facilitated compar-
isons of statistical power between competing trial
designs. Following our guidance on selecting a design
will result in more efficient trials.
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Appendix
Appendix 1: Derivation of the Design Effect
Throughout this appendix we will use the following notation (which is different
in some cases to the rest of this thesis):
i is the number of clusters in each sequence,
k is the number of sequences,
z = ik is the number of clusters
Xlj is an indicator variable of whether cluster l is receiving the inter-
vention in period j
b is the number of observations before rollout relative to the number
collected in each period, so if twice as many are collected before
rollout this would be 2.
a is the number of observations are collected after rollout relative to
the number collected in each period.
β is the proportion of the total cluster size that are before rollout
α is the proportion of the total cluster size that are after rollout
δ = α + β is the proportion of the total cluster size that is outside rollout
n is the number of observations collected in each cluster in each
period.
m is the total cluster size.
ρ is the ICC.
The formula for the variance of the intervention effect from the Hussey and
Hughes analysis model [1]:
V ar
(
θˆ
)
=
I σ
2
w
n
(
σ2w
n
+ Tσ2b
)
(IU −W ) σ2w
n
+ (U2 + ITU − TW − IV )σ2b
where σ2w is the within cluster variance , and σ2b is the between-cluster
variance of the cluster means in a given period, and the other terms are
defined as follows:
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I = ik
T = b+ (k − 1) + a
U =
∑
lj
Xlj
W =
∑
j
(
∑
l
Xlj)2
V =
∑
l
(
∑
j
Xlj)2
We want this formula in terms of the total variance σ2, so can use the following
substitutions (see Woertman et al [2] for derivations):
σ2w
n
= (1− ρ)σ
2
n
σ2b = ρσ2 =
nρσ2
n
V ar
(
θˆ
)
=
I (1−ρ)σ
2
n
(
(1−ρ)σ2
n
+ T nρσ2
n
)
(IU −W ) (1−ρ)σ2
n
+ (U2 + ITU − TW − IV ) nρσ2
n
= I (1− ρ)σ
2
n
((1− ρ) + Tnρ)
(IU −W ) (1− ρ) + (U2 + ITU − TW − IV )nρ
We can work out the component parts to substitute into this:
U = i((1 + 2 + ...+ (k − 1)) + ak)
= i(12k
2 − 12k + ak)
W = (1i)2 + (2i)2 + ...+ ((k − 1)i)2 + a(ki)2
= i2
(
k3
3 −
k2
2 +
k
6 + ak
2
)
V = i(a)2 + i(a+ 1)2 + i(a+ 2)2 + ...+ i(a+ (k − 1))2
= i(k
3
3 −
k2
2 +
k
6 + a
2k + ak2 − ak)
Now we can combine these to get the component parts:
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IU −W = ik
(
i
(1
2k
2 − 12k + ak
))
− i2
(
k3
3 −
k2
2 +
k
6 + ak
2
)
= i
2
6 k
(
k2 − 1
)
U2 = i2k2(12k −
1
2 + a)
2
= i2k
(1
4k
3 − 12k
2 + ak2 − ak + a2k + 14k
)
ITU = ik (b+ k − 1 + a)
(
i
(1
2k
2 − 12k + ak
))
= i2k
(1
2bk
2 − 12bk + abk +
1
2k
3 − k2 + 12k +
3
2ak
2 − 32ak + a
2k
)
TW = (b+ k − 1 + a)
(
i2
(
k3
3 −
k2
2 +
k
6 + ak
2
))
= i2k
(1
3bk
2 − 12bk +
1
6b+ abk +
1
3k
3 − 56k
2 + 46k −
1
6 +
4
3ak
2
)
+i2k
(
−32ak +
1
6a+ a
2k
)
IV = i2k
(
k3
3 −
k2
2 +
k
6 + a
2k + ak2 − ak
)
U2 − IV = i2k
(1
4k
3 − 12k
2 + ak2 − ak + a2k + 14k
)
−i2k
(
k3
3 −
k2
2 +
k
6 + a
2k + ak2 − ak
)
= i2k
(
− 112k
3 + 112k
)
ITU − TW = i2k
(1
2bk
2 − 12bk + abk +
1
2k
3 − k2 + 12k +
3
2ak
2 − 32ak + a
2k
)
−i2k
(1
3bk
2 − 12bk +
1
6b+ abk +
1
3k
3 − 56k
2 + 46k −
1
6 +
4
3ak
2
)
−i2k
(
−32ak +
1
6a+ a
2k
)
= i2k
(1
6bk
2 − 16b+
1
6k
3 − 16k
2 − 16k +
1
6 +
1
6ak
2 − 16a
)
U2 + ITU − TW − IV = i2k
(
− 112k
3 + 112k +
1
6bk
2 − 16b+
1
6k
3 − 16k
2
)
+i2k
(
−16k +
1
6 +
1
6ak
2 − 16a
)
= i
2k (k2 − 1)
6
(
b+ 12k − 1 + a
)
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Substituting this into the variance formula gives:
V ar
(
θˆ
)
= I (1− ρ)σ
2
t
n
((1− ρ) + Tnρ)
(IU −W ) (1− ρ) + (U2 + ITU − TW − IV )nρ
= ik (1− ρ)σ
2
t ((1− ρ) + (b+ k − 1 + a)nρ)
n
[(
i2
6 k (k2 − 1)
)
(1− ρ) +
(
i2
6 k (k2 − 1)
(
b+ 12k − 1 + a
))
nρ
]
= (1 + ρ (bn+ kn+ an− n− 1))(
1 + ρ
(
bn+ 12kn+ an− n− 1
)) 6 (1− ρ)(
k − 1
k
) σ2t
nik
To give this formula in terms of the total cluster sizem, and proportions before
and after rollout β and α respectively, we can use the following substitutions:
m = bn+ nk − n+ an
β = bn
m
α = an
m
So the variance becomes
V ar
(
θˆ
)
= 6σ2 (1 + ρ (m− 1))(
1 + ρ
(
m− 1− 12kn
)) (1− ρ)(
k − 1
k
) 1
nik
= 6σ2 (1 + ρ (m− 1))(
1 + ρ
(
m− 1− 12kn
)) (1− ρ)(
k − 1
k
) 1
zm(1−β−α)(k−1)
= 6σ2 (1 + ρ (m− 1))(
1 + ρ
(
m− 1− 12kn
)) (1− ρ)(
k − 1
k
) k − 1
zm(1− β − a)
= 6σ
2
mz
(1 + ρ (m− 1)) k(k + 1)
× (1− ρ)
(1− β − a)
(
1 + (m− 1) ρ− 12 kk−1 (1− β − α) ρm
) (6.1)
The variance of a trial with this sample size if it was individually randomised
would be:
V ar(θind) =
4σ2
mz
So our design effect becomes:
DE = 32 (1 + ρ (m− 1))
k
(k + 1)
(1− ρ)
(1− β − α)
(
1 + (m− 1) ρ− 12 kk−1 (1− β − α) ρm
)
We can rewrite this in terms of the cluster mean correlation defined by Girling
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and Hemming [3]:
R = ρm(1 + ρ (m− 1))
Our design effect becomes:
DE = 32 (1 + ρ (m− 1))
k (k − 1)
(k + 1)
(1−R)
(1− β − α) (k (1− 0.5R (1− β − α))− 1)
In this paper we discuss minimising the design effect in terms of the number of
sequences, k, and the proportion outside of rollout β+α. Note that to do this
only the last 2 terms of the DE are manipulated. All other parts of the design
effect are held constant. Also note that these last 2 terms are the same as the
last 2 terms in the variance formula equation (6.1). So minimising the design
effect with respect to k and α+β is equivalent to minimising the variance. We
can also rearrange equation (6.1) to give a formula for the number of clusters,
these last 2 terms remain the same with all other terms remaining constant
regardless of the values of k and β + α . This means that the results we find
for the values of k and β + α to minimise the design effect give the optimal
values to minimise the number of clusters, or the variance.
Appendix 2: Optimal Number of Sequences and Optimal
Proportion of Observations Outside Rollout
We want to find the combination of number of sequences k and the proportion
outside rollout, α + β, that minimises the design effect. We can do this by
partially differentiating the design effect, firstly in terms of the number of
sequences to get an equation for the optimal k, and secondly in terms of α+β
to get an equation for the optimal α+ β. We will then solve these 2 equations
simultaneously to find an optimum design for a given m and ρ.
We have boundaries on these values so we also need to check for optimal values
at the boundaries. The boundaries are:
k ≥ 2
0 ≤ α + β ≤ 1
Let δ = α + β be the proportion of observations that are outside rollout.
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Substituting this into the design effect gives:
DE = (1 + ρ (m− 1)) 3k2 (k + 1)
(1− ρ)
(1− δ)
(
1 + (m− 1) ρ− 12 kk−1 (1− δ) ρm
)
Optimising the number of sequences k
Although k will be an integer, we will treat it as continuous and assume that
the optimal k will be one of the integers either side of the identified continuous
optimal value. This means that we can differentiate the design effect with
respect to k to get an equation for the optimal number or sequences for a
given δ:
DE = (1 + ρ (m− 1)) 3k2 (k + 1)
(1− ρ)
(1− δ)
(
1 + (m− 1) ρ− 12 kk−1 (1− δ) ρm
)
d(DE)
dk
= 3 (1 + ρ (m− 1)) (1− ρ)2 (1− δ)
× d
dk
 k
(k + 1)
(
1 + (m− 1) ρ− 12 kk−1 (1− δ) ρm
)

= 3 (1 + ρ (m− 1)) (1− ρ)2 (1− δ)
×k
2 (1 + ρ (mδ − 1))− 2k (1 + ρ (m− 1)) + (1 + ρ (m− 1))(
(k2 − 1) (1 + ρ (m− 1))− 12 (1− δ) ρmk (k + 1)
)2
The optimal number of sequences is when the derivative is equal to zero. So:
k2 (1 + ρ (mδ − 1))− 2k (1 + ρ (m− 1)) + (1 + ρ (m− 1)) = 0
k =
2 (1 + ρ (m− 1))±
√
(2 (1 + ρ (m− 1)))2 − 4 (1 + ρ (mδ − 1)) (1 + ρ (m− 1))
2 (1 + ρ (mδ − 1))
=
(1 + ρ (m− 1))±
√
(1− δ) ρm (1 + ρ (m− 1))
(1 + ρ (mδ − 1))
There are 2 solutions here. The negative square root will only give a number
of sequences greater than 2 when :
ρ <
1
(3m+ 1)
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This suggests that the negative square root does not give the minimum. Graph-
ical inspection and numerical example support that the positive square root
gives a minimum value of the design effect. So the optimal number of sequences
fixing all other parameters is:
k =
(1 + ρ (m− 1)) +
√
(1− δ) ρm (1 + ρ (m− 1))
(1 + ρ (mδ − 1))
Optimising the proportion outside rollout δ = α + β
To find the minimum of the DE with respect to δ = α + β, differentiate with
respect to δ:
d(DE)
dδ
= (1 + ρ (m− 1)) (1− ρ) 3k2 (k + 1)
× d
dδ
 1
(1− δ)
(
(1 + ρ (m− 1))− 12 kk−1ρm (1− δ)
)

= (1 + ρ (m− 1)) (1− ρ) 3k2 (k + 1)
×
 (1 + ρ (m− 1))− kk−1ρm (1− δ)
(1− δ)2
(
(1 + ρ (m− 1))− 12 kk−1ρm (1− δ)
)2

The turning point is when:
d(DE)
dδ
= 0
⇒ δ = 1− (k − 1) (1 + ρ (m− 1))
ρmk
Taking the second derivative shows that this is a minimum.
δ can get infinitely small but this is not possible under our constraint of δ ≥ 0
so we must limit this value to 0 for any value smaller than 0. This happens
when:
(k − 1)
k
(1 + ρ (m− 1))
ρm
> 1
Or equivalently
ρm
(1 + ρ (m− 1)) <
k − 1
k
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We can write this as the proportion outside rollout fixing all other parameters:
δ = α + β =
1−
(k−1)
k
(1+ρ(m−1))
ρm
, ρm(1+ρ(m−1)) ≥ k−1k
0 otherwise
Since 1 < (1+ρ(m−1))
ρm
<∞, this optimal α + β has boundaries:
0 ≤ α + β ≤ 1
k
This can also be written in terms of the cluster mean correlation R:
δ = α + β =
1−
(k−1)
k
1
R
, R ≥ k−1
k
0 otherwise
Solving the equations
We now have the simultaneous equations:
δ = 1− (k − 1) (1 + ρ (m− 1))
ρmk
k =
(1 + ρ (m− 1)) +
√
(1− δ) ρm (1 + ρ (m− 1))
(1 + ρ (mδ − 1))
There is no solution to these simultaneous equations. This means that there
is no minimum value within the boundaries. We must also check for optimal
values at the boundaries of k and δ.
Boundary (1) δ = 0
We have a boundary at δ = 0, with all observations during rollout.
The equation for optimal k becomes:
k =
(1 + ρ (m− 1)) +
√
ρm (1 + ρ (m− 1))
(1− ρ)
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Substituting this k and δ = 0 into the design effect we get:
DE(1) = 3
(
2ρm (1 + ρ (m− 1)) + (1 + ρ (2m− 1))
√
ρm (1 + ρ (m− 1))
)
(
(2 + ρ (m− 2)) +
√
ρm (1 + ρ (m− 1))
)
× (1− ρ) (1 + ρ (m− 1))(
ρm (1 + ρ (m− 1)) + (2 + ρ (m− 2))
√
ρm (1 + ρ (m− 1))
)
Boundary (2) δ = 1/k
Although 0 < δ < 1, in our derivation of the optimal value of δ, we found that
this had a boundary at δ = 1/k
The design effect in this case is:
DE = (1 + ρ (m− 1)) 3k
2
2 (k2 − 1)
(1− ρ)
((1 + ρ (0.5m− 1)))
k2
(k2−1) decreases as k increases so at this boundary the optimal design is to
have a large number of sequences. The design effect here becomes:
DE(2) =
3 (1− ρ) (1 + ρ (m− 1))
(2 + ρ (m− 2))
Boundary (3) k = 2
The final boundary to the design effect is the lower limit of k. The optimal
value of δ when k = 2 is:
δ =
1−
1
2
(1+ρ(m−1))
ρm
, ρm(1+ρ(m−1)) ≥ 12
0 otherwise
With these values the design effect becomes:
DE(3) =

4ρm(1−ρ)
(1+ρ(m−1)) ,
ρm
(1+ρ(m−1)) ≥ 12
(1 + ρ (m− 1)) otherwise
Which boundary is optimal?
We can work out which of these is optimal by looking at the ratio of these
design effects.
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δ = 0 vs δ = 1/k
Taking the ratio of the design effects when δ = 0 and when δ = 1/k gives:
DE(2)
DE(1)
=
(
2ρm (1 + ρ (m− 1)) + (1 + ρ (2m− 1))
√
ρm (1 + ρ (m− 1))
)
(
(2 + ρ (m− 2)) +
√
ρm (1 + ρ (m− 1))
)
× (2 + ρ (m− 2))(
ρm (1 + ρ (m− 1)) + (2 + ρ (m− 2))
√
ρm (1 + ρ (m− 1))
)
We are interested in when this ratio is less than 1. Using Mathematica software
[4] shows that this inequality is true for all 0 < ρ < 1, m > 0 .
This means that the design with no observations outside rollout and the op-
timal number of sequences for that design, will always be more efficient than
the design with 1/k observations outside rollout and the optimal number of
sequences for that design.
δ = 0 and optimal k vs k = 2 and optimal δ
To compare the design on the δ = 0 boundary to the design on the k = 2
boundary we need to split the comparison.
When ρm(1+ρ(m−1)) ≥ 12 so when ρ > 1(m+1) , we can look at the ratio of design
effects for these 2 designs which gives:
DE(3a)
DE(1)
=
4ρm
(
(2 + ρ (m− 2)) +
√
ρm (1 + ρ (m− 1))
)
3
(
2ρm (1 + ρ (m− 1)) + (1 + ρ (2m− 1))
√
ρm (1 + ρ (m− 1))
)
×
(
ρm (1 + ρ (m− 1)) + (2 + ρ (m− 2))
√
ρm (1 + ρ (m− 1))
)
(1 + ρ (m− 1))2
We can find out when this ratio of design effects is greater than 1, i.e. when
the design effect at k = 2 optimal δ is smaller that the design effect at optimal
k and δ = 0, and rearrange to get:
2ρm (1 + ρ (m− 1))
(
ρ2 (m− 3) (m+ 1) + 2ρ (m+ 3)− 3
)
+
(
ρ3
(
2m3 − 5m2 + 4m+ 3
)
+ ρ2
(
5m2 − 8m− 9
))√
ρm (1 + ρ (m− 1))
+ (ρ (4m+ 9)− 3)
√
ρm (1 + ρ (m− 1)) > 0
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If each component of the sum is greater than zero, then there sum will also be
greater than zero and the inequality will hold.
Using Mathematica software shows that:
(
ρ2 (m− 3) (m+ 1) + 2ρ (m+ 3)− 3
)
> 0
when ρ > 1/(m + 1). This is multiplied by 2 positive numbers so this term
will be positive if ρ > 1/(m+ 1).
Secondly:
(
ρ3
(
2m3 − 5m2 + 4m+ 3
)
+ ρ2
(
5m2 − 8m− 9
)
+ ρ (4m+ 9)− 3
)
> 0
when ρ > 1/(m + 1). Since the square root term is also positive, this whole
second term will be positive when ρ > 1/(m+ 1).
So all terms are positive and so the total is positive when ρ > 1/(m + 1).
This means that, under this conditions, the design with δ = 0 has the smaller
design effect.
But, we are currently looking in the region where ρm(1+ρ(m−1)) ≥ 12 . In this region
ρ > 1/(m+ 1).
This means that in the region where ρm(1+ρ(m−1)) ≥ 12 , DE(3a) > DE(1) and so
the design effect is smaller at δ = 0 and optimal k.
Now looking at when ρm(1+ρ(m−1)) <
1
2 .
In this region, both designs have δ = 0 so we are comparing a design with
δ = 0 and an optimal number of sequences that can equal 2 if that is optimal
in DE(1), and a design with the number of sequences fixed to 2 and δ = 0
in DE(3b). By definition the design when the number of sequences is allowed
to vary will be either the same or more efficient than the design where the
number of sequences is fixed to 2, so DE(3b) > DE(1) and the design effect is
smaller at δ = 0 and optimal k.
Conclusion
We can conclude that the optimal stepped-wedge design is to have δ = 0, or
equivalently α + β = 0, and k as:
k =
(1 + ρ (m− 1)) +
√
ρm (1 + ρ (m− 1))
(1− ρ)
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The equation for k can be written as:
k = 1
1−√R
Appendix 3 SWT with No Observations Outside Rollout
Compared to a CRT
We will compare an SWT with no observations outside rollout to a CRT in
2 ways. Firstly we can compare the ratio of the design effects of a CRT to a
specific SWT design. Secondly we can investigate when the optimal number
of sequences in the SWT is < 2.5 so that the SWT becomes equivalent to a
CRT.
Comparison of design effects
DE of SWT:
DE = (1 + ρ (m− 1)) 3k2 (k + 1)
(1− ρ)(
(1 + ρ (m− 1))− 12 kk−1ρm
)
DE of CRT:
DE = (1 + ρ (m− 1))
Note that when k = 2 the SWT DE cancels to the CRT DE as with no
observations outside rollout and k = 2 the design is a CRT.
The ratio of the design effects is:
DESWT
DECRT
= 3k2 (k + 1)
(1− ρ)(
1 +
(
m
(
1− 12 kk−1
)
− 1
)
ρ
)
We are interested in when this ratio is less than 1, so the SWT design effect
is smaller than the CRT design effect:
3k
2 (k + 1)
(1− ρ)(
1 +
(
m
(
1− 12 kk−1
)
− 1
)
ρ
) < 1
3k(k − 1) (1− ρ)
(k − 1 + (m (0.5k − 1)− (k − 1)) ρ) < 2 (k + 1)
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Before multiplying by the left hand side denominator we need to check when
it is positive:
(k − 1 + (m (0.5k − 1)− (k − 1)) ρ) > 0
This is true when:
k >
1 + ρ (m− 1)
1 + ρ (0.5m− 1)
1 < 1+ρ(m−1)1+ρ(0.5m−1) < 2 because 0 < ρ < 1 and m > 1.
So the left hand side denominator is positive for all k > 2 so we can multiply
the left hand side denominator to both sides of the inequality:
3k(k − 1) (1− ρ) < 2 (k + 1) (k − 1 + (m (0.5k − 1)− (k − 1)) ρ)
(k − 1) (k − 2) < ρ (m (k + 1) (k − 2) + (k − 1) (k − 2)))
Since k > 2 we can divide through by (k − 2):
(k − 1) < ρ (m (k + 1) + (k − 1))
ρ >
1
(k+1)
(k−1)m+ 1
Optimal number of sequences is two
Another way to assess when a CRT will require a larger sample size than an
SWT this is to look at when the optimal number of sequences for the SWT is
≥ 2.5. Note that is only approximately true, the function is not symmetrical
so if the optimal number of sequences is 2.5, 2 sequences may be more efficient
than 3 sequences in some cases. It should be right for the majority of cases,
or good as a rule of thumb:
optimal k =
(1 + ρ (m− 1)) +
√
ρm (1 + ρ (m− 1))
(1− ρ)
(1 + ρ (m− 1)) +
√
ρm (1 + ρ (m− 1))
(1− ρ) ≥ 2.5√
ρm (1 + ρ (m− 1)) ≥ 2.5 (1− ρ)− (1 + ρ (m− 1))
In order to square the left hand side we need to know whether both sides are
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positive. ρm (1 + ρ (m− 1)) > 0 for all values but the right hand side could
be positive or negative.
If right hand side is negative we cannot square both sides but the inequality
will still hold. This is the case when:
2.5 (1− ρ)− (1 + ρ (m− 1)) ≤ 0
ρ ≥ 32m+ 3 =
9
6m+ 9
Otherwise, if the right hand side is positive, i.e.:
ρ <
3
2m+ 3 =
9
6m+ 9
we can square both sides:
ρm (1 + ρ (m− 1)) ≥
(5
2 (1− ρ)− (1 + ρ (m− 1))
)2
0 ≥ ρ2 (16m+ 9)− ρ (16m+ 18) + 9
ρ =
(16m+ 18)±
√
(16m+ 18)2 − 4 ∗ 9 (16m+ 9)
2 (16m+ 9)
= 1 OR 916m+ 9
So we have (ρ− 1)
(
ρ− 916m+9
)
≤ 0. Since ρ < 1 we are left with:
ρ ≥ 916m+ 9
So our 2 solutions combine to show that the optimal number of sequences in
the SWT is greater than 2.5 when:
ρ ≥ 916m+ 9
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Appendix 4 Optimal Proportion of Observations at Baseline
in a CRT
Our results from Appendix A boundary (3) give the optimal proportion of
observations outside rollout for a CRT:
β =
1−
1
2
(1+ρ(m−1))
ρm
, ρm(1+ρ(m−1)) ≥ 12
0 otherwise
In terms of the cluster-mean correlation this is:
β =
1−
1
2R , R ≥ 12
0 otherwise
Appendix 5 Comparison between the Optimal SWT and a
CRT with Baseline Measurements
This comparison has been seen in Appendix 2, “Which boundary is optimal?
δ = 0 vs k = 2”. This was a comparison of an SWT with δ = 0 and an
optimised number of sequences (the optimal SWT design), and an SWT with
k = 2 (or a CRT with and without baseline observations). We saw that in the
region where baseline observations would be beneficial, i.e. when:
R = ρm(1 + ρ (m− 1)) ≥
1
2
the optimised SWT design effect was always smaller than the design effect of
the CRT with baseline observations.
Appendix 6 Comparison between the Optimal SWT and the
Hybrid Design
Comparison with an SWT with no observations outside rollout
Girling and Hemming 2016 [3] define a hybrid design, which consists of a
proportion of the clusters contributing to the design as an SWT with δ =
α + β = 1/k, and the remaining clusters contributing as a parallel CRT. We
will compare this design, with a large number of sequences in the SWT and
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an optimal proportion allocated to the SWT, to an SWT with δ = α + β = 0
and k sequences.
Let us define γ as the proportion of clusters assigned to the SWT.
The design effect for the hybrid design is [3]:
DEH =
η
4 (aD − bDR)
where:
η = 1− ρ = (1 + ρ (m− 1)) (1−R)
4aD = 1− γ
2
3
(
1 + 2
k2
)
4bD = 1− γ3
(
2 + 1
k2
)
R = ρm1 + ρ (m− 1)
So:
DEH =
(1 + ρ (m− 1)) (1−R)
1− γ23
(
1 + 2
k2
)
−
(
1− γ3
(
2 + 1
k2
))
R
For the optimal hybrid design, γ = R and there are many sequences so that
1/k2 ≈ 0. The design effect becomes:
DEH =
3 (1 + ρ (m− 1)) (1−R)
3− 3R +R2
Comparing this to our SWT with no observations outside rollout (δ = 0) and
k sequences gives:
DES
DEH
= (1 + ρ (m− 1)) 3k (k − 1)2 (k + 1)
(1−R)
(k (1− 0.5R)− 1)
3− 3R +R2
3 (1 + ρ (m− 1)) (1−R)
= k (k − 1) (3− 3R +R
2)
2 (k + 1) (k (1− 0.5R)− 1)
This is the function that is shown graphically in figure 3.
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Appendix 7 Optimal Design of an SWT with Observations
Outside Rollout
In appendix 2 we showed that for a a fixed number of sequences k, the optimal
proportion of observations outside rollout is:
α + β =
1−
(k−1)
k
(1+ρ(m−1))
ρm
, ρm(1+ρ(m−1)) ≥ k−1k
0 otherwise
or in terms of R:
α + β =
1−
(k−1)
k
1
R
, R ≥ k−1
k
0 otherwise
Substituting this into the design effect gives:
DE =

3k2
(k2−1)
ρm(1−ρ)
(1+ρ(m−1)) ,
ρm
(1+ρ(m−1)) ≥ k−1k
(1 + ρ (m− 1)) 3k2(k+1) (1−ρ)(1+(m−1)ρ− 12 kk−1ρm) otherwise
or in terms of R:
DE =
(1 + ρ (m− 1))
3k2
(k2−1)R (1−R) , R ≥ k−1k
(1 + ρ (m− 1)) 3k(k−1)2(k+1) (1−R)(k(1−0.5R)−1) otherwise
Impact on sample size of increasing the number of sequences in an
SWT with the optimal proportion of observations outside rollout
While ρm(1+ρ(m−1)) ≥ k−1k the number of sequences affects to the design effect by
a factor of
k2
(k2 − 1)
This factor reduces as the number of sequences increases as show in table A1.
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Table A1: Sample size of an SWT with the optimal proportion of observa-
tions outside rollout and with an increased number of sequences relative to an
original number of sequences
Increased number of sequences
2 3 4 5 6 7 8
Original number of sequences
2 1.00 0.84 0.80 0.78 0.77 0.77 0.76
3 1.00 0.95 0.93 0.91 0.91 0.90
4 1.00 0.98 0.96 0.96 0.95
5 1.00 0.99 0.98 0.99
6 1.00 0.99 0.99
7 1.00 1.00
8 1.00
The maximum relative difference in sample size after 5 sequences is
1
52
(52−1)
= (5
2 − 1)
52 = 0.96
Comparison with a CRT with baseline observations
We have previously stated that a CRT with baseline observations can be
thought of as an SWT with 2 sequences. Since the design effect decreases as
the number of sequences increase a CRT with baseline observations (or equi-
valently an SWT with 2 sequences and the optimal proportion outside rollout)
will always require a larger sample size than an SWT with more sequences and
an optimal proportion of observations outside rollout.
Comparison with a CRT
When ρm(1+ρ(m−1)) ≥ k−1k an SWT with k sequences may benefit from some
observations being collected outside rollout. Within this region an SWT with
k sequences and the optimal proportion of observations outside rollout will
always have a smaller sample size than a CRT. We can show this by comparing
the design effect from Appendix 7 to the design effect for a CRT:
DESWT
DECRT
= 3k
2
(k2 − 1)
ρm (1− ρ)
(1 + ρ (m− 1))
1
(1 + ρ (m− 1))
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We are interested in when the design effect of the SWT is smaller than the
design effect of the CRT. When this is the case this ratio will be less than 1
so we can look at if and when this is true:
3k2
(k2 − 1)
ρm (1− ρ)
(1 + ρ (m− 1))
1
(1 + ρ (m− 1)) < 1
Using Mathematica software shows that this is true when 0 < ρ < 1, m > 0,
and k > 2.
So when ρm(1+ρ(m−1)) ≥ k−1k the SWT is more efficient than the CRT.
When ρm(1+ρ(m−1)) <
k−1
k
the SWT will have the smallest sample size with no
observations outside rollout, a comparison given in the paper.
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7 Paper B: Bias and Inference
from Misspecified Mixed-Effect
Models in Stepped-Wedge Trial
Analysis
In the next three chapters I will address the second aim of this thesis: improv-
ing the robustness of SWT analysis.
This paper addresses objectives one and two of this thesis and investigates how
sensitive model 3.1 is to deviations from the model assumptions, and explores
alternative analysis models. In this Chapter, model 3.1 is referred to as the
standard model.
At the start of this PhD, my literature review found limited published research
into the performance of the standard model. Since then, published research
has considered this issue, but only within a limited range of within-cluster cor-
relation structures and period effect assumptions. there remains no literature
on the impact of the intervention effect varying between clusters.
In order to identify whether or not a more robust analysis method was required
for SWTs, I needed to examine whether the standard model was sensitive to
the assumptions it made about the data. This paper focuses on the impact
of assuming that either the period effect or intervention effect is common to
all clusters, when these effects truly vary between clusters. I also demonstrate
the weight given to horizontal comparison by the standard model.
Objective two of my second aim was to identify alternative analysis mod-
els. To address this objective, I also assessed two alternative analysis mod-
els to the standard model; models 3.4 and 3.6. Model 3.4, referred to as
the random-period model, relaxes the assumption of a common period effect
and exchangeability between periods. Model 3.6, referred to as the random-
intervention model, relaxes the assumption of a common intervention effect
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and exchangeability between the control and intervention. It is not possible
to allow both the period and intervention effects to vary in the same model
as this over-parameterises the model. Including these alternative models also
aided interpretation of the results of the standard model; for each scenario, a
correctly specified model can be directly compared to an incorrectly specified
model.
The paper consists of a simulation study and a worked example; the example
uses the deworming trial data described in section 2.1 and the simulation study
was also based on this trial data. The paper uses the term “groups” to describe
what have been called “sequences” elsewhere in this thesis.
Ethics approval is given in Appendix B. The paper has been peer reviewed
and is published in Statistics in Medicine, titled “Bias and inference from
misspecified mixed effect models in stepped-wedge trial analysis”, by myself,
Katherine Fielding, Calum Davey, Alexander Aiken, James Hargreaves, and
Richard Hayes. The paper is licensed under CC BY 2.0. The licence to repro-
duce the paper is given in Appendix C. The supporting information has been
edited to improve consistency with the formatting of this thesis.
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Bias and inference from misspeciﬁed
mixed-effect models in stepped wedge
trial analysis
Jennifer A. Thompson,a,b*† Katherine L. Fielding,a
Calum Davey,c Alexander M. Aiken,a James R. Hargreavesc and
Richard J. Hayesa
Many stepped wedge trials (SWTs) are analysed by using a mixed-effect model with a random intercept and ﬁxed
effects for the intervention and time periods (referred to here as the standard model). However, it is not known
whether this model is robust to misspeciﬁcation.
We simulated SWTs with three groups of clusters and two time periods; one group received the intervention
during the ﬁrst period and two groups in the second period. We simulated period and intervention effects that
were either common-to-all or varied-between clusters. Data were analysed with the standard model or with
additional random effects for period effect or intervention effect. In a second simulation study, we explored
the weight given to within-cluster comparisons by simulating a larger intervention effect in the group of the trial
that experienced both the control and intervention conditions and applying the three analysis models described
previously.
Across 500 simulations, we computed bias and conﬁdence interval coverage of the estimated intervention
effect.
We found up to 50% bias in intervention effect estimates when period or intervention effects varied between
clusters and were treated as ﬁxed effects in the analysis. All misspeciﬁed models showed undercoverage of 95%
conﬁdence intervals, particularly the standard model. A large weight was given to within-cluster comparisons in
the standard model.
In the SWTs simulated here, mixed-effect models were highly sensitive to departures from the model
assumptions, which can be explained by the high dependence on within-cluster comparisons. Trialists should
consider including a random effect for time period in their SWT analysis model. © 2017 The Authors. Statistics
in Medicine published by John Wiley & Sons Ltd.
Keywords: stepped wedge trials; cluster randomised trials; mixed-effect model; model misspeciﬁcation;
simulation study
1. Introduction
Recent reanalysis of a high-proﬁle stepped wedge trial (SWT) has brought into question methods
commonly used to analyse these complex studies [1–3]. SWTs are often analysed by using models that
make strong assumptions about the clustering in the data [4]. It is currently unknown if estimates from
these models are robust to deviations from these assumptions.
An SWT is a type of cluster randomised trial where clusters are randomised into groups. Each group
begins to receive the intervention at a different time so that all clusters start the trial in the control
condition, and by the end of the trial, all clusters are receiving the intervention.
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The control and intervention conditions can, in principle, be compared in two directions known as the
vertical and horizontal comparisons [4]. Vertical comparisons compare the outcomes of clusters in the
intervention condition with the outcomes of clusters in the control condition within the same time
period; because the order of rollout is randomised, each of these comparisons is randomised. Horizontal
comparisons compare outcomes from periods in the intervention condition with outcomes from periods
in the control condition in the same cluster; these are non-randomised before–after comparisons that are
confounded with time period.
In practice, most analysis methods for SWTs incorporate information from both the vertical and
horizontal comparisons in the intervention effect estimate and so need some way to adjust for period
effects [4]. The most common analysis model (hereafter referred to as the standard model) is a mixed-
effect model with a random intercept to account for clustering and adjusting for period effects as a ﬁxed
categorical variable; this model is described by Hussey and Hughes [5]. Despite its wide use, guidance
for using this analysis model is lacking. The model makes strong assumptions about the correlation
structure of the data: The intervention effect and the period effects are assumed to be common to all
clusters. It is not currently known whether the intervention effect estimate and its precision are robust
to misspecifying these assumptions.
In the context of SWTs, we are most interested in estimation of the intervention effect and how robust
this effect is to misspeciﬁcation of the intervention effect itself as well as misspeciﬁcation of the period
effect. Previous research has found that misspecifying the random effects led to biased effect estimates
as well as biased precision of estimates [6]. In parallel cluster randomised trials with baseline
measurements and in cluster crossover randomised trials, it has been shown that analyses with
hierarchical models should include a random effect for period, sometimes referred to as a cluster-period
interaction, to avoid residual confounding [7–10].
The importance of specifying the period effect correctly will depend on how much the horizontal
comparisons contribute within the model. This has not been explored in the literature. If a large weight
is given to this comparison, any residual confounding of the intervention effect by the period effects
could lead to a biased estimate of the intervention effect.
In this paper, we will explore both issues with a simulation study comparing the standard model with
other mixed-effect models, focusing on a binary outcome with cross-sectional measurements. We then
run a second set of simulations to explore the weight given to horizontal comparisons by each analysis
model. Following the simulation studies, we explore the impact of misspecifying analysis models in our
motivating example.
2. Motivating example
There has been much debate in recent literature about the results of a reanalysis of a highly cited
SWT that investigated the effect on school attendance of a mass deworming intervention for school
children in Kenya [1–3]. The trial included 75 schools (clusters) that were randomised into three
groups and ran over 2 years. School attendance was measured as a binary outcome with multiple
observations for each individual child during each year. There was a geometric mean of 1180
(interquartile range (IQR) 908.5, 1864) observations in each school each year, with the attendance
assessed on the same children in year 2 as year 1. Children from schools in the ﬁrst group began
receiving the intervention at the start of the ﬁrst year. Children from schools in the second group
received no intervention during the ﬁrst year and began receiving the intervention in the second year
of the study. Children from schools in the third group did not receive the intervention during these
two years (Figure 1).
In the reanalysis of this trial, it was found that the odds ratios (ORs) for school attendance for year 1
and year 2 were both smaller when analysed individually (OR = 1.48 and 1.23 respectively) than the OR
given by the standard model when the data were pooled from both years (OR = 1.82) [2]. We
hypothesised that this could have been because the analysis model was misspeciﬁed and explored two
potential types of misspeciﬁcation:
(1) The period effects varied between clusters. The standard model assumes that the period effects are
common to all clusters. This could lead to a biased estimation of the intervention effect through
biased estimation of the period effects.
(2) The intervention effect varied between clusters. The standard model assumes that the intervention
effect is common to all clusters. Treating an effect that truly varies as a ﬁxed effect has been
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shown to lead to biased estimation of that covariate [6], and so the estimate of the intervention
effect could be biased.
In this paper, we ﬁrst used a simulation study based on the motivating example to explore the effect of
ignoring variability between the clusters in the period effect and intervention effect in the analysis of
SWTs. Second, we hypothesised that the effect of misspeciﬁcation would by highly inﬂuenced by the
weight given to horizontal comparisons in each analysis model and so also performed a further set of
simulations to investigate this question. We then analysed the motivating example with different
analysis models and compared the results in light of the ﬁndings of the simulation studies.
3. Simulation study methods
3.1. Simulation study 1
To investigate the impact of ignoring heterogeneity between clusters in the period effect and intervention
effect, we compared analysis models that assumed these effects were common to all clusters (the
standard model) to analysis models which allowed these effects to vary between clusters. We performed
this with data in which the true underlying period effect and intervention effect were either common to
all clusters or varied between clusters. A description of the scenarios we used to compare the analysis
models is given, followed by the three analysis models we compared. A summary of the data scenarios
simulated is given in Table I.
We used the same trial design as our motivating example with clusters randomised into three groups
and followed for two time periods. During the ﬁrst period, only the ﬁrst group had received the
intervention, and during the second time period, the ﬁrst and second groups had received the
intervention. The third group never received the intervention. This trial design was chosen due to its
simplicity; because there are only two time periods, the period effect is simple to model. The horizontal
comparison is only possible in one group; this allowed us to explore the weight given to this comparison.
To mimic the motivating example and to avoid issues with small sample size, we assigned 25 clusters to
each group and the number of observations in a cluster in each time period was drawn from a log-normal
distribution (μ=6.9, σ =0.74); this gave a geometric mean number of observations in each cluster in
each time period of 1027 (IQR 669, 1798).
The cluster-level distribution of the outcome in the ﬁrst period and the change from period 1 to period
2 (the period effect) was based on group 3 of the motivating example. This group was chosen because it
did not receive the intervention. We modelled the log-odds in the ﬁrst period and the log-OR period
effect from the motivating example as a bivariate normal distribution. This gave mean values for the
log-odds in period 1 and log-OR period effect, together with a 2 × 2 covariance matrix. This distribution
described the outcome and how it varied between the clusters in each period. The mean values were used
in all the simulation scenarios, but we manipulated the covariance matrix to create four scenarios of how
Figure 1. Schematic of motivating example: A stepped wedge trial (SWT) with 75 clusters randomised to three
groups. The trial consisted of two time periods (years). Group 1 switched to the intervention at the start of period
1. Group 2 switched to the intervention at the start of period 2. Group 3 did not switch to the intervention.
J. A. THOMPSON ET AL.
© 2017 The Authors. Statistics in Medicine published by John Wiley & Sons Ltd. Statist. Med. 2017
136
the outcome varied between the clusters and periods (Figure 2). The mean odds in the ﬁrst period was
6.61 (a proportion of 87%), and the mean OR period effect between the second and ﬁrst period was
0.32, which was equivalent to an odds of 2.12 (proportion of 68%) in the second period. The covariance
matrices for each of the four scenarios are given in Data S1 and are described in the succeeding texts:
(1) Common period effect, high variability:
The period effect was common to all clusters with between-cluster variance = 1.81. This was the
amount of between-cluster variability observed in year 1 of the motivating example. This
represents a simple scenario with a large intracluster correlation coefﬁcient (ICC = 0.20), where
the standard model would have a correctly speciﬁed period effect.
Figure 2. Simulated cluster-level log odds in each period effect scenario. A sample of 25 clusters is shown in
time periods 1 and 2. All are in control condition.
Table I. Summary of simulation study data scenarios.
Description Similar to
motivating
example?
Common to all simulations
Number of groups 3 Yes
Number of time periods 2. In period 1, group 1 received the
intervention.
In period 2, groups 1 and 2 received
the intervention.
Yes
Number of clusters 75 Yes
Cluster size Log-normal(6.9, 0.74) in each year.
Geometric mean = 1027
Yes
Correlation of measurements
within clusters
Independent within cluster-periods No
Mean outcome in year 1 Odds = 6.61 Yes
Mean change in outcome
from year 1 to year 2
Odds ratio = 0.32 Yes
Different scenarios
Period effect (1) Common period effect, high variability No
(2) Common period effect, low variability No
(3) Varying period effect, decreasing variability Yes
(4) Varying period effect, stable variability No
Intervention effect (a) Log(OR) = 0.41 common to all clusters No
(b) Log(OR) = 0.41, varying between clusters No
Intervention effect in group 2
Simulation study 1 Intervention effect in group 2 the same as group
1 log(OR) = 0.41
No
Simulation study 2 Intervention effect in group 2 is log(OR) = 1.5,
and group 1 is log(OR) = 0.41
No
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(2) Common period effect, low variability:
The period effect was common to all clusters with between-cluster variance = 0.25. This was the
amount of between-cluster variability observed in year 2 of the motivating example. This
represents a simple scenario with a lower ICC (ICC = 0.05), where, again, the standard model
would have a correctly speciﬁed period effect.
(3) Varying period effect, decreasing variability:
The period effect varied between clusters with the variability between the clusters decreasing
from the ﬁrst period to the second period. The initial between-cluster variance was 1.81, and
the period effect variance was 1.89. The decrease in variability from period 1 to period 2 resulted
from a negative covariance between the initial value and the period effect of 1.72. This complex
scenario reﬂects the underlying trends seen in the motivating example. In this scenario, the
standard model would have a misspeciﬁed period effect.
(4) Varying period effect, stable variability:
The period effect varied between the clusters, but the between-cluster variance remained the same
for both periods. Here, the initial between-cluster variability and period effect variability
remained the same as in scenario (3), but the covariance was reduced to 0.94. This scenario
was chosen to assess the effect of a varying period effect without the additional complication
of the between-cluster variation reducing in the second period. In this scenario, the standard
model would have a misspeciﬁed period effect.
We simulated two scenarios for the intervention effect; these were not based on the motivating example:
(a) An intervention effect that was common to all clusters. We simulated an intervention effect log
(OR) = 0.41 (equivalent to OR = 1.5) for all clusters. We also simulated log(OR) = 0 to calculate
the type I error rate. In these scenarios, the standard model would have a correctly speciﬁed
intervention effect.
(b) An intervention effect that varied between clusters drawn from the distribution log(OR) ~N
(0.41, 0.3). This gave a geometric mean OR = 1.5 with an IQR = 1.05–1.97. We also simulated
a distribution log(OR) ~N(0, 0.3) to calculate the type I error rate. In these scenarios, the standard
model would have a misspeciﬁed intervention effect.
The variation in the intervention effect was modelled as being independent of the underlying outcome
and period effect between-cluster variability. This meant that the intervention effect varying between
clusters would lead to increased variability between the clusters in period 2 as more clusters were
receiving the intervention in this period.
Each scenario led to the odds of the outcome occurring in each cluster-period. From this, the
observations within each cluster-period were sampled from a binomial distribution, assuming
independence within each cluster-period. This assumes a cross-sectional design and is a deviation from
the motivating example, where children were observed multiple times during the study, chosen for
simplicity.
All combinations of these parameters were simulated.
3.2. Simulation study 2
Second, we hypothesised that the horizontal comparisons would depend on the model assumptions more
heavily than the vertical comparisons. To aid interpretation of the results of simulation study 1, we
sought to investigate the contribution of the horizontal comparisons to each analysis in each scenario.
In the trial design used for this paper, only group 2 contributed horizontal comparisons because
groups 1 and 3 remained in the same condition for both periods of the study (Figure 1). This meant that
we could investigate the weights given to the horizontal and vertical comparisons by identifying how
much weight was given to group 2 relative to groups 1 and 3.
To do this, we reran the simulations but with an intervention effect log(OR) = 1.5 in group 2 of the
trial but kept an intervention effect in group 1 of log(OR) = 0.41. An unbiased intervention effect
estimate from horizontal comparisons alone would have an expectation of E(log(OR)) = 1.5. An
unbiased intervention effect estimate from vertical comparisons alone would have an expectation of
0.41<E(log(OR))<1.5 depending on the weights given to each cluster and to periods 1 and 2 of the
trial. Comparing the intervention effect estimates of each model in each scenario to the horizontal
comparison E(log(OR)) = 1.5 allowed us to see how much the horizontal comparisons contributed to
the analysis compared with the vertical comparisons. Such a large imbalance in the intervention effect
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between groups is, of course, unlikely (although not impossible); this simulation study was designed to
investigate the contributions of vertical and horizontal comparisons, rather than to explore a realistic
scenario.
4. Analysis models
Each simulated data set was analysed with three analysis models, each making different assumptions
about the period effect and intervention effect.
4.1. Standard model
First, we used the standard method of analysis [4,5]: a mixed-effect logistic regression with a random
intercept and ﬁxed effects for intervention effect and period effect:
yijk ¼ μþ βZ j þ θX ij þ ui (1)
where yijk is the log odds of the outcome in cluster i in year j for observation k, μ is the mean log odds of
the outcome in period 1 in the control condition, β is the period effect log-OR comparing the outcome in
periods 2 and 1, Zj is an indicator of year, 0 for the ﬁrst year and 1 for the second year, θ is the
intervention effect log-OR, and Xij is an indicator of whether cluster i received the intervention in year
j, uieN 0; σ2u  is a random intercept allowing for variability in the outcome between clusters.
This model assumes that the period effect and the intervention effect are common to all clusters so is a
misspeciﬁed model in scenarios where either the period effect or intervention effect varied between
clusters.
4.2. Random period model
Second, we added a random effect for period to the standard model:
yijk ¼ μþ β þ við ÞZ j þ θX ij þ ui (2)
where
ui
vi
 eMVN 00
 
;
σ2u σ
2
u;v
σ2u;v σ
2
v
 ! !
are a random intercept and random effect for period
respectively.
This model assumes that the intervention effect is common to all clusters but allows the period effect
to vary between clusters. It is a misspeciﬁed model in scenarios where the intervention effect varies
between the clusters.
Sometimes, other literatures have used a different model to allow the period effect to vary between the
clusters [11,12]. For details on how these models relate to one another, see Data S2.
4.3. Random intervention model
Third, we added a random effect for the intervention to the standard model:
yijk ¼ μþ βZ j þ θ þ zið ÞX ij þ ui (3)
where
ui
zi
 eMVN 00
 
;
σ2u σ
2
u;z
σ2u;z σ
2
z
 ! !
are a random intercept and random effect for intervention
respectively.
This model assumes that the period effect is common to all clusters but allows the intervention effect
to vary between clusters. The model is a misspeciﬁed model in scenarios where the period effect varies
between the clusters.
Whilst the random period and random intervention models allow for variability in the period and
intervention effect respectively, they can estimate a variability of close to zero if the effect is common
to all clusters. The random period model is correctly speciﬁed in the scenario with common period
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effect, and likewise, the random intervention model is correctly speciﬁed in the scenario with common
intervention effect. Similarly, the random intervention model allows for a covariance between the
intervention effect and the intercept (σ2u;z ) but allows this covariance to be zero, as is the case in our
simulation study.
5. Estimands and performance measures
We ran 500 simulations for each combination of parameters. This allowed us to estimate the intervention
effect to within 5% accuracy, assuming a variance estimate of 0.05. This variance is conservative as it is
larger than the estimated variance we saw in the motivating example.
From the analysis models, we collected the estimated ﬁxed effects, their standard errors, and the
estimated between-cluster covariance matrix.
We calculated the mean, standard deviations, 95% conﬁdence intervals (CIs), and the IQR of the
intercept, intervention effect, and period effect estimates from the 500 simulations. We calculated
percentage bias as
percentage bias ¼ β^  β
β
 !
where β is the true effect and β^ is the mean of the effect estimates.
We calculated the coverage of 95% CIs as the proportion of simulations with the true effect contained
within the 95% CI of the estimate. We calculated the type 1 error rate as the proportion of simulations
with true OR = 1 with P < 0.05 against a null of the intervention effect OR = 1.
In the set of simulations with a different intervention effect in group 2 (simulation study 2), we
compared the mean of the intervention effect estimates with the horizontal intervention effect of log
(OR) = 1.5.
Simulations were run in R version 3.2; the lme4 package was used for mixed-effect models.
6. Results
6.1. Model convergence
The standard model converged in all simulations for both simulation studies. When either the period
effect or the intervention effect varied between clusters, the random period and random intervention
models also converged in >99% of all simulations. However, when both period effect and intervention
effect were common to all clusters, the random period model failed to converge in 3% to 9% of
simulations and the random intervention model failed to converge in 4% to 33% of simulations.
Estimates from these models were excluded from performance statistics. Further details of convergence
of the models are given in Data S3.
6.2. Simulation study 1 results
6.2.1. Bias of ﬁxed-effect estimates. Figure 3 gives the mean and IQR of intervention effect estimates
for each scenario. A table of the mean values is given in Data S4.
Where there were common period and intervention effects, all three models performed similarly, with
estimation of the intervention effect in line with the true underlying effect.
Where the period effect varied between the clusters, only the random period model gave unbiased
estimates of the intervention effect. Depending on the scenario, the standard model had between
20% and 8% bias and the random intervention model between 51% and 8% bias. Bias was larger
when the period effect varied with decreasing variability than with stable variability but was similar
regardless of whether there was a common or varying intervention effect. We also observed bias in
the period effect estimates and intercept estimates from the standard model and random intervention
model (Data S5 and S6).
Where the intervention effect varied between the clusters and there was a common period effect, the
random intervention model and the random period model gave unbiased estimates of the intervention
effect. Only the standard model intervention effect estimates had substantial bias (9% and 16% bias
for common period effects with high and low variabilities respectively).
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Where either the period effect or intervention effect varied between clusters, the standard model
intervention effect estimates had greater variability compared with the random period model or random
intervention model. Differences were larger when the period effect varied between clusters than when
the intervention effect varied between clusters. For example, the standard model intervention effect
estimates were 3.6 times as variable as the random period model estimates when the period effect varied
between clusters with decreasing variability with common intervention effect, whereas the standard
model intervention effect estimates were 1.5 times as variable as the random intervention model
estimates when the intervention effect varied between clusters with common period effect with high
variability.
6.2.2. Standard errors, coverage, and type 1 error. In scenarios with a common period and intervention
effect, 95% coverage was maintained regardless of the analysis model and the estimated standard errors
were similar across analysis models (Figure 4 and Data S7 and S8).
When period effect or intervention effect varied between clusters, the standard model gave
standard errors that were markedly smaller than the random period model and random intervention
model. The mean intervention effect standard error from the standard model was less than 0.33
and 0.26 times the mean standard error of the random period model and random intervention model
respectively.
The inappropriately small standard errors given by the standard model were in part explained by
downward bias in the estimation of between-cluster variability (Data S9). For example, when variability
was stable over the two time periods with a variance of 1.79, the standard model estimated the variance
as 1.26.
The bias in estimates, standard errors, and increased variability in estimates led to undercoverage of
the 95% CIs of the intervention effect estimates (Figure 4). For the standard model, undercoverage
was severe when either the intervention effect or the period effect varied between clusters (<25%
coverage). Similarly, the random intervention model had undercoverage when the period effect varied
between clusters (74% and 88% coverage for decreasing and stable variability respectively) regardless
of intervention effect variability. Finally, the random period model had undercoverage of CIs when
the intervention effect varied between clusters with a common period effect (86% and 88% coverage
for common period effect with high and low variabilities respectively).
Type 1 error rates followed the same patterns as coverage (Data S10).
Figure 3. Comparison of intervention effect log(OR) from different analysis models and scenarios with true
geometric mean intervention effect log(OR) = 0.41 in all groups. Vertical grey line: true log(OR). Hollow point:
mean estimate. Solid barred line: 95% conﬁdence interval. Dashed line: interquartile range (IQR) of estimates.
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6.3. Simulation study 2 results
Figure 5 gives the estimated log(OR) for each scenario where the group 1 and 2 intervention effects
differed (log(OR)=0.41 in group 1 and log(OR)=1.5 in group 2).
All analysis models gave a mean estimated intervention effect close to the group 2 effect when there
was a common period effect and a common intervention effect; this was the case in the high and low
variability scenarios. This suggests that, in these scenarios, the intervention effect is largely estimated
from horizontal within-cluster comparisons in group 2; groups 1 and 3 appeared to contribute to
estimation of the period effect but had little inﬂuence on the intervention effect estimate.
The standard model estimates remained close to the group 2 intervention effect in all scenarios. The
downward bias we observed in our ﬁrst set of simulations suggests that at least some of the movement
away from the group 2 effect is because of bias and not because of a reduction in the contribution of the
Figure 5. Comparison of intervention effect log odds ratios from different analysis models for all scenarios
with the intervention effect larger in group 2 than group 1. Vertical grey lines: true intervention effect in group
1 (log(OR) = 0.41) and group 2 (log(OR) = 1.5). Hollow point: mean estimate. Solid barred line: 95%
conﬁdence interval. Dashed line: interquartile range (IQR) of estimates.
Figure 4. Comparison of estimated intervention effect (a) standard errors and (b) 95% conﬁdence interval
coverage for different analysis models and scenarios with a geometric mean intervention effect of log
(OR) = 0.41 in all groups. Vertical grey line: 95% coverage. Hollow point: mean estimate. Solid barred line:
95% conﬁdence interval. Dashed line: interquartile range (IQR) of estimates.
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horizontal comparisons. This implies that the standard model was continuing to estimate the intervention
effect largely from horizontal comparisons in group 2.
In contrast, when the period effect varied between clusters, the random period model gave
intervention effect estimates much further from the horizontal comparison estimates. This implies that
the horizontal comparisons in group 2 could not contribute as much information to the analysis because
there was less certainty about separating the period effect and intervention effect in these comparisons.
This was similar in the scenarios where the intervention effect varied between clusters but the period
effect was common for both the random period and random intervention models, but to a smaller degree.
7. Example
For our motivating example, we hypothesised that the standard model gave a larger intervention effect
than either of the two time periods analysed separately because the standard model was misspeciﬁed by
ignoring variability in either the period effect or the intervention effect. Our simulation study suggests
that this is not the case because we would expect the standard model to underestimate the intervention
effect with these types of misspeciﬁcation, rather than overestimate the effect. However, we also found
that the standard model gave a very large weight to the horizontal comparisons. This does help to explain
the counterintuitive results seen in the motivating example [2].
We reanalysed the deworming trial by using the three analysis models investigated in the simulation
study and additionally looked at years 1 and 2 separately by using a mixed-effect model with a ﬁxed
effect for intervention and a random intercept to attain estimates for the intervention effect from vertical
comparisons. In line with the published reanalysis of this study, we ignored pupil-level clusters from
multiple observations of the same pupils; this is in line with research suggesting that it is sufﬁcient to
adjust for the highest level of clustering alone, known as passing the buck [13].
The results in Table II are different from the published reanalysis as we have used a different version
of the data (see Data S11 for details) and have not adjusted for covariates other than period [14].
We found that the standard model combining data from both years of the study gave a larger estimate
of the intervention effect than either year analysed separately, which is as was found in the reanalysis
[4].
Adjusting for variation between clusters in the period effect or intervention effect (i.e. using either the
random period model or random intervention model) increased the intervention effect standard error and
reduced the intervention effect towards the null. Both approaches gave an intervention effect estimate
between the estimated effect in year 1 and year 2. This suggests that the horizontal comparisons are
contributing less to these analysis models than to the standard model; this is consistent with the ﬁndings
of our second simulation study into the contribution of the horizontal comparisons.
The random period model found strong evidence of variability in the period effect (p < 0.001), and
the random intervention model found strong evidence of variability in the intervention effect
(p < 0.001). Because the period effect and intervention effect are confounded with one another,
evidence of variability in the intervention effect could be caused by variability in the period effect or vice
versa. The random period model estimated a between-cluster covariance matrix similar to the simulation
study scenario with varying period effect with decreasing variability. The random intervention model
Table II. Intervention effect estimates from motivating example with different analysis models.
Model Odds ratio
(95% CI)
Standard
error
P-value P-value of
random period
or intervention
effect
Separate year analysis
(vertical comparisons)
Year 1 1.67 (0.90,3.10) 0.32 0.11
Year 2 1.19 (0.95, 1.50) 0.12 0.13
Combined analysis
Standard model 1.74 (1.67, 1.81) 0.02 <0.001
Random period model 1.26 (1.02, 1.57) 0.11 0.03 <0.001
Random intervention model 1.25 (0.96, 1.62) 0.13 0.09 <0.001
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estimated lower variability between clusters in the intervention condition than in the control condition
because of the reduced variability in year 2. This is a scenario that we did not consider in our simulation
study where we only investigated a scenario with greater variability in the intervention condition.
Inspection of the data suggests that the random period model is the most appropriate one. A mixed-effect
model with a random effect for period run on observations from group 3, which never received the
intervention, ﬁnds strong evidence of variability in the period effect (p < 0.001). But a mixed-effect
model with a random effect for intervention run on observations from groups 1 and 3, where the
intervention effect is not confounded with the period effect, ﬁnds no evidence of variability in the
intervention effect (p = 0.34).
The random period model suggests that there is some evidence that the deworming intervention
increased school attendance (OR = 1.26, 95% CI 1.02, 1.57; p = 0.03). The effect found by using this
model is weaker, both in terms of absolute size and level of statistical signiﬁcance, than the effect found
by using the standard model. There are still limitations in these data and this analysis, on which further
information has been published elsewhere [1–3].
8. Discussion
We found biased estimates and serious undercoverage of CIs in the SWT scenarios we simulated when
the analysis model ignored variability between clusters in the period effect or intervention effect. In
these scenarios, results from the standard model were driven largely by the horizontal comparisons.
We have shown that, in the scenarios we considered, misspecifying the random effects of mixed-
effect models can result in biased intervention effect estimates. The standard model underestimated
the intervention effect when either the period or the intervention effect varied between the clusters.
The underestimation when the period effect varied may result from the standard model estimating an
intervention effect averaged over the two periods, whereas the true effect for this scenario was a
within-period intervention effect. This is analogous to the difference between the population-averaged
effect and the cluster-speciﬁc effects that are given by different analysis methods. In the presence of
intervention effect variability, the standard model also gave biased estimates of the intervention effect.
The random intervention model had even larger bias when it was misspeciﬁed than the standard model.
Conversely, the random period model had only negligible bias in estimates in all scenarios we
considered. These results are consistent with previous research into misspecifying mixed-effect models
in cluster randomised trials [7,9]. We have built on this literature and shown that these results extend to
SWTs. This highlights how sensitive mixed-effect models can be to misspeciﬁcation of model
assumptions.
Caution is needed beyond estimation of the intervention effect itself. In our simulation study, the bias
extended to standard errors and between-cluster variability. The latter has implications for reporting the
ICC, as recommended by the Consolidated Standards of Reporting Trials guidelines [15]. In addition to
the implications for inference, the bias in standard errors has implications for determining the power and
sample size of SWTs. Because the standard error from the standard model is used in most current
methods of SWT sample size calculations [12,16–18], they should not be applied when the period effect
or intervention effect is expected to vary between clusters, at least in relation to the characteristics of the
trial exemplar used in this paper. Instead, the method developed by Hooper et al. may be more
appropriate [11].
The result of these biases was undercoverage of CIs for the intervention effect. If model assumptions
do not hold, we risk being overconﬁdent in our conclusions. We found particularly severe
undercoverage when using the standard model. This has been seen in previous research into misspeciﬁed
random effects [6,19] and has recently been seen in the setting of SWTs [20]. This is reﬂected in our
analysis of the motivating example; we see a large increase in the standard error of the intervention
effect, and so CIs are much wider when moving from the standard model to the random period model
or random intervention model.
The results from our simulation study could be explained by the excessive weight given to the
horizontal comparisons, even with a lower ICC = 0.05. Because the horizontal comparisons are
within-cluster comparisons, they avoid the additional variability of between-cluster variation. This
means that if the period and intervention effects can be separated, the horizontal comparisons will be
given more weight than the vertical comparisons by all the analysis models we considered. However,
by making the stringent assumption that period and intervention effects are the same in every cluster,
the standard model assumes too much certainty in separating the period and intervention effects. The
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reason that the standard model performed poorly in the simulation study was because of its reliance on
the horizontal comparisons.
In the design we studied, the weight given to horizontal comparisons also meant that greater weight
was given to some groups of clusters than others. The implications of this are not well understood. When
there is a large difference in the weight given to each group, the intervention effect estimate no longer
represents an average effect across the clusters and interpretation becomes more difﬁcult. Further
research is needed to explore this issue in more traditional SWT designs with more groups and when
all clusters have observations in the control and intervention conditions, and so all clusters contribute
through horizontal comparisons.
A criticism of the random intervention model and, to a lesser extent, the random period model is that
they sometimes had problems with convergence. This occurred almost exclusively when both the period
effect and the intervention effect were common to all clusters; the non-convergence resulted from the
models attempting to estimate a true variance of zero, the boundary of the parameter. In this scenario,
all the analysis models gave unbiased effect estimates and appropriate CI coverage. We would suggest
that an analysis plan gives an alternative, simpler model to use in case of convergence issues due to lack
of variability. In our simulation study, this procedure gave good coverage and no bias in the scenarios
with common period effect and intervention effect, where convergence was an issue (data not shown).
Given that the mixed-effect model can be so sensitive to model assumptions, other analysis methods
should be considered. This choice should be prespeciﬁed and prior knowledge used to justify the
assumptions made by the chosen analysis method. We found the random period model to be the most
robust of the models considered, but there was still undercoverage of CIs in some scenarios. Some have
suggested using permutation tests on the standard model [20]. Although this will give correct inference,
there is still a risk of biased intervention effect estimation. Alternative analysis methods that make fewer
assumptions may be more appropriate. Generalised estimating equations have been suggested for the
analysis of SWTs [21] and have been shown to be more robust to misspeciﬁcation of the correlations
in the data in other settings [22], but this robustness has yet to be assessed in the context of SWTs.
Analysis methods that only make use of the vertical comparisons are desirable as they require no
assumptions about period effects, but there are no such methods currently published, and these analyses
are less efﬁcient [23]. Sensitivity analysis could also be used to assess the robustness of results.
We have only considered a limited range of designs in this simulation study. We used a very simple
SWT design to make the analyses as transparent as possible; this design only had two steps, and not all
clusters received the intervention in the course of the study. Further research is needed to conﬁrm that
our ﬁndings hold for other SWT designs. In more traditional SWTs, all clusters receive both the control
and intervention conditions, and so all clusters contribute horizontal comparisons. Because the problems
we highlight arise from the horizontal comparisons, this might exacerbate the problems we identiﬁed.
We have only considered two values for the ICC when the period effect was common to all clusters
and have not assessed the effect of ICC when period effects vary between clusters. In scenarios where
these effects varied between clusters, the baseline ICC was 0.20, which, in many contexts, would be
considered large. Additionally, there was large variability in the period effect; the effect of a less variable
period effect needs further exploration. It is not known how common it is for the period and intervention
effects to vary between clusters in practice; however, we have based this simulation on real trial data.
Large clusters were used in the simulation study to reﬂect the motivating deworming trial; however,
similar results were seen with a smaller mean cluster size of 250 (data not shown). We used a large
number of clusters in each group to avoid small sample issues.
Whilst further research is needed to explore the potential for bias in a wider range of designs and
settings, we have demonstrated that there is a potential for the standard model to give biased intervention
effect estimates and undercoverage of CIs. These simulations provide clear evidence that the standard
model for analysis of SWTs can be both highly sensitive to the data meeting the model assumptions
and highly dependent on non-randomised horizontal comparisons. We urge those conducting SWTs
to ensure an appropriate analysis is used.
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Chapter 7. Paper B: Bias and Inference from Misspecified Mixed-Effect
Models in Stepped-Wedge Trial Analysis
Supporting Information
In the tables S3-S10, the geometric mean of the intervention effect log odds
ratio is given where the intervention effect varies between clusters. All odds
and odds ratios are reported on the log scale.
S1: Covariance Matrices
Below are the covariance matrices used in the data generating process for each
scenario. These are given in the format: var(intercept) cov(period, intercept)
cov(period, intercept) var(period)

1. Common period effect, high variability 1.808 0
0 0

2. Common period effect, low variability 0.251 0
0 0

3. Varying period effect, decreasing variability 1.808 −1.721
−1.721 1.885

4. Varying period effect, stable variability 1.808 −0.943
−0.943 1.885

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S2: Comparison of the Random-Period Model and
Cluster-Period Interaction Model
Parameterisation A
In this paper, we used the following model to allow the period effect to vary
between clusters:
yijk = µ+ (β + vi)tj + θXij + ui
where yijk is the log odds of the outcome in cluster i in year j for observation
k, µ is the mean log odds of the outcome in period one in the control condition,
β is the period effect log odds ratio comparing the outcome in periods two and
one, tj is an indicator of year; 0 for the first year and 1 for the second year,
θ is the intervention effect log odds ratio, and Xij is an indicator of whether
cluster i received the intervention in year j, and: ui
vi
 ∼MVN
 0
0
 ,
 σ2u σ2u,v
σ2u,v σ
2
v

are a random intercept and random effect for period respectively.
Parameterisation B
Other literature has sometimes used an alternative parameterisation:
yijk = µ+ βtj + θXij + v∗ij + u∗i
where now u∗i ∼ N(0, σ2u∗) and v∗ij ∼ N(0, σ2v∗).
The parameterisation used in this paper, parameterisation A, is more flex-
ible than the parameterisation sometimes used elsewhere, parameterisation
B. Parameterisation A allows the total variability to change between periods.
This is necessary to correctly model our motivating example. Parameterisation
B assumes that the total variability is the same in each period.
We can add the restraint that the variance is the same in each period to para-
meterisation A by setting σ2u,v = −12σ2v . When we do this, parameterisations
A and B are equivalent and
σ2u∗ = σ2u −
1
2σ
2
v
σ2v∗ =
1
2σ
2
v
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S3: Table of Convergence of Analysis Models by Simulation
Parameters
Simulation study one: Group two intervention effect log odds ratio the
same as group one
Group one
intervention
effect
Intervention
effect
Period effect
Standard
model
Random
Period
Model
Random
Intervention
Model
0.41 Common
Common period effect,
high variability
100 95 67
0.41 Common
Common period effect,
low variability
100 96 94
0.41 Common
Varying period effect,
Decreasing variability
100 99 100
0.41 Common
Varying period effect,
Stable variability
100 100 100
0.41 Varying
Common period effect,
high variability
100 100 100
0.41 Varying
Common period effect,
low variability
100 100 100
0.41 Varying
Varying period effect,
Decreasing variability
100 100 100
0.41 Varying
Varying period effect,
Stable variability
100 100 100
0 Common
Common period effect,
high variability
100 95 73
0 Common
Common period effect,
low variability
100 97 96
0 Common
Varying period effect,
Decreasing variability
100 100 100
0 Common
Varying period effect,
Stable variability
100 100 100
0 Varying
Common period effect,
high variability
100 100 100
0 Varying
Common period effect,
low variability
100 100 100
0 Varying
Varying period effect,
Decreasing variability
100 100 100
0 Varying
Varying period effect,
Stable variability
100 100 100
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Simulation study two: Group two intervention effect log odds ratio different
to group one
Group one
Intervention
effect
Intervention
effect
Period effect Standard
model
Random
Period
Model
Random
Intervention
Model
0.41 Common Common period effect,
high variability
100 91 73
0.41 Common Common period effect,
low variability
100 99 94
0.41 Common Varying period effect,
Decreasing variability
100 100 100
0.41 Common Varying period effect,
Stable variability
100 100 100
0.41 Varying Common period effect,
high variability
100 100 100
0.41 Varying Common period effect,
low variability
100 100 100
0.41 Varying Varying period effect,
Decreasing variability
100 100 100
0.41 Varying Varying period effect,
Stable variability
100 100 100
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S4: Table of Mean of Intervention Effect Log Odds Ratio
Estimates by Simulation Parameters
Simulation study one: Group two intervention effect log odds ratio the
same as group one
Group one
intervention
effect
Intervention
effect
Period effect Standard
model
Random
Period
Model
Random
Intervention
Model
0.41 Common Common period effect,
high variability
0.4 0.4 0.4
0.41 Common Common period effect,
low variability
0.41 0.41 0.41
0.41 Common Varying period effect,
Decreasing variability
0.37 0.4 0.2
0.41 Common Varying period effect,
Stable variability
0.37 0.4 0.36
0.41 Varying Common period effect,
high variability
0.37 0.4 0.41
0.41 Varying Common period effect,
low variability
0.34 0.39 0.4
0.41 Varying Varying period effect,
Decreasing variability
0.32 0.4 0.21
0.41 Varying Varying period effect,
Stable variability
0.37 0.41 0.37
0 Common Common period effect,
high variability
0 0 0
0 Common Common period effect,
low variability
0 0 0
0 Common Varying period effect,
Decreasing variability
-0.01 -0.01 -0.18
0 Common Varying period effect,
Stable variability
-0.01 -0.01 -0.05
0 Varying Common period effect,
high variability
-0.03 0 0
0 Varying Common period effect,
low variability
-0.07 -0.01 -0.01
0 Varying Varying period effect,
Decreasing variability
-0.07 0 -0.18
0 Varying Varying period effect,
Stable variability
-0.06 -0.02 -0.07
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Simulation study two: Group two intervention effect log odds ratio different
to group one
Group one
Intervention
effect
Intervention
effect
Period effect Standard
model
Random
Period
Model
Random
Intervention
Model
0.41 Common Common period effect,
high variability
1.5 1.5 1.5
0.41 Common Common period effect,
low variability
1.48 1.48 1.47
0.41 Common Varying period effect,
Decreasing variability
1.51 0.93 0.82
0.41 Common Varying period effect,
Stable variability
1.42 0.95 1.05
0.41 Varying Common period effect,
high variability
1.44 1.44 1.4
0.41 Varying Common period effect,
low variability
1.38 1.29 1.14
0.41 Varying Varying period effect,
Decreasing variability
1.43 0.94 0.8
0.41 Varying Varying period effect,
Stable variability
1.33 0.94 1.03
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S5a: Figure of Mean and Spread of Intercept Log Odds
Estimates by Simulation Parameters
Hollow point: Mean estimate, solid barred line: 95% confidence interval,
dashed line: IQR of estimates.
153
Chapter 7. Paper B: Bias and Inference from Misspecified Mixed-Effect
Models in Stepped-Wedge Trial Analysis
S5b: Table of Mean of Intercept Log Odds Estimates by
Simulation Parameters
True intercept is log(6.62)=1.89.
Simulation study one: Group two intervention effect log odds ratio the
same as group one
Group one
intervention
effect
Intervention
effect
Period effect Standard
model
Random
Period
Model
Random
Intervention
Model
0.41 Common Common period effect,
high variability
1.89 1.89 1.89
0.41 Common Common period effect,
low variability
1.89 1.89 1.89
0.41 Common Varying period effect,
Decreasing variability
1.55 1.89 1.71
0.41 Common Varying period effect,
Stable variability
1.78 1.89 1.82
0.41 Varying Common period effect,
high variability
1.9 1.89 1.89
0.41 Varying Common period effect,
low variability
1.92 1.89 1.89
0.41 Varying Varying period effect,
Decreasing variability
1.58 1.89 1.72
0.41 Varying Varying period effect,
Stable variability
1.78 1.89 1.82
0 Common Common period effect,
high variability
1.89 1.89 1.89
0 Common Common period effect,
low variability
1.89 1.89 1.89
0 Common Varying period effect,
Decreasing variability
1.55 1.89 1.72
0 Common Varying period effect,
Stable variability
1.77 1.89 1.83
0 Varying Common period effect,
high variability
1.9 1.89 1.89
0 Varying Common period effect,
low variability
1.92 1.89 1.89
0 Varying Varying period effect,
Decreasing variability
1.59 1.89 1.72
0 Varying Varying period effect,
Stable variability
1.8 1.89 1.83
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Simulation study two: Group two intervention effect log odds ratio different
to group one
Group one
Intervention
effect
Intervention
effect
Period effect Standard
model
Random
Period
Model
Random
Intervention
Model
0.41 Common Common period effect,
high variability
1.52 1.53 1.53
0.41 Common Common period effect,
low variability
1.53 1.53 1.54
0.41 Common Varying period effect,
Decreasing variability
1.19 1.72 1.64
0.41 Common Varying period effect,
Stable variability
1.43 1.71 1.71
0.41 Varying Common period effect,
high variability
1.55 1.54 1.59
0.41 Varying Common period effect,
low variability
1.57 1.6 1.77
0.41 Varying Varying period effect,
Decreasing variability
1.22 1.71 1.66
0.41 Varying Varying period effect,
Stable variability
1.46 1.71 1.72
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S6a: Figure of Mean and Spread of Period Effect Log Odds
Ratio Estimates by Simulation Parameters
Hollow point: Mean estimate, solid barred line: 95% confidence interval,
dashed line: IQR of estimates.
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S6b: Table of Mean of Period Effect Log Odds Ratio
Estimates by Simulation Parameters
True period odds ratio is log(0.32) = -1.14.
Simulation study one: Group two intervention effect log odds ratio the
same as group one
Group one
intervention
effect
Intervention
effect
Period effect Standard
model
Random
Period
Model
Random
Intervention
Model
0.41 Common Common period effect,
high variability
-1.13 -1.13 -1.13
0.41 Common Common period effect,
low variability
-1.14 -1.14 -1.14
0.41 Common Varying period effect,
Decreasing variability
-0.76 -1.13 -0.76
0.41 Common Varying period effect,
Stable variability
-1.07 -1.13 -1.07
0.41 Varying Common period effect,
high variability
-1.14 -1.13 -1.14
0.41 Varying Common period effect,
low variability
-1.14 -1.13 -1.14
0.41 Varying Varying period effect,
Decreasing variability
-0.77 -1.13 -0.77
0.41 Varying Varying period effect,
Stable variability
-1.08 -1.14 -1.08
0 Common Common period effect,
high variability
-1.14 -1.14 -1.14
0 Common Common period effect,
low variability
-1.13 -1.13 -1.13
0 Common Varying period effect,
Decreasing variability
-0.79 -1.13 -0.79
0 Common Varying period effect,
Stable variability
-1.06 -1.13 -1.06
0 Varying Common period effect,
high variability
-1.13 -1.13 -1.13
0 Varying Common period effect,
low variability
-1.14 -1.13 -1.14
0 Varying Varying period effect,
Decreasing variability
-0.79 -1.14 -0.79
0 Varying Varying period effect,
Stable variability
-1.05 -1.13 -1.05
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Simulation study two: Group two intervention effect log odds ratio different
to group one
Group one
Intervention
effect
Intervention
effect
Period effect Standard
model
Random
Period
Model
Random
Intervention
Model
0.41 Common Common period effect,
high variability
-1.13 -1.13 -1.13
0.41 Common Common period effect,
low variability
-1.13 -1.13 -1.13
0.41 Common Varying period effect,
Decreasing variability
-0.76 -0.94 -0.77
0.41 Common Varying period effect,
Stable variability
-1.06 -0.95 -1.07
0.41 Varying Common period effect,
high variability
-1.13 -1.12 -1.13
0.41 Varying Common period effect,
low variability
-1.13 -1.07 -1.13
0.41 Varying Varying period effect,
Decreasing variability
-0.76 -0.95 -0.76
0.41 Varying Varying period effect,
Stable variability
-1.07 -0.95 -1.07
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S7: Table of Mean of Standard Error Estimates by
Simulation Parameters
Simulation study one: Group two intervention effect log odds ratio the
same as group one
Group one
intervention
effect
Intervention
effect
Period effect Standard
model
Random
Period
Model
Random
Intervention
Model
0.41 Common Common period effect,
high variability
0.02 0.03 0.03
0.41 Common Common period effect,
low variability
0.02 0.02 0.03
0.41 Common Varying period effect,
Decreasing variability
0.02 0.12 0.16
0.41 Common Varying period effect,
Stable variability
0.02 0.24 0.21
0.41 Varying Common period effect,
high variability
0.02 0.08 0.11
0.41 Varying Common period effect,
low variability
0.02 0.07 0.09
0.41 Varying Varying period effect,
Decreasing variability
0.02 0.15 0.18
0.41 Varying Varying period effect,
Stable variability
0.02 0.24 0.22
0 Common Common period effect,
high variability
0.02 0.03 0.03
0 Common Common period effect,
low variability
0.02 0.02 0.02
0 Common Varying period effect,
Decreasing variability
0.02 0.12 0.16
0 Common Varying period effect,
Stable variability
0.02 0.24 0.21
0 Varying Common period effect,
high variability
0.02 0.08 0.11
0 Varying Common period effect,
low variability
0.02 0.07 0.09
0 Varying Varying period effect,
Decreasing variability
0.02 0.15 0.18
0 Varying Varying period effect,
Stable variability
0.02 0.24 0.22
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Simulation study two: Group two intervention effect log odds ratio different
to group one
Group one
Intervention
effect
Intervention
effect
Period effect Standard
model
Random
Period
Model
Random
Intervention
Model
0.41 Common Common period effect,
high variability
0.03 0.03 0.03
0.41 Common Common period effect,
low variability
0.03 0.03 0.03
0.41 Common Varying period effect,
Decreasing variability
0.03 0.16 0.19
0.41 Common Varying period effect,
Stable variability
0.03 0.26 0.23
0.41 Varying Common period effect,
high variability
0.03 0.08 0.11
0.41 Varying Common period effect,
low variability
0.03 0.09 0.13
0.41 Varying Varying period effect,
Decreasing variability
0.03 0.19 0.2
0.41 Varying Varying period effect,
Stable variability
0.03 0.27 0.24
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S8: Table of Coverage of 95% Confidence Intervals by
Simulation Parameters
Simulation study one: Group two intervention effect log odds ratio the
same as group one
Group one
intervention
effect
Intervention
effect
Period effect Standard
model
Random
Period
Model
Random
Intervention
Model
0.41 Common Common period effect,
high variability
96 96 97
0.41 Common Common period effect,
low variability
95 95 95
0.41 Common Varying period effect,
Decreasing variability
7 93 74
0.41 Common Varying period effect,
Stable variability
9 93 88
0.41 Varying Common period effect,
high variability
22 86 95
0.41 Varying Common period effect,
low variability
25 88 96
0.41 Varying Varying period effect,
Decreasing variability
9 94 77
0.41 Varying Varying period effect,
Stable variability
7 95 89
0 Common Common period effect,
high variability
96 97 96
0 Common Common period effect,
low variability
95 95 95
0 Common Varying period effect,
Decreasing variability
9 96 80
0 Common Varying period effect,
Stable variability
8 95 88
0 Varying Common period effect,
high variability
22 85 95
0 Varying Common period effect,
low variability
26 83 93
0 Varying Varying period effect,
Decreasing variability
10 95 82
0 Varying Varying period effect,
Stable variability
9 95 88
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Simulation study two: Group two intervention effect log odds ratio different
to group one
This is the percentage of simulations where the 95% confidence interval con-
tained the group 1 true effect
Group one
Intervention
effect
Intervention
effect
Period effect Standard
model
Random
Period
Model
Random
Intervention
Model
0.41 Common Common period effect,
high variability
0 0 0
0.41 Common Common period effect,
low variability
0 0 0
0.41 Common Varying period effect,
Decreasing variability
0 7 41
0.41 Common Varying period effect,
Stable variability
0 43 23
0.41 Varying Common period effect,
high variability
0 0 0
0.41 Varying Common period effect,
low variability
0 0 0
0.41 Varying Varying period effect,
Decreasing variability
1 17 46
0.41 Varying Varying period effect,
Stable variability
0 47 30
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S9a: Figure of Mean and Spread of Intercept
Between-Cluster Variance Estimates by Simulation
Parameters
Hollow point: Mean estimate, dashed line: IQR of estimates.
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S9b: Table of Mean of Intercept Between-Cluster Variance
Estimates by Simulation Parameters
True variance isV ar(ui) = 0.25 for the scenario with common period effect and
low variability, and V ar(ui) = 1.79 otherwise.
Simulation study one: Group two intervention effect log odds ratio the
same as group one
Group one
intervention
effect
Intervention
effect
Period effect Standard
model
Random
Period
Model
Random
Intervention
Model
0.41 Common Common period effect,
high variability
1.79 1.79 1.79
0.41 Common Common period effect,
low variability
0.25 0.25 0.25
0.41 Common Varying period effect,
Decreasing variability
0.38 1.78 1.08
0.41 Common Varying period effect,
Stable variability
1.26 1.77 1.47
0.41 Varying Common period effect,
high variability
1.91 1.88 1.79
0.41 Varying Common period effect,
low variability
0.38 0.34 0.25
0.41 Varying Varying period effect,
Decreasing variability
0.51 1.88 1.06
0.41 Varying Varying period effect,
Stable variability
1.39 1.88 1.5
0 Common Common period effect,
high variability
1.78 1.78 1.79
0 Common Common period effect,
low variability
0.25 0.25 0.25
0 Common Varying period effect,
Decreasing variability
0.37 1.77 1.07
0 Common Varying period effect,
Stable variability
1.26 1.78 1.48
0 Varying Common period effect,
high variability
1.91 1.89 1.78
0 Varying Common period effect,
low variability
0.39 0.35 0.25
0 Varying Varying period effect,
Decreasing variability
0.5 1.88 1.07
0 Varying Varying period effect,
Stable variability
1.37 1.87 1.49
164
Chapter 7. Paper B: Bias and Inference from Misspecified Mixed-Effect
Models in Stepped-Wedge Trial Analysis
Simulation study two: Group two intervention effect log odds ratio different
to group one:
Group one
Intervention
effect
Intervention
effect
Period effect Standard
model
Random
Period
Model
Random
Intervention
Model
0.41 Common Common period effect,
high variability
2.06 2.07 2.09
0.41 Common Common period effect,
low variability
0.51 0.51 0.48
0.41 Common Varying period effect,
Decreasing variability
0.76 1.85 1.08
0.41 Common Varying period effect,
Stable variability
1.53 1.84 1.49
0.41 Varying Common period effect,
high variability
2.13 2.11 1.94
0.41 Varying Common period effect,
low variability
0.59 0.53 0.27
0.41 Varying Varying period effect,
Decreasing variability
0.84 1.94 1.06
0.41 Varying Varying period effect,
Stable variability
1.6 1.95 1.49
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S10a: Figure of Type-one Error by Simulation Parameters
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S10b: Table of Type-one Error by Simulation Parameters
Simulation study one: Group two intervention effect log odds ratio the
same as group one
Group one
intervention
effect
Intervention
effect
Period effect Standard
model
Random
Period
Model
Random
Intervention
Model
0.41 Common Common period effect,
high variability
4 4 3
0.41 Common Common period effect,
low variability
5 5 5
0.41 Common Varying period effect,
Decreasing variability
93 7 26
0.41 Common Varying period effect,
Stable variability
91 7 12
0.41 Varying Common period effect,
high variability
78 14 5
0.41 Varying Common period effect,
low variability
75 12 4
0.41 Varying Varying period effect,
Decreasing variability
91 6 23
0.41 Varying Varying period effect,
Stable variability
93 5 11
0 Common Common period effect,
high variability
4 3 4
0 Common Common period effect,
low variability
5 5 5
0 Common Varying period effect,
Decreasing variability
91 4 20
0 Common Varying period effect,
Stable variability
92 5 12
0 Varying Common period effect,
high variability
78 15 5
0 Varying Common period effect,
low variability
74 17 7
0 Varying Varying period effect,
Decreasing variability
90 5 18
0 Varying Varying period effect,
Stable variability
91 5 12
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Simulation study two: Group two intervention effect log odds ratio different
to group one
This is the percentage of simulations that rejected at the 5% level the null hy-
pothesis that the intervention effect was equal to the true group 1 intervention
effect.
Group one
Intervention
effect
Intervention
effect
Period effect Standard
model
Random
Period
Model
Random
Intervention
Model
0.41 Common Common period effect,
high variability
100 100 100
0.41 Common Common period effect,
low variability
100 100 100
0.41 Common Varying period effect,
Decreasing variability
100 93 59
0.41 Common Varying period effect,
Stable variability
100 57 77
0.41 Varying Common period effect,
high variability
100 100 100
0.41 Varying Common period effect,
low variability
100 100 100
0.41 Varying Varying period effect,
Decreasing variability
99 83 54
0.41 Varying Varying period effect,
Stable variability
100 53 70
S11: Deworming Trial Data Cleaning
We performed the same data cleaning steps used for the reanalysis of the trial
[1, 2] to the data available at:
https://dataverse.harvard.edu/dataset.xhtml?persistentId=doi:10.7910/DVN/28038
(data downloaded 19/11/2015) These were as follows:
1. Carry forward missing school ID
2. Remove observations after a pupil moved school
3. Remove observations of pupils who have died, finished school, or moved
to secondary school
4. Recode pupil drop out as unattended
5. Remove unscheduled visits.
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6. Remove pupils from the data if they were never observed in school during
the 2 years
7. Remove visits that had more the 70% missing attendance data for pupils.
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8 Paper C: Robust Analysis of
Stepped-Wedge Trials using
Cluster-Level Summaries Within
Periods
In this chapter, I address the second objective of my second aim: to propose
an alternative analysis method of SWT analysis.
In chapter 7, I identified that model 3.1 (the standard model) is sensitive
to violations of model assumptions. Although model 3.4 (the random-period
model) had better properties than model 3.1, there was still under coverage
of confidence intervals in some scenarios. In addition, model 3.4 becomes in-
creasingly complex as the number of periods in the study increases. Therefore,
it will not be applicable to all situations in which SWTs are conducted, and
so there is a need for an alternative analysis method.
Here, I describe a novel analysis method that makes no assumptions about
the period effect: a cluster-summary, within-period analysis. This method is
described with a worked example using data from the TB diagnostic trial de-
scribed in section 2.2. A simulation study is then used to assess the properties
of the method. The simulation study was based on the NHS health-check data
described in section 2.3.
In this chapter, model 3.1 is referred to as the standard model, all other ter-
minology is consistent with the rest of this thesis.
Ethics approval for this work is given in Appendix D. This paper is currently
under review at Statistics in Medicine.
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Chapter 8. Paper C: Robust Analysis of Stepped-Wedge Trials using
Cluster-Level Summaries Within Periods
Abstract
Cluster-summary analysis methods are one way to account for clustering in
parallel cluster-randomised trials that has benefits over other methods [1]. In
stepped-wedge trials (SWTs), a cluster-summary analysis is more complex;
outcomes cannot be summarised across the cluster because the cluster exper-
iences both the control and intervention, and the intervention is confounded
with time. Instead, outcomes can only be summarised within periods of the
trial in which clusters remain in the same condition.
We propose a cluster-summary method to analyse SWTs. This method es-
timates the intervention effect by performing cluster-summary analyses com-
paring intervention and control arms within each of the trial periods where
each cluster is in either the intervention or control arm. The effects from each
period are combined with an inverse-variance-weighted average. We use per-
mutation tests to generate a p-value and confidence intervals. We present an
example where we apply this method to a previously published SWT. Using
simulated data, we compared the cluster-summary method to a commonly
used mixed-effect model (the standard model), which has a random effect for
cluster and fixed effects for period and the intervention. We simulate scenarios
with cluster-specific period effects drawn from a distribution informed by real
data, and period effects common to all clusters.
The cluster-summary method provided unbiased estimates of the intervention
effect and valid inference for all scenarios. The standard model failed to provide
reliable inferential statistics in scenarios with period effects that vary between
clusters, but had greater power than the cluster-summary method when period
effects were common to all clusters.
The cluster-summary method for analysing SWT is a more robust analysis
than the standard model. Our new method provides an alternative method
for analysing SWTs when there is uncertainty about the assumptions necessary
for the mixed-effects model.
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8.1 Introduction
Background
Parallel cluster-randomised trials (CRTs) with sufficient numbers of clusters
can be analysed using cluster summaries of observation-level data, or by ac-
counting for correlation in the observation-level data using statistical models.
Cluster-summary methods are robust and allow simple computation of risk dif-
ferences and risk ratios [1, 2]. In contrast, observation-level models with binary
outcomes tend to provide an odds ratio, which is more difficult to interpret [3].
Stepped-wedge trials (SWTs) randomise clusters to sequences that start re-
ceiving an intervention at different times. The trial is divided into periods
between the times when clusters switch from the control to the intervention.
Outcomes are typically observed during all periods [4], and they may also be
observed before the first sequence starts receiving the intervention and after
the last sequence starts to receive the intervention.
The intervention effect can be estimated from two directions of comparison,
sometimes referred to as vertical and horizontal comparisons.
Vertical comparisons compare observations corresponding to the control con-
dition with observations corresponding to the intervention condition during
each period of the trial, i.e. within periods. These comparisons are random-
ised comparisons.
Horizontal comparisons compare observations corresponding to control and
intervention conditions within each cluster across periods, i.e. between periods.
Horizontal comparisons are confounded with changes in the outcome over time
(period effects) since the intervention condition is later in time than the control
condition.
The most commonly used method to analyse SWTs [5, 6] is a mixed-effect
model proposed by Hussey and Hughes [7]. The method combines vertical
and horizontal comparisons. The model uses observation-level regression to fit
a random effect for the clusters, a fixed effect for the intervention, and fixed
effects for periods. Since the model adjusts for period effects with fixed effects
for each period, it assumes that the period effects are the same in all clusters,
and so it assumes exchangability of observations within clusters. This model
has been shown to severely underestimate the standard error of the intervention
effect when period effects vary between clusters, resulting in under coverage of
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confidence intervals [8–11].
The correlation structure of the outcomes within clusters is often not known
in advance of a trial. To avoid underestimating the required sample size, it
may be safer to plan an analysis that does not assume that the period effects
are the same in all clusters. There are a few such methods published that
use more complex mixed-effect models [10, 12]. However, a recent review of
SWTs found that 70% (26/37) of recently conducted SWTs had fewer than 30
clusters in total [13]; in such scenarios mixed-effect models can be unreliable
[1], so an alternative method is required.
In this paper, we introduce a simple cluster-summary method for the analysis
of SWTs that uses only the vertical, within-period comparisons. Since the
method uses cluster summaries instead of random effect to account for clus-
tering, it does not require a large number of clusters to remain reliable [1], and
enables the simple calculation of a risk difference for a binary outcome. We
evaluate the performance of this method against the commonly used mixed-
effects model (referred to as the standard model).
The Cluster-Summary Analysis Method
We extend a cluster-summary analysis method for CRTs to SWTs. We fo-
cus on binary outcomes, which are common in SWTs [6], and demonstrate
calculation of a risk difference. The principles of the method can be applied
to other outcome types (continuous, time-to-event, etc.) and effect measures
(risk ratios, odds ratios, etc.).
The method uses vertical comparisons only. Since vertical comparisons are
not possible during periods where all clusters are in one condition, the method
only uses data collected after the first sequence switches to the intervention
and before the last sequence switches to the intervention.
The method uses the following three stages:
1. First, we calculate the risk of the outcome in each cluster i during each
period j, as the proportion of individuals with the outcome of interest,
pij.
2. Next, we calculate the period-specific risk difference as the difference
between the mean risk in the intervention and the control conditions
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during period j:
θˆj =
1
c1j
∑
i:Xij=1
pij − 1
c0j
∑
i:Xij=0
pij
where c1j and c0j are the numbers of clusters in the intervention condition
and the control condition respectively during period j, Xij is an indicator
of whether cluster i was allocated to receive the intervention or control
condition during period j, equal to 1 for intervention and 0 for control.
3. Last, we combine the period-specific risk differences using an inverse-
variance weighted average, to give an overall estimated risk difference
θˆ:
θˆ =
j=J∑
j=1
wj
w
θˆj
where w = ∑j=Jj=1 wj.
We use weights based on the pooled variance of the period-specific estim-
ated risk difference allowing for the unequal number of clusters in each
condition. These weights are calculated as:
wj = V ar
(
θˆj
)−1
=
((
(c0j − 1)s20j + (c1j − 1)s21j
c0j + c1j − 2
)(
1
c0j
+ 1
c1j
))−1
where s20j and s21j are the empirical variances of the risks in the control
and intervention conditions respectively at each period j.
To calculate a ratio, such as a risk ratio, take the log of the cluster-period
summaries in stage (1). The log risk is not defined for a proportion of 0.
To include these clusters, a heuristic adjustment can be used adding a half to
both the number of individuals with the outcome of interest and the number of
individuals without the outcome, in the affected clusters only [14]. If using log
odds, this adjustment will also be required in cluster-periods with a proportion
of 1.
We use permutation tests to calculate a p-value and confidence intervals, be-
cause they require no assumptions about the correlation between the period-
specific effects [15]. We randomly permute the assignment of clusters to se-
quences, and therefore the time at which clusters switch from control to inter-
vention conditions. We calculate an intervention effect for each permutation,
as described above. The p-value against the null hypothesis of no intervention
effect is given by the proportion of permutations with an estimated interven-
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tion effect the same as or more extreme than that observed. Throughout this
paper, we have used 1000 permutations to allow us to calculate p-values to 3
decimal places.
Permutation tests can generate 95% confidence intervals using an iterative pro-
cess. The following process is conducted iteratively for several given intervention-
effect values to find the values that return a one-sided p-value of 0.025: these
are then the upper and lower confidence limits.
Continuing with our example using the risk difference, first, we test for evidence
against a given risk difference θA by subtracting it from the observed risks in
the intervention condition:
p∗ij =
pij − θA if Xij = 1pij if Xij = 0
A permutation test is performed (as described above) using the new intervention-
condition risks and the original control-condition risks, p∗ij. This provides a
p-value testing the null hypothesis that θ = θA.
R code for conducting this analysis, from stage (2) onwards, is given in S1.
The cluster-summary method assumes the clusters are independent of one
another within each period and assumes that observations are independent
within clusters within each period. No assumptions are made about correla-
tions between observations or cluster summaries over different periods, and no
assumptions are made about the period effects. We assume that the interven-
tion effect is the same for all clusters in all periods.
The Standard Model
As a comparison to our novel method we used the mixed-effect model described
by Hussey and Hughes [7], herein referred to as the standard model, adapted
to a logistic model for a binary outcome as shown below:
logit {P (yijk = 1 | Xij, ui)} = µ+ βjZj + θXij + ui
where yijk is the outcome in patient k at time j in cluster i, µ is the log odds
of the outcome in the first period in the control condition, βj is the change in
the outcome from the first period to period j, Zj is one in period j and zero
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otherwise, θ is the intervention effect, Xij is an indicator as to whether cluster
i has the intervention during period j, ui ∼ N(0, σ2u) is a random effect for
cluster.
This analysis model assumes that clusters are independent of one another. The
model assumes that the intervention effect and period effects are common to
all clusters, and that observations are equally correlated within clusters across
all periods.
8.2 Application to Tuberculosis Diagnostic Trial
We applied the cluster-summary method to a SWT conducted in Brazil that
assessed the effect of a new tuberculosis (TB) diagnostic test on patient out-
comes [16].
The new diagnostic test (Xpert MTB/RIF) is more sensitive than the standard
smear microscopy method and provides a result for rifampicin drug resistance
[17]. The impact of this new test on patient outcomes is unclear, and so this
trial aimed to clarify this effect. The trial defined unfavourable outcomes as
death, lost-to-follow-up during treatment, transfer out of clinic (including to
more specialist centres for those not responding to treatment), or suspected
drug resistance. Clusters were defined as laboratories used to diagnose TB
in two cities in Brazil. After one month of baseline data collection with all
laboratories in the control condition, randomly selected pairs of the 14 trial
laboratories started using the new diagnostic technology at the start of each
month. Data were collected for one month after all laboratories had received
the intervention. Unlike the published analysis of this trial we do not include
data from the periods when all laboratories were in the control condition, or
when they were all in the intervention condition. We estimated from the data
that patients’ outcomes had an intra-cluster correlation coefficient (ICC) of
0.003 throughout the trial.
In the published report [16], the authors found no evidence that the new dia-
gnostic test reduced unfavourable outcomes. They used a mixed-effects model
with a fixed effect for the intervention, and a random effect for cluster (crude
OR=0.92 95% CI 0.79, 1.06; a similar result was found in an analysis ad-
justing for sex, age, city, HIV status and diagnosis status). This analysis did
not adjust for period effects. We found a similar result when we repeated
this analysis on our subset of data that excludes data from the period when
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all laboratories were in the control or all were in the intervention condition
(results not shown).
We applied the cluster-summary method to estimate the intervention effect
risk difference and odds ratio. We compared this to the mixed-effects model
estimate of the intervention effect odds ratio, which used a fixed effect for
period (allowing the outcome to change over time but assuming the same
change in all clusters) [7].
Table 8.1: Stages of estimating the risk difference using the cluster-summary
method. The mean and variance of cluster-level risks are calculated for each
condition in each period. These are used to calculate the risk difference and
its variance in each period. An inverse-variance weighted average of these
gives an overall effect estimate.
Period
Stage in cluster-summery
method:
2 3 4 5 6 7
(1) Control: Mean of
cluster-level risks (%)
30.5 26.5 33.9 32.4 40.7 38.4
Intervention: Mean of
cluster-level risk
32.2 23.8 23.9 30.2 33.3 34.6
(2) Risk difference (%) +1.7 -2.7 -10.0 -2.2 -7.4 -3.7
(3) Control
Number of clusters 12 10 8 6 4 2
Variance of cluster-level
risks (%)
0.009 0.005 0.006 0.005 0.012 0.036
Intervention
Number of clusters 2 4 6 8 10 12
Variance of cluster-level
risks
0.040 0.015 0.001 0.001 0.007 0.020
Weight 0.05 0.13 0.27 0.41 0.11 0.03
Weighted average of risk
difference (%)
-4.8
Table 8.1 shows the three stages in estimating the intervention effect risk dif-
ference using the cluster-summary method. The risk difference for the inter-
vention effect ranged from +1.7% to -10.0% across the 6 periods with negative
values indicating a reduced risk of an unfavourable outcome in the interven-
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tion. The overall estimated risk difference, combining estimates across the 6
periods, was -4.8%.
The cluster-summary method estimated a -4.8% (95% CI -10.0%, -0.3%) re-
duction in the risk of an unfavourable outcome using the new diagnostic test
with some evidence of an effect (p=0.04). The cluster-summary method es-
timated an OR=0.78 (95% CI 0.61, 0.96; p=0.02). The standard model with
a fixed effect for period gave an odds ratio similar to this (OR= 0.83 95% CI
0.67, 1.03; p=0.10).
8.3 Simulation Study
Methods
We performed a simulation study to investigate the performance of the cluster-
summary method in scenarios with different period effects and intracluster
correlation coefficients (ICCs), and for several SWT designs.
We used local-authority-level data on uptake of NHS health checks in England
in 2013-2014, available from Public Health England [18]. Health checks were
offered to all adults aged 40-74 every five years by general practices (GPs) and
third parties to assess risk of diabetes, heart disease, kidney disease, stroke,
and dementia [19]. The mean of the local authority-level percentage of patients
accepting health checks when offered was 49% in the first quarter of 2013; this
increased to 54% in the last quarter. At the start of 2014, the mean was 46%;
this increased to 56% in the last quarter.
Data generation
We used these health check data to generate four scenarios (Figure 8.1). Details
of how we generated the scenarios to be used in the simulation study from these
data are given in S2.
We simulated period effects that were common to all clusters, and period effects
that varied between clusters to the degree that was observed in the data to
check that the cluster-summary method remained unbiased and gave correct
confidence interval coverage in a range of scenarios.
We simulated two ICC scenarios to assess the power of the analysis with dif-
ferent values of ICC. For one we used the between-cluster variability observed
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Figure 8.1: Simulation study scenarios secular trends and ICC. Based on
NHS health-check uptake in England
in the data (ICC=0.08 in the first quarter of 2013, hereafter referred to as
‘high ICC’) and for another we used one-fifth of the observed between-cluster
variability (ICC=0.02 in the first quarter of 2013, hereafter referred to as ‘low
ICC’).
The four scenarios were therefore: (1) common period effects and high ICC,
(2) common period effects and low ICC, (3) varying period effects and high
ICC, and (4) varying period effects and low ICC.
When the period effects varied between the clusters, the between-cluster vari-
ance changed over time. Therefore, the ICC changed over time. Over the
two years the ICC varied between 0.06 and 0.19 for the high ICC and varying
period effects scenario, as observed in the data, and between 0.01 and 0.04 for
the low ICC and varying period effects scenario.
Trial designs
We simulated SWTs in each of these four scenarios that assessed the effect
of an intervention designed to increase the acceptance of health checks. The
simulated intervention effect had an odds ratio of 1.3 favouring the intervention
(log odds ratio=0.26).
We simulated four trial designs for each of the four scenarios to assess how the
numbers of sequences, the number of clusters per sequence, and the total num-
ber of clusters affected the power of the cluster-summary method. The four
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trial designs had either 3 or 11 sequences with either 3 or 11 clusters per se-
quence (Figure 8.2). This resulted in four trials design with a total of 9 clusters
(3 sequences with 3 clusters per sequence), 33 clusters (3 sequences with 11
clusters per sequence, or 11 sequences with 3 clusters per sequence), or 121
clusters (11 sequences with 11 clusters per sequence). Unlike the mixed-effects
model, the cluster-summary method requires clusters in both the control and
intervention condition at each period so our trial designs began after the first
sequence switched to the intervention, and finished before the final sequence
switched to the intervention (Figure 8.2).
Figure 8.2: Trial schematics used in simulation study
The total number of observations for each cluster across the trial was selected
from a log-normal distribution (µ = 5.3, σ2 = 0.25) regardless of the trial
design; this gave a median cluster size of 200 (IQR 143 - 281) with observations
evenly distributed across the periods. In scenarios with common period effects
and high ICC, this would give the smallest trial (9 clusters) approximately
31% power to detect an odds ratio of 1.3 with the standard model, and the
largest trial (121 clusters) approximately 100% power [20].
Each of the four trial designs for each of the four scenarios was simulated 1,000
times, allowing us to estimate coverage of 95% confidence intervals to within
1.4%.
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Analysis methods and evaluation
We analysed each simulated trial using the cluster-summary method and the
standard model. The cluster-summary method calculated an odds ratio for
comparability with the standard model, although this is unlikely to be the
measure of choice in practice. We compared the two analysis methods in
terms of bias, coverage, and power for each trial design and scenario, in line
with recommendations from Burton et al. [21].
We calculated the proportion of standard models that converged and the pro-
portion of cluster-summary analyses that required the heuristic adjustment.
Bias was calculated as the deviation of the mean of the estimated intervention
effect log odds ratio from the true log odds ratio. Effect estimates within half
a standard deviation of the true effect were considered unbiased. Below this
cut off, bias has been shown to have little effect on the type-one error rate
[21, 22]. We compared the variability of the estimates given by each analysis
method using the ratio of the variances. The coverage of the 95% confidence
intervals was calculated as the proportion of simulations with p>0.05 against
the true effect, i.e. the proportion of confidence intervals that contained the
true effect. We calculated the power to detect an effect at 5% significance as
the proportion of simulations with p<0.05 against no intervention effect.
Simulation Study Results
For all simulations, the cluster-summary method provided an effect estimate
and p-value and the mixed-effects model converged. The heuristic adjustment
was used in 83%-100% of simulations with a trial design of 11 clusters per
sequence and 11 sequences (mean of 2-7 times per simulation), 9% - 63% with
3 clusters per sequence and 11 sequences (mean of 0-1 times per simulation),
in 1 simulation with 11 cluster per sequence and 3 sequences, and was never
used with 3 clusters per sequence and 3 sequences. See S3 for more details.
Bias and variability
Figure 8.3 shows the mean and half a standard deviation either side of the
mean of the estimated intervention effects for each analysis method, scenario,
and trial design. The mixed-effect model estimates were unbiased. The cluster-
summary method eestimates were consistently larger than the true effect in
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all scenarios with 11 sequences, however this small bias was never larger than
half a standard deviation (see S4).
Figure 8.3: Intervention effect estimates in each scenario and trial design,
by analysis method. Hollow circle is the mean, solid line is ± 1/2 standard
deviation. Grey dotted line is true effect
The cluster-summary method estimates were between 1.76 and 6.07 times more
variable than the standard model estimates when period effects were common
to all clusters. When period effects differed between clusters, the variability of
the estimates was more alike between analyses: the cluster-summary method
estimates were between 0.83 and 2.08 times as variable as the standard model
estimates. This difference between the common-period-effect scenarios and
varying-period-effect scenarios was largely driven by an increase in variability
of standard model estimates. In all scenarios, the difference in variability was
greater when there were more sequences and when the ICC was higher because
of a reduction in variability in the standard model estimates and an increase
in variability in the cluster-summary analysis estimates respectively.
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Coverage
Figure 8.4 shows the coverage of the 95% confidence intervals, and its confid-
ence interval, for each method, scenario, and trial design (see S5 for further
details).
Figure 8.4: Coverage of 95% confidence intervals in each scenario and trial
design, by analysis method. Hollow circle is the coverage. Barred lines are
95% confidence intervals
When period effects were common to all clusters, shown in the upper half
of Figure 8.4, both analysis methods gave reasonable coverage (92%-95%), al-
though there was some suggestion that the standard model gave under-covered
confidence intervals with 9 clusters (94% coverage and 92% coverage for high
and low ICC respectively).
When period effects varied between clusters, shown in the lower half of Figure
8.4, the cluster-summary analysis achieved 93%-96% coverage for both levels
of ICC and all trial designs. In contrast, the standard model produced severe
under coverage of 95% confidence intervals for both levels of ICC and most
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trial designs. The degree of under coverage was more severe when the ICC
was high (67%-80% coverage and 87%-92% coverage for high and low ICC
respectively) and with fewer sequences.
Power
Table 8.2 shows the power for each method, scenario, and trial design. When
period effects vary, the power for the standard model is not shown because of
under coverage of confidence intervals (see Figure 8.4).
Table 8.2: Statistical power in each scenario and trial design, by analysis
method. When period effects vary, the power for the mixed-effects model is
not shown because of the under coverage of confidence intervals (see Figure
8.4).
Period
effect ICC
Number
of
sequences
Clusters
per
sequence
Power (%)
Cluster-
summary
analysis
Mixed-effect
model
Difference
Common 0.02 3 3 24 48 22
0.02 3 11 73 90 17
0.02 11 3 76 97 21
0.02 11 11 100 100 0
0.08 3 3 10 35 25
0.08 3 11 27 73 46
0.08 11 3 31 93 62
0.08 11 11 81 100 19
Varying 0.02 3 3 27
0.02 3 11 82
0.02 11 3 83
0.02 11 11 100
0.08 3 3 11
0.08 3 11 37
0.08 11 3 40
0.08 11 11 88
The power of the cluster-summary method ranged from 11% to 100%. Power
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was higher with more clusters and lower ICC. For example, with common
period effects, 11 sequences, and 3 clusters per sequence the cluster-summary
method had 31% and 76% power for high and low ICC respectively. Whether
period effects were common or varying had limited impact on the power of the
cluster-summary analysis.
When period effects were common, the cluster-summary analysis had lower
power than the standard model for both levels of ICC and all trial designs.
The difference ranged from 0% to 63% less power; power loss was greatest
when ICC was high and with 11 sequences.
8.4 Discussion
We have presented a cluster-summary approach to analyse SWTs. To the best
of our knowledge the analysis of SWTs using cluster-summaries of vertical
comparisons has not been used previously, despite many of the trials having
a small number of clusters where model based approaches to analysis are less
appropriate.
We have shown that the cluster-summary method accounts for period effects
by using an example where time was a confounder. The original analysis of
the TB diagnostic SWT concluded that there was no evidence of an effect
on patient outcomes. In contrast, both the cluster-summary method and the
mixed-effects model accounting for period effects found larger effect estimates
with some evidence of an intervention effect.
Our simulation study found that the cluster-summary method is more robust
than the standard model, which produced confidence intervals with severe
under coverage when period effects varied between clusters. Previous research
has also identified this under coverage [8–11].
The cluster-summary method, however, had inferior performance to the stand-
ard model when period effects were common to all clusters (i.e. when the
mixed-effects model assumptions were true). In this scenario, the cluster-
summary method had much higher variability in the estimated intervention
effects and, therefore, lower power, particularly when the ICC was high. The
challenge is knowing if period effects will be common to all clusters when cre-
ating an analysis plan and calculating the sample size for a trial. Choosing a
method that is robust irrespective of the period effects avoids under-powering
the trial if this assumption is not met.
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The cluster-summary method required a heuristic for when the prevalence of
the outcome in a cluster during a period was either 0 or 1 when calculating
an odds ratio. The heuristic was required in the scenarios with 11 sequences
because the cluster size in each period was smaller in these scenarios. The use
of the heuristic increased with the total number of clusters. The heuristic was
not required for calculating risk difference and would not be required for other
difference estimates, such as mean differences or rate differences, but it would
be required for other ratio estimates.
In our study, there was a small bias away from the null in scenarios with 11
sequences but not in scenarios with 3 sequences. This small bias has been pre-
viously observed for estimation of odds ratios when clusters are small [23, 24].
When clusters are small, the cluster-level log-odds are overestimated [24], lead-
ing to biased effect estimates as observed. Cox and Snell [24] suggest a simple
adjustment of adding a half to the number of individuals with and without the
outcome in all clusters to correct this overestimation and we recommend using
this adjustment when using a cluster-level analyses to calculate an odds ra-
tio. This correction also negates the need to specifically correct clusters where
individuals all have the same outcome.
This study confirms the findings of Wang and DeGruttola [11], that the mag-
nitude of under coverage of confidence intervals from the standard model when
period effects vary between clusters is dependent on the degree of clustering.
Our study also builds on previous research by showing that the degree of under
coverage increases with fewer sequences; this was caused by greater variabil-
ity in the intervention effect estimates in the scenario with fewer sequences.
Our simulation study also suggests that the mixed-effect model may produce
under-covered confidence intervals when used with only 9 clusters, similar to
the findings of Barker et al [25].
We have found that the power of the cluster-summary method is dependent on
the total number of clusters, and only marginally on the number of sequences.
This contradicts the findings of Moulton et al [26] who found that the power of
a vertical analysis decreased as the number of sequences increased. The con-
tradiction may be due to Moulton et al ignoring clustering. Further research
is needed to understand how the number of sequences affects the power of this
methods in a wider range of scenarios. Consistent with previous research [7,
27], the statistical power of the standard model was dependent on the number
of sequences as well as the number of clusters.
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A strength of the simulation study is that we used NHS health check uptake
data at the local-authority level to demonstrate the effect of realistic variab-
ility in period effects. We explored the performance of the cluster-summary
method in a range of realistic settings by varying the ICC and looking at
several different trial designs.
The simulation study has limitations. For our results to be most applicable
to epidemiological research we explored binary outcomes and to enable com-
parison with a mixed-effect model estimated an odds ratio. Further research
is required to examine whether the standard model is more robust to mis-
specification with a continuous outcome, and to explore the properties of the
cluster-summary method with continuous and rate outcomes. Other features
of SWTs, such as delayed intervention, sparse data collection, or lags were not
considered. The performance of the cluster-summary analysis in the presence
of more extreme ICCs requires further research.
There may be other analysis methods that are able to provide robust estimates
whilst including the horizontal comparisons. Research is needed into gener-
alized estimating equations or the addition of robust standard errors in the
context of SWTs as these methods have been shown to be robust to misspe-
cification in other settings [28]. However, these methods still rely on having
many clusters and generally compute odds ratios.
The weights used for each period-specific effect were chosen to minimise the
number of assumptions. The permutation test was chosen as this makes no
assumptions about the composition of the data other than that of exchange-
ability and a common intervention effect [15]. There may be improvements in
power available from making assumptions about the data. Granston provided
a variance formula for a within-period analysis under the assumptions of the
Hussey and Hughes analysis model, which would remove the need for per-
mutation tests [29]. However, the addition of assumptions negates many of
the benefits of the cluster-summary method. The method could be exten-
ded to incorporate an adjustment for baseline individual-level covariates, as
described by Hayes and Moulton [1].
We have shown that the cluster-summary method can be simply adapted to
provide estimates of risk differences. The method could also be extended
to calculate risk ratios. While there are methods to estimate risk ratios for
CRT with at least 50 clusters using a Poisson model [30], which could be
adapted for SWT, we are not aware of methods to estimate risk differences.
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Presenting absolute as well as relative effect sizes can improve interpretation,
as is recommended by the CONSORT statement [31].
A limitation of a cluster-summary method is that power is lost when there is
high variability in cluster sizes. Whilst we allowed cluster size to vary, we did
not explore the effect of different levels of variability on power. When there is
high variability in cluster size the method could be extended to weight clusters
in the analysis by their size as described by Hayes and Moulton to improve
precision [1].
A cluster-summary approach to the analysis of SWTs is an unbiased and ro-
bust alternative to the commonly used mixed-effects modelling approach. Re-
searchers designing and analysing SWTs should consider this as an alternative
to mixed-effects models.
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8.5 Supporting Information
S1: R Code for Cluster Summary Analysis
cluster.summary <- function(data, cluster, sequence, time, rx,
summary, null) {
f.effect <- function(x){
#Aggregate data by time and intervention condition
slices.long <- aggregate(summary ~ time + rx,
data = x,
FUN = function(X)
c(mean = mean(X, na.rm = TRUE),
n = sum(!is.na(X)),
var = var(X, na.rm = TRUE)))
slices.long$mean <- slices.long$summary[,1]
slices.long$n <- slices.long$summary[,2]
slices.long$var <- slices.long$summary[,3]
#reshape so one row per time slice
slices <- reshape(direction = "wide",
data = slices.long[,c("time", "rx", "mean",
"n", "var")],
v.names = c("mean", "n", "var"),
idvar = c("time"),
timevar = "rx")
#calculate difference
slices$diff <- slices$mean.1 - slices$mean.0
#Calculate a weight assuming the same variance in both arms
slices$wgt <- ( (((slices$n.0 - 1) * slices$var.0 +
(slices$n.1 - 1) * slices$var.1) /
(slices$n.0 + slices$n.1 - 2)) *
(1/slices$n.0 + 1/slices$n.1) )^-1
weighted.mean(slices$diff, slices$wgt, na.rm = TRUE)
}
f.permute <- function(y, design) {
design$cluster <- sample(design$cluster, replace = FALSE)
design.long <- reshape(design,
direction = "long",
idvar = c("cluster", "sequence"))
permuted.data <- merge(y[, c("cluster", "time", "summary")],
design.long,
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by = c("cluster", "time"))
return(f.effect(permuted.data))
}
dataset <- data.frame(cluster = eval(substitute(cluster), data),
sequence = eval(substitute(sequence), data),
time = eval(substitute(time), data),
rx = as.numeric(eval(substitute(rx),data)),
summary = eval(substitute(summary),data))
dataset$summary <- dataset$summary - null * dataset$rx
#Calculate observed effect
mean.effect <- f.effect(dataset)
#Create a dataset of the design
design <- reshape(direction = "wide",
idvar = c("cluster", "sequence"),
timevar = "time",
v.names = "rx",
data = unique(dataset[,c("cluster", "sequence",
"rx", "time")]))
#Calculate p-value under null = 0
permutations <- replicate(10000,
f.permute(dataset, design),
simplify = TRUE)
p <- sum(abs(permutations) > abs(mean.effect)) / 10000
return(c(mean.effect, p))
}
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S2: Data Generating Process
We based the simulations on an outcome that might plausibly be the target of
an SWT (uptake of NHS health checks) with realistic clusters (English local
authorities).
Across England, GP surgeries and third parties offer all adults between the
ages of 40-74 a health check to assess the patient’s risk of diabetes, heart
disease, kidney disease, stroke, and dementia. A recent study found that,
while uptake of health checks has improved since their introduction, uptake
is still low: in 2012, 30% of patients accepted the offer of a health check [19].
Data on the uptake of these health checks is published on the Public Health
England website for each year quarter, by local authority [18]. In this study
we used data from 2013-2014 to simulate trials designed to study the effect of
an unspecified intervention to improve uptake of health checks.
Local authorities were removed from the dataset if at any time point they
recorded 100%, or 0% uptake of health checks, they had no offers of health
checks, or they had more cases of health check uptake than offers. We then
visually inspected the log odds of health check uptake to identify any outlying
local authorities; a further 2 local authorities were removed as they had un-
usually high uptake in some quarters. This process removed a total of 29/152
local authorities.
In the remaining 123 local authorities we analysed the health check uptake
to assess how uptake was changing over time, and how this varied between
the local authorities. For each local authority we modelled the acceptance of
health checks as:
logit (P (yijk = 1)) = µi + β1it1ij + β2itγi2ij
Where yijk is health check acceptance in local authority i at time j, µi is the
log odds of acceptance in local authority i in the first quarter of 2013, t1ij is an
indicator of year; 0 in 2013 and 1 in 2014, β1i is the log odds ratio comparing
health check acceptance in 2014 to 2013 in local authority i, tγi2ij is the quarter
1,2,3 or 4 within each year to a power γi selected using fractional polynomials
to allow for a non-linear trend (more details below), and β2i is the log odds
ratio for quarter in local authority i. This meant that we were assuming the
same effect of quarter in both years.
This model was run for each local authority using fractional polynomials to
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select a value γi for each local authority. The most common value selected was
γi = 3.
We then ran a mixed effect model across all the local authorities where:
logit (P (yijk = 1)) = µ+ ui + (β1 + v1i) t1j + (β2 + v2i) t32j
ui
v1i
v2i
 ∼ N


0
0
0
 ,

σu cov (u, v1) cov (u, v2)
cov (u, v1) σv1 cov (v1, v2)
cov (u, v2) cov (v1, v2) σv2


where ui is a random intercept, v1i is a random effect for year, and v2i is a
random effect for quarter.
The resulting model gave coefficient µ = −0.14, β1 = −0.04, and β2 = 0.01
with the following multivariate normal distribution:
ui
v1i
v2i
 ∼ N


0
0
0
 ,

0.306 −0.150 −0.002
−0.150 0.253 −0.001
−0.002 −0.001 0.001


We simulated two scenarios for the period effects of quarter and year:
1. Period effect differs between clusters. The coefficients for quarter, year,
and the constant for our clusters were sampled from the multivariate
normal distribution as seen in the data and given above.
2. Period effect common to all clusters. The mean coefficient for quarter
and year were selected for all clusters and the constant was sampled
from a normal distribution with mean and variance from the multivariate
normal distribution. i.e.
ui
v1i
v2i
 ∼ N


0
0
0
 ,

0.306 0 0
0 0 0
0 0 0


We wanted to compare our analysis methods in data with a smaller ICC so we
used two scenarios for the intra-cluster correlation (ICC).
1. High ICC: corresponding to the original data and the original multivari-
ate normal distribution. When period effects differed between cluster
this meant that the ICC varied between 0.06 and 0.15 over the two
years. When period effects were common to all clusters this meant that
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the ICC remained the same as the ICC in the first quarter of 2013 in the
original data, so ICC=0.08 throughout.
2. Low ICC: The between-cluster variance was reduced by multiplying the
covariance matrix by 0.2. When period effects differed between the
cluster this meant that the ICC varied between 0.01 and 0.03 over the
two years. When period effects were common to all cluster this meant
that the ICC remained at ICC=0.02 throughout.
This gave us four data scenarios for how acceptance of health checks varied
over time, and how this varied between local authorities.
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S3: Table of the Number of Times the Heuristic
Adjustment was used in each Scenario and Trial Design
Period
effects
ICC Number
of
sequences
Clusters
per
sequence
Number of
simulations
Mean
times per
simulation
p=0
Mean
times per
simulation
p=1
Common 0.02 3 3 0 0.0 0.0
Common 0.02 3 11 0 0.0 0.0
Common 0.02 11 3 86 0.0 0.1
Common 0.02 11 11 827 0.5 1.2
Common 0.08 3 3 0 0.0 0.0
Common 0.08 3 11 0 0.0 0.0
Common 0.08 11 3 417 0.2 0.4
Common 0.08 11 11 992 1.8 3.4
Varying 0.02 3 3 0 0.0 0.0
Varying 0.02 3 11 0 0.0 0.0
Varying 0.02 11 3 115 0.0 0.1
Varying 0.02 11 11 881 0.6 1.5
Varying 0.08 3 3 0 0.0 0.0
Varying 0.08 3 11 1 0.0 0.0
Varying 0.08 11 3 627 0.2 0.8
Varying 0.08 11 11 1000 2.0 5.2
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S4a: Table of the Mean of Intervention Effect Log Odds
Ratio Estimates in each Scenario and Trial Design by
Analysis Method
Period
effects
ICC Number
of
sequences
Clusters
per
sequence
Standard
model
Cluster-
summary
method
Common 0.02 3 3 0.25 0.26
Common 0.02 3 11 0.26 0.26
Common 0.02 11 3 0.26 0.27
Common 0.02 11 11 0.26 0.28
Common 0.08 3 3 0.26 0.26
Common 0.08 3 11 0.26 0.26
Common 0.08 11 3 0.26 0.27
Common 0.08 11 11 0.26 0.28
Varying 0.02 3 3 0.26 0.26
Varying 0.02 3 11 0.26 0.26
Varying 0.02 11 3 0.26 0.27
Varying 0.02 11 11 0.26 0.28
Varying 0.08 3 3 0.25 0.25
Varying 0.08 3 11 0.26 0.27
Varying 0.08 11 3 0.26 0.28
Varying 0.08 11 11 0.25 0.28
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S4b: Table of the Standard Deviation of Intervention Effect
Log Odds Ratio Estimates in each Scenario and Trial Design
by Analysis Method
Period
effects
ICC Number
of
sequences
Clusters
per
sequence
Standard
model
Cluster-
summary
method
Ratio
of
variance
Common 0.02 3 3 0.15 0.19 1.76
Common 0.02 3 11 0.08 0.10 1.54
Common 0.02 11 3 0.07 0.10 2.10
Common 0.02 11 11 0.04 0.05 1.92
Common 0.08 3 3 0.18 0.37 4.55
Common 0.08 3 11 0.10 0.19 3.73
Common 0.08 11 3 0.08 0.19 6.07
Common 0.08 11 11 0.04 0.10 5.16
Varying 0.02 3 3 0.17 0.17 1.05
Varying 0.02 3 11 0.09 0.09 1.12
Varying 0.02 11 3 0.08 0.09 1.49
Varying 0.02 11 11 0.04 0.05 1.42
Varying 0.08 3 3 0.35 0.32 0.83
Varying 0.08 3 11 0.17 0.17 0.92
Varying 0.08 11 3 0.12 0.17 2.08
Varying 0.08 11 11 0.07 0.09 1.68
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S5: Table of Intervention Effect 95% Confidence Interval
Coverage in each Scenario and Trial Design by Analysis
Method
Period
effect
ICC Number of
sequences
Clusters
per
sequence
Standard
model
Cluster-
summary
method
Common 0.02 3 3 0.92 0.94
Common 0.02 3 11 0.95 0.95
Common 0.02 11 3 0.94 0.94
Common 0.02 11 11 0.94 0.95
Common 0.08 3 3 0.94 0.95
Common 0.08 3 11 0.95 0.95
Common 0.08 11 3 0.95 0.95
Common 0.08 11 11 0.94 0.94
Varying 0.02 3 3 0.87 0.95
Varying 0.02 3 11 0.89 0.94
Varying 0.02 11 3 0.92 0.95
Varying 0.02 11 11 0.92 0.93
Varying 0.08 3 3 0.67 0.96
Varying 0.08 3 11 0.73 0.96
Varying 0.08 11 3 0.80 0.94
Varying 0.08 11 11 0.77 0.96
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9 Paper D: A Stata Command for
Conducting Permutation Tests
for Stepped-Wedge Cluster
Randomised Trials
In CRTs, it has been noted that publication of methodological literature is not
sufficient to change practice [1]. Further efforts are also required to improve
uptake of new methods.
This chapter addresses the final objective of my second aim: to facilitate the
use of the identified analysis method.
In chapter 8, I introduced a novel analysis strategy: analyse each period sep-
arately, combine these estimates, and use permutation tests for a p-value and
confidence interval.
A limitation of this analysis method is the complexity of implementation. Run-
ning this analysis would involve manually coding repetitions of the analysis in
each period and manually coding the permutation tests. This is likely to limit
the uptake of this analysis method by trialists.
To limit this barrier to use, I wrote a Stata command that would perform
this analysis for the user. As well as performing the within-period analysis
described in chapter 8, the command can also run the analyses described by
Ji et al [2], Wang and DeGruttola [3], and Bellan et al [4] where permutation
tests are used for hypothesis testing on model 3.1 estimates.
Stata [5] is commonly used for the analysis for cluster randomised trials [6].
Not all software allows users to contribute to the software’s capabilities, how-
ever, Stata does allow this. Users are able to write commands using the same
language as when using Stata for analysis. Once a user written command is
installed, the commands are executed in the same way as the official Stata
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commands. User-written commands are published in the Stata Journal, and
added to the Statistical Software Components archive (SSC) [7]. Once a com-
mand has been listed on SSC, users can install the command using the Stata
command “ssc install”. Users can also provide a dialog box so that the com-
mand can be executed using Stata’s user interface. Drukker [8] provides details
of how to create a command in his series of blogs “Programming an estimation
command in Stata”.
The command is written so that it can conduct permutation tests on estimates
from a range of analysis models. To accomplish this, I used a prefix command.
This means that my command is specified, followed by a colon, followed by a
second command giving the analysis required to produce an estimate.
I have tested the command in a wide range of scenarios following the processes
described by Gould [9], and the code includes checks that users of the com-
mand have provided appropriate input. I have written the command in a way
which minimises the time taken for it to run, however, for a large number of
permutations it can take a few minutes to complete.
In this chapter, this Stata command is described and worked examples of its
use are given using data from the TB diagnostic trial described in section
2.2. This paper will be submitted to The Stata Journal with the title “swper-
mute: Permutation tests for stepped-wedge cluster randomised trials”. Ethics
approval is given in Appendix E.
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Abstract
Permutation tests are useful in stepped-wedge trials to provide robust stat-
istical tests of intervention-effect estimates. However, the Stata command
permute does not produce valid tests in this setting because individual ob-
servations are not exchangeable. We introduce the swpermute command that
permutes clusters to sequences to maintain exchangeability. The command
provides additional functionality to aid users in performing analyses of stepped-
wedge trials. In particular, we include the option “withinperiod” to perform
the specified analysis separately in each period of the study and the resulting
period-specific intervention-effect estimates are combined as a weighted av-
erage. Examples of the application of swpermute are given using data from
a trial testing the impact of a new tuberculosis diagnostic test on bacterial
confirmation of a tuberculosis diagnosis.
9.1 Introduction
Permutation tests are a commonly used non-parametric statistical technique,
used to calculate p-values without making distributional assumptions. In in-
dividually randomised trials, they are used because they make no distribu-
tional assumptions, provide exact confidence intervals, and do not rely on
large sample approximations [10]; the Stata command permute provides an
intuitive and simple way to perform permutation tests in this simple scenario.
While the benefits for permutation tests hold for more complex randomised
designs, such as parallel and stepped-wedge cluster-randomised trials, permute
cannot perform a valid test for such designs.
In a cluster-randomised trial, the allocation of clusters of individuals, such as
villages or hospital wards, are randomised. In a parallel cluster-randomised
trial (CRT), each cluster is randomised to receive either a control, or inter-
vention condition for the duration of the trial, as in figure 9.2a. But, ran-
domisation can be more complex than this. A stepped-wedge trial (SWT) is
a cluster-randomised trial run over a number of periods. Clusters are ran-
domised to sequences, where each sequence receives the control condition for a
different number of periods, and then receive an intervention condition for the
remaining periods of the trial, as in figure 9.2b. For both of these designs but
particularly SWTs, it is difficult to assess the assumptions required by para-
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metric methods and so permutations tests, which make fewer assumptions, are
appealing [2, 3, 11, 12].
Figure 9.1: Schematics of cluster-randomised trial designs. White = time in
control condition, Grey = time in intervention condition
(a) a parallel cluster-randomised trial (b) a stepped-wedge cluster-
randomised trial
SWTs are commonly analysed with parametric models [13], but some have sug-
gested that the intervention-effect estimate from such models may be biased if
the correlation structure of the data is misspecified [14]. A “within-period”
analysis strategy for SWTs has been suggested that makes fewer assump-
tions about this correlation structure [12]. First, the trial is separated into
the periods between the times when clusters switch from control to inter-
vention. Within each of these periods, an analysis is conducted to provide
an intervention-effect estimate and weight for that period. The results are
then combined using a weighted average of the within-period estimates, and
permutation tests are used to calculate a p-value for evidence of an effect
accounting for the correlation of observations in the same cluster.
Here we introduce a new command, swpermute. The new command allows
specification of clustering and allocation to a time dependent sequence of in-
tervention conditions to enable use with cluster-randomised trials with a par-
ticular focus on SWTs. An option is provided to conduct a within-period
analysis, and we provide an option to test null hypothesis values other than
zero to simplify the process of constructing confidence intervals.
9.2 Technical Details
The swpermute command is designed for trials with two treatment conditions;
usually this will be a control and intervention condition so we will use this
terminology throughout this paper. In this section, we will provide details of
the permutation test, and how this is implemented in swpermute.
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Permutation Tests: Individual Randomisation
In an individually randomised trial, we have some outcome observations yk,
k = 1, ..., K. Half of these observations are collected under a control condi-
tion, the other half under an intervention condition, and we are interested in
knowing whether the control and intervention conditions lead to different out-
comes. As with most frequentist methods, we investigate this by constructing
a distribution for the difference between the outcomes in control and inter-
vention under the assumption that there is no difference. The true difference
between control and intervention is the intervention effect θ = θA. If there is
truly no difference between the two conditions, then assignment of observa-
tions to each condition is arbitrary, and for any set of assignments of the yk to
the control and intervention conditions, we can calculate an intervention effect
θ = θˆ∗. By repeating this process for each unique assignment of observations
to conditions, we obtain the exact distribution of θ under the null hypothesis
that θ = 0. The observed intervention effect can then be compared to this
distribution to calculate the p-value as the probability of an intervention effect
the same as or more extreme than that observed:
p = f/F
where F is the number of unique permutations, and f is the number of these
that produced an intervention effect the same or more extreme than the ob-
served intervention effect.
It becomes unfeasible to calculate θˆ∗ for all unique permutations when the num-
ber of observations is large. In such cases, it is sufficient to randomly sample
a number of permutations from all possible permutations, with or without re-
placement, a process known as Monte-Carlo permutations [10]. Both permute
and swpermute perform Monte-Carlo permutations with replacement. The
p-value is now given by:
p = f ∗/F ∗
where F ∗ is the number of permutations, and f ∗ is the number of these that
produced an intervention effect the same as or more extreme than the observed
intervention effect. Because Monte-Carlo permutations involve randomly se-
lecting permutations, the p-value calculated may differ when the process is
repeated with a different set of permutations.
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With Monte-Carlo permutations, the number of permutations is chosen by the
user and affects the accuracy with which a p-value can be computed. Good
[15] recommends using between 100 and 1,600 permutations, increasing this
number if the uncertainty around the p-value makes interpretation difficult.
A confidence interval can be constructed for the p-value from a binomial dis-
tribution where the number of permutations is the number of Bernoulli trials,
and the p-value is the probability of a success.
Two assumptions are required for permutation tests to be valid. Firstly, per-
mutation tests test a strong null hypothesis, meaning they test if θ = 0 for
every observation rather than θ = 0 on average. So, permutation tests are not
valid where the effect of an intervention is expected to vary between obser-
vations. Secondly, permutations tests assume exchangeability of observations.
This means that any assignment of observations to the conditions is equally
likely. This second assumption does not hold for an SWT; in the next section
we will discuss how to meet the assumption of exchangeability in these studies.
Extending Permutation Tests to Stepped-Wedge Trials
In the context of cluster-randomised trials, exchangeability holds at the unit
of the cluster, but will not hold at the individual observation level. Because of
this, the assignment of clusters must be permuted rather than assignment of
individual observations. In SWTs, it is the assignment of clusters to a sequence
that must be permuted to maintain the assumption of exchangeability. The
permute command permutes at the level of the individual observations, so is
not a valid test for SWTs. The swpermute command permutes clusters to
sequences of allocations observed in the data and so is valid for SWTs.
Selecting an Intervention Effect Estimator
So far we have only discussed tests related to an intervention effect but we have
not described an appropriate method for estimating an intervention effect.
In this section, we will discuss the analyses currently recommended in the
literature for SWTs.
A key design feature of all SWTs is that the intervention effect is confounded
with time. This can be accounted for either by adjusting for period effects, or
by conditioning on periods.
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Adjusting for period
The most common analysis model used for SWTs, introduced by Hussey and
Hughes [16], is an example of an analysis that adjusts for period effects:
yijk = µ+ βj + θXij + ui + eijk (9.1)
where yijk is the outcome of individual k in period j from cluster i, µ is the
mean outcome in the first period, βj is the difference between period j and the
first period with β1=0, θ is the intervention effect, Xij is 1 if cluster i received
the intervention in period j and 0 otherwise, ui ∼ N (0, σ2u) is a random effect
for cluster, and eijk ∼ N (0, σ2e) is the within-cluster variability. This model
can be extended to a generalised linear mixed model for outcomes that are not
normally distributed.
Despite the popularity of this analysis model, it has been criticised for in-
flated type-one error rates if the period effects differ between the clusters. One
solution that has been suggested is to use this analysis model to estimate an
intervention effect but to use permutation tests to calculate a p-value and
confidence intervals [2–4].
Other analysis models that adjust for time can also be used with permutation
tests.
Conditioning on period: a within-period analysis
Using model 3.1 to estimate an intervention effect requires that this model gives
an unbiased estimate; Thompson et al [14] showed that this is not always the
case.
As an alternative, SWTs can be analysed with what is known as a within-
period analysis, sometimes known as a vertical analysis because of how the
trial schematics of these designs are drawn as shown in figure 9.2b. The general
process is as follows:
1. An intervention effect is estimated for each period of the study using any
analysis method that would be valid for a CRT.
2. These within-period estimates are given weights.
3. The within-period estimates are combined by taking a weighted average
to get an overall intervention-effect estimate.
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4. The permutation test is used to perform hypothesis tests on the overall
intervention-effect estimate.
This procedure conditions on period, and so removes any confounding between
the intervention effect and the period effects without making assumptions
about the period effect or about the correlation of observations between peri-
ods. Any analysis that can be used for a CRT could be used within each
period, for example Thompson and Davey et al [12] suggested using a cluster-
level analysis in each period allowing for a simple, intuitive calculation of an
intervention-effect estimate, but an appropriate individual-level analysis could
also be used and either type of analyses could be extended to adjust for cov-
ariates.
The overall intervention effect estimate variability can be reduced by using
appropriate weights for each period [11]. This is an area of ongoing research.
Matthews and Forbes assume that the variance of the observations does not
change over time and so suggest weighting periods by the imbalance in the
number of clusters in the control and intervention [17]. Others have suggested
that the weights given to each period should reflect the uncertainty around the
within-period estimates [12], so that within-period estimates that are estim-
ated with greater precision are given greater weight. The estimate’s precision
will depend on the variability of the observations and on the imbalance in the
number of clusters in the control and intervention conditions in a particular
period. In periods with more variability between the observations, the inter-
vention effect estimate will have lower precision than periods with less vari-
ability between observations. Periods with a larger imbalance in the number
of clusters in control and intervention will have an intervention effect estimate
with lower precision than periods with an equal number in each condition. The
estimated variance of the intervention effect estimate will incorporate both of
these factors but, since it is only an estimate of the variance, can introduce
additional variability into the overall intervention effect estimate. Therefore,
if the total variability of the observations is not expected to change between
periods, it may be more efficient to weight the periods only by the imbalance
between the number of clusters in each condition.
We introduce a within-period option for swpermute to perform this procedure,
thus making such an analysis easier to perform.
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Constructing Confidence Intervals
Confidence intervals are created by finding the set of values for the true inter-
vention effect that are not rejected at the α level, i.e., hypothesised interven-
tion effects for which p > α. One way to identify this set of values is to test
many values. Values with p ≥ 0.05 fall within the 95% confidence interval and
p < 0.05 fall outside this interval.
If the effect of the intervention was to increase the outcome by θA, then after
subtracting θA from the observations collected under the intervention condi-
tion, there should be no difference between the control and intervention con-
ditions. Therefore, a null hypothesis of θ = θA is tested by first subtracting
θA from observations collected in the intervention condition, then running the
permutation test as described above to get a p-value.
This process is simple for the case of an absolute difference in a continuous
outcome. To test a relative difference, take the log of the observations before
subtracting log(θA). Similarly, the process is simple if we have summarised the
outcome for each cluster-period: we might calculate the risk, log risk, odds,
log odds, rate, or log rate for each cluster-period and can subtract the null
value from these summaries.
However, when the outcome is on a different scale to the intervention effect,
the outcome observations must be transformed before subtracting the null
value. Take as an example, testing a null hypothesis of an odds ratio for an
individual-level binary outcome. We start with the outcomes on the binary
scale, either a 0 or 1 for each observation. First, we would need to group
these to the binomial scale in the format d cases out of D observations in each
cluster-period. From this, the log odds of the outcome in each group can be
calculated and the null log odds ratio subtracted from these log odds. This
would then need to be back-transformed to a number of d∗ cases out of D
observations.
9.3 The swpermute Command
The permutation test for SWT, described in section 9.2, is implemented in
swpermute. swpermute runs a permutation test for SWTs on any analysis
specified by the user. The algorithm identifies sequences in the observed data
and permutes clusters between these sequences for each permutation. The
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specified analysis can be run either across all periods in the study or within
each period with results combined as a weighted average. Users can specify
several null hypothesis values to be tested in order to construct confidence
intervals if they have cluster-level or continuous outcomes.
Data Requirements
The swpermute command requires specification of a clustering variable identi-
fied in cluster(), a period variable identified in period(), and an intervention
variable identified in intervention(). These three variables define the design
of the study; each cluster is assigned to an intervention status in each period.
The data should be in long format, with observations in each period given in
different rows of the dataset. All observations within a cluster must follow the
same sequence.
Syntax
The syntax of the swpermute command is as follows:
swpermute exp , cluster(varname) period(varname)
intervention(varname) [ reps(num) left|right
strata(varlist) saving(filename, ...) null(numlist )
outcome(varname)withinperiod weightperiod(weightperiod)
nodots level(num) seed(num) ] : command
exp specifies the result to be collected from results stored by the
execution of command. Examples are r(mu_1)-r(mu_2) the
mean difference estimated by ttest, or _b[varname] a coeffi-
cient estimate from a regression model .
cluster(varname) specifies the variable identifying the clusters.
cluster() is required and must be a numeric variable. Ob-
servations with cluster() missing will be excluded from the
analysis.
period(varname) specifies the variable identifying the periods.
period() is required and must be a numeric variable. Ob-
servations with period() missing will be excluded from the
analysis.
213
Chapter 9. Paper D: A Stata Command for Conducting Permutation Tests
for Stepped-Wedge Cluster Randomised Trials
intervention(varname) specifies the variable identifying the in-
tervention assignment. intervention() is required and must
be a binary variable where 0 and 1 represent the control and in-
tervention conditions, respectively. All observations within each
value of cluster()must have the same value of intervention()
in each period() or the command will return an error. If all
values of intervention() are missing for a cluster() in a
period(), this is assumed to be part of the sequence, for ex-
ample as a washout period, and the missing value will be per-
muted. Otherwise, observations with intervention() missing
will be excluded from the analysis.
reps(num) specifies the number of permutations to perform. The
default is reps(500).
left|right requests that one-sided p-values be computed. If left
is specified, the p-value reported is the proportion of permuta-
tions where exp gives a value less than or equal to the observed
value. If right is specified, the p-value reported is the propor-
tion of permutations where exp gives a value greater than or
equal to the observed value. The default is two-sided p-values,
where the p-value reported is the proportion of permutations
where exp is the same or further from zero than the observed
value.
strata(varlist) specifies that the permutations be performed within
each stratum defined by the values of varlist. This option should
be used if randomisation of clusters was stratified [10].
saving(filename, ...) creates a Stata file (.dta file) consisting of
a row for each permutation for each value in null(). The file
consists of three variable containing the null() value being
tested, the observed value of exp for that null value, and values
of exp for each permutation. A new filename is required unless
replace is specified. The option double specifies that results
should be stored in double precision, the default is to store
results as float. The option every(num) writes results to file
every num permutations. This will allow recovery of partial
results should the command not complete running.
null(numlist) specifies a list of values to test as the null hypo-
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thesis. For each value specified, the value will be subtracted
from the variable specified in outcome() if the variable defined
in intervention() is equal to 1. The permutation test is run
on this modified dataset to calculate a p-value. This option
should only be used with cluster-level or continuous outcomes.
The null values are assumed to be on the same scale as the out-
come (e.g. risk differences if the outcomes are cluster-period
risks). Ratios such as risk ratios, or odds ratios should be given
on the log scale. The default is null(0). When values other
than the default are specified the option outcome(varname) is
required.
outcome(varname) specifies the variable identifying the outcome.
This option is only required when null(numlist) is specified
with numlist!= 0. outcome() is assumed to be on the same
scale as the values specified in null(). For example, outcome()
should contain risks if null() gives risk differences, or log risks
if null() gives log risk ratios.
withinperiod specifies that a within-period analysis should be
performed. command is run within each unique value of the
variable specified in period() and the resulting values of exp
are combined as a weighted average using the weights specified
in weightperiod().
weightperiod(weightperiod) specifies the weights to be used if
withinperiod is specified. This option is only required when
withinperiod is specified and is one of the following:
weightperiod(none): each period is given equal weight,
so the weight wj = 1 for all periods j.
weightperiod(N): periods are weighted by the num-
ber of clusters in the control and intervention con-
ditions as:
wj =
(
1
coj
+ 1
c1j
)−1
where c0j and c1j are the number of clusters in
the control condition and intervention condition
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respectively in period j. It is equivalent to weight-
ing by the variance if the variance of the outcome
does not change over time.
weightperiod(variance exp2): each period is weighted
by the inverse of the statistic exp2 stored by the
execution of command. That is
wj =
(
1
exp2j
)
exp2 is assumed to be the variance of each within-
period estimate and will be different to the exp
defined earlier in the command. This specification
is suggested by Thompson and Davey et al [12].
nodots suppresses display of the dots at the completion of each
permutation. By default, one . is displayed for each successful
permutation. A red x is displayed if command returns an error
or if the statistic in exp is missing for a permutation.
level(num) specifies the confidence level, as a percentage, for con-
fidence intervals of the p-value. The default is level(95) or as
set by set level; see [u] 20.7 Specifying the width of
confidence intervals.
seed(num) sets the random-number seed. Specifying this option
is equivalent to typing:
set seed num
prior to calling swpermute. If no seed is specified, swpermute
will return different results each time it is run due to the random
selection of permutations.
Stored Results
swpermute stores the following in r():
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Scalars
r(N_cluster) number of clusters
r(N_strata) number of strata if strata option has been used
r(obs_value) value of exp observed in the data
r(N_reps) number of permutations
Matrices
r(design) a matrix of 0 and 1 values showing the design of the SWT
r(obs_period) value of exp observed in the original data within each
period if a within-period analysis is specified
r(p) p-values with their confidence intervals for each null value
9.4 The Dialog Box
The swpermute command can be used both as a coded command, and through
a drop-down dialog box. To install the dialog box run the follow commands:
. window menu append submenu "stUser" "&Cluster RCTs"
. window menu append item "Cluster RCTs" "Permute for stepped-wedge
trials (&swpermute)" "db swpermute"
. window menu refresh
Running these commands from within Stata will only install the dialog box for
the current session of Stata. To install the menus permanently, place the above
commands into your profile.do file. See [u] [GSW] B.3, [u][GSM] B.1, or
[u][GSWU] B.1 Executing commands every time Stata is started for
more details on how to do this.
The supporting information S1 shows the dialog box for this command.
9.5 Example
To demonstrate the use of swpermute we will use data from an SWT conducted
in Brazil that assessed whether switching to a new tuberculosis (TB) diagnostic
test increased the proportion of patients with a bacterially confirmed TB dia-
gnosis [18]. The real data could not be shared with the command. Instead,
a simulated dataset is included that closely mimics the characteristics of this
trial data.
217
Chapter 9. Paper D: A Stata Command for Conducting Permutation Tests
for Stepped-Wedge Cluster Randomised Trials
The standard diagnostic test for TB, sputum smear microscopy, is quick and
cheap but has low sensitivity [19]. Because of this, many patients are dia-
gnosed with TB based on clinical symptoms alone, even if their test comes
back negative [19]. A new TB diagnostic test (Xpert MTB/RIF) is known to
be more sensitive than the standard smear microscopy method of diagnosis.
It also provides a result for rifampicin drug resistance at the time of diagnosis
[20].
This SWT in Brazil sought to explore the impact of switching from smear
microscopy to the Xpert test. Here, we focus on a secondary outcome of the
trial: whether patients had their TB diagnosis bacterially confirmed by either
a smear microscopy test or the Xpert test [18].
The trial included 14 laboratories that covered most diagnoses in the cities of
Rio de Janeiro and Manaus in Brazil. At initiation of the study, all laboratories
were using sputum smear microscopy to diagnose TB. Following a month of
baseline data collection, the Xpert test was rolled out to two randomly assigned
laboratories each month, so that 7 months later, all laboratories were using
the Xpert test.
Our dataset contains 3,924 patients diagnosed with TB during the study in the
14 laboratories; their type of diagnosis was recorded as either clinical (with a
negative test or no test done), or bacterially confirmed. 2,147 (55%) patients
were diagnosed with the Xpert test, and 2,833 (72%) had a confirmed TB
diagnosis.
The output below describes the dataset we will use.
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Each row gives the diagnosis type, confirmed, of a patient. lab identifies
which laboratory they were diagnosed in and so assigns the patient to a cluster.
study_month identifies which month of the study they were diagnosed in, and
arm identifies whether the laboratory was using smear microscopy or the Xpert
diagnostic at the time of diagnosis. The Xpert diagnostic was rolled out to
laboratories as follows, where 0 assigns the laboratory to using smear micro-
scopy and 1 assigns the laboratory to the Xpert diagnostic:
Figure 9.2 shows the proportion of patients with a confirmed diagnosis in each
study month by whether they were diagnosed with a smear microscopy test,
or an Xpert test.
We will explore four analyses with permutation tests; the first will use the
analysis model 9.2 with a permutation test, the last three analyses will demon-
strate different within-period analyses.
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Figure 9.2: Proportion of patients in the TB diagnostic trial with a confirmed
diagnosis in each study month by type of test used
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Analysing the data using model 9.2 gives the following results:
There is strong evidence that the use of the Xpert test increased the odds that
a patient’s TB diagnosis would be confirmed (odds ratio (OR)=1.52 96% CI
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1.19, 1.93; p=0.001)
This analysis can also be run using the above model to calculate the interven-
tion effect, but using permutation tests to calculate the p-value. Stata stores
all regression coefficients in the system variables _b[*], and stores the stand-
ard errors of these coefficients in _se[*]. In this example, we want to use the
model coefficient for the variable arm in the permutation test, and so we set
the exp to _b[arm] in the swpermute command:
swpermute first of all repeats command and exp. It then shows the design-
pattern matrix. Each row represents a unique sequence of allocations observed
within the data, each column represents a period. For each sequence and
period, a 0 or 1 is shown representing the intervention condition of clusters
in that sequence in that period. The left most column shows the number of
clusters assigned to each sequence.
The table below this gives the results of the permutation test. Notice that
the observed value of _b[arm], shown in column 1 of the table, is identical to
the value from the model run without the permutation tests; this is because
the permutation test does not affect the estimate itself. The second column
of this table shows the null hypothesis being tested, in this example we only
test a null hypothesis of no difference. The third column gives the number of
permutations with a value of exp the same or more extreme than the observed
value and the fourth column gives the total number of permutations success-
fully completed. Here, we found that only 2/1000 permutation gave a result
221
Chapter 9. Paper D: A Stata Command for Conducting Permutation Tests
for Stepped-Wedge Cluster Randomised Trials
the same or more extreme than that observed; this gives the p-value shown
in column 5. The last 2 columns give a two-sided 95% confidence interval for
the p-value. For this dataset, the permutation test gave a similar result to the
parametric model.
In running this command, we specified that the results were saved to a Stata
dataset. We can look at this dataset to see more details of the permutation
test. A sample of the dataset is given below:
The estimates can be plotted in a histogram to show the distribution of exp
under the null hypothesis, as shown in figure 9.3. The vertical lines show
the observed values of exp and -exp. These are at the tails of the distribution,
hence only 2 permutations had values of exp more extreme than that observed.
Figure 9.3: Distribution of the permutation test log odds ratio under the null
hypothesis of no effect
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Within-Period Analysis and Specifying Null Values
In this example, we will use a within-period analysis to calculate the difference
in the risk (the proportion) of a confirmed diagnosis and show how to construct
confidence intervals. In order to calculate a risk difference (the difference in
proportions), we will use a cluster-level analysis within each period.
First, we calculate the proportion of confirmed diagnoses in each cluster-period.
We run swpermute with regress as the command to calculate a risk difference
and its variance. We select the withinperiod option to run the regression
within each period, and set the period weights as variance weights. The null()
option is specified with several null values using trial and error to identify the
boundaries of the 95% confidence interval.
We see a warning that study month 1 and study month 8 are not included
in this analysis; this is because all clusters are in the same condition during
these periods so an intervention effect cannot be calculated. As well as the
table of results we discussed in the previous example, we also see a list of effect
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estimates and weights for each period in the study. Since we specified variance
weights, the weights are the inverse of the variance of each effect estimate.
Greatest weight is given to study month 6, despite the imbalance in clusters
in the control and intervention conditions, because there was less variability
in the cluster-level outcomes during this period.
The observed value in the table of results is the weighted average of these
period-specific estimates. This method estimates that there is a 10.5% in-
crease in the proportion of patients with a confirmed diagnosis using the Xpert
test compared to using smear microscopy. The permutation test gives p=0.06
against a null hypothesis of no difference between the diagnostic tests.
As well as testing a null hypothesis of no difference, we have also tested several
other values to construct a confidence interval. The boundaries for rejecting the
null hypothesis at the 5% level are -0.4% and 20.0%, hence the 95% confidence
interval is (-0.4%, 20.0%).
Within-Period Analysis Adjusting for a Cluster-Level
Confounder
We saw in the previous example that the within-period analysis does not use
observations from the first period of the study. We might want to incorporate
this information by adjusting for the proportion of confirmed diagnoses in each
cluster during this period.
The data must be reshaped so that the proportion in the first period is given
as a variable, rather than as rows that contribute as outcomes.
We then add this variable as a covariate in command. We have demonstrated
this analysis through use of the dialog box in Supporting Information S1.
Inputting these setting runs the following command:
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The intervention effect is similar to when we did not adjust for baseline, but
the evidence of an effect is now stronger.
9.6 Concluding Remarks
swpermute is an extension of the Stata command permute that permutes
clusters between sequences and can perform within-period analyses. We also
incorporated functionality to test non-zero null hypotheses to facilitate the
construction of confidence intervals. Although this command has been de-
signed for use with SWTs, it can also be used with other trial designs such as
CRTs and crossover cluster-randomised trials.
The command does, however, have limitations. Testing non-zero null hypo-
thesis values is only available for continuous outcomes and cluster-level ana-
lyses. For other outcome types, the process would involve manipulating the
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dataset to a such degree that we felt that it was safer for the user to perform
this themselves. Whilst we have incorporated stratification of randomisation
by a list of variables, some randomisation strategies such as restricted random-
isation cannot be captured in this way [21]. It is a limitation of permutation
tests generally that confidence intervals have to be constructed by the user.
swpermute facilitates the use of robust analysis methods for an SWT, making
complex analysis easier to perform.
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9.7 Supporting Information
S1: Screen Shots of Dialog Boxes that run Example 5.3
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10 Discussion and Conclusions
Since the start of this PhD, the landscape of the literature on SWTs has
evolved. Before I began, almost all literature on the design and analysis of
SWTs focused on model 3.1, and in this setting I identified gaps in the literature
on efficient SWT design and robust analysis.
In chapter 6, I identify a more efficient SWT design. I developed a new formu-
lation of a design effect. This allowed me to algebraically explore the impact of
the size of periods outside rollout and the number of sequences on the required
sample size whilst holding all other parameters, such as the cluster size, ICC,
and power, constant. In chapters 7, 8, and 9, I explore methods of robust
analysis. This involved identifying problems with model 3.1, suggesting an
alternative analysis method, and facilitating use of that method.
During the last three years, the analysis literature is now starting to place a
greater emphasis on identifying alternative analyses to model 3.1. My work
in chapters 7, 8, and 9 has contributed to this, along with the work of others
notably Heuvel et al [1], Ji et al [2], and Wang and DeGruttola [3].
The sample size literature has also begun to move away from model 3.1, and
now focuses on model 3.2. Whilst this is an improvement given my findings in
chapter 7 that confidence intervals from model 3.1 sometimes have low cover-
age, model 3.2 is yet to be verified as an appropriate analysis model in typical
SWT settings. Understanding of efficient SWT design has also improved over
the past three years. The work in this thesis, along with that of Lawrie et al
[4] and Girling and Hemming [5], has improved the understanding of how to
increase the power of SWTs.
In this final chapter, I will summarise my findings and bring them together
in the context of the current literature. Section 10.1 will give a discussion of
the findings from the novel work of this thesis. Section 10.2 gives details of
how I have disseminated these results and worked to increase their impact.
Section 10.3 explores the strengths and limitations of my work, and section
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10.4 provides ideas for the direction of future research to build on this work.
Lastly, I will provide the overall conclusions from the thesis in section 10.5.
10.1 Synthesis of Findings
In this section I will give the main findings of each paper and discuss how they
relate to one another and to the wider literature. These are important findings
for the SWT literature and will have practical implications for researchers
designing SWTs in the future.
10.1.1 Summary of Results
In chapter 6, I found that, in a complete SWT with an equal allocation of
clusters to sequences, it is inefficient to collect observations outside the rollout
period. With this modified design, the optimal number of sequences increases
as the cluster-mean correlation increases. When a non-optimal number of
sequences is used, there may be some efficiency gains from including some
observations outside rollout, and I provide a formula for the size of the period
outside rollout.
The findings of this chapter complement the recent results of Girling and Hem-
ming [5] who found that the sample size could be reduced by allowing a se-
quence of clusters to remain in the control condition and a sequence to remain
in the intervention condition for the duration of the trial. However, my find-
ings contradict the results of several other papers that found that the statistical
power increased with the number of sequences. A more in depth discussion of
this contradiction is given later in this section.
In chapter 7, I conducted a large simulation study to assess how robust model
3.1 is to misspecification of the random effects. I found that, for all types of
misspecification I considered, model 3.1 (the standard-model) produced con-
fidence intervals with low coverage and, when the intervention effect varied
between the clusters gave biased intervention-effect estimates. I identified
that the random-period model (model 3.4) had better properties, but still
produced confidence intervals with low coverage when the intervention effect
varied between the clusters.
The bias in the intervention effect estimates have not been observed in the con-
text of SWTs prior to this work, but have been observed for longitudinal data
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with binary outcomes [6]. With a binary outcome and logit link, the relation-
ship between the cluster-specific and marginal effect estimates are dependent
on the correlation structure of the data. When the correlation structure of
the data is misspecified, this relationship is misspecified and can led to bias in
the cluster-specific estimates [6]. For linear mixed effect models, correct spe-
cification of the correlation structure is required for estimation of the standard
errors, but does not affect the consistency of the parameter estimates [6].
This paper also explored the weight each model gave to horizontal comparisons.
I found that, compared to the Hussey and Hughes model (model 3.1), the
random-period model and random-intervention model gave less weight to the
horizontal comparisons when the period or intervention effects varied between
clusters. This partly explains why the Hussey and Hughes model is so sensitive
to misspecified random effects.
This chapter has confirmed that model 3.1 is prone to confidence intervals with
low coverage [2, 3, 7]. The investigation of the impact of the intervention effect
varying between the clusters and the resulting identification of potential bias of
the intervention-effect estimates are novel. The use of the random-period and
random-intervention models are also novel in the context of SWTs. My finding
that model 3.1 gives a large weight to horizontal comparisons is expected, but
this is the first work that explicitly shows this to be the case; this finding has
since been confirmed by others [8].
To address the need for a more robust analysis that was demonstrated in
chapter 7, chapter 8 introduces a novel analysis method that makes very few
assumptions. Each period of the study is analysed separately to calculate a
period-specific intervention-effect estimate and a variance for that estimate.
The estimates are then combined using an inverse-variance weighted average
and permutation tests are used to calculate a p-value and confidence interval.
I used a cluster-summary analysis within each period as this is most widely
applicable, but any analysis valid for a CRT, such as a random-effect model
on individual level data could potentially be used here. A cluster-summary
analysis has the benefit that the analysis is reliable even with a small number
of clusters, and, for binary outcomes, risk differences can be calculated with
ease [9]. This is a simple, transparent method of analysis that makes only two
assumptions about the data: clusters are exchangeable between sequences and
the intervention effect is common to all clusters. However, this comes at the
cost of reduced power compared to methods that make stronger assumptions.
The cluster-summary, within-period analysis performed well in my simulation
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study, regardless of the form of the period-effect between-cluster variability.
Similar methods have been suggested in the analysis of longitudinal data [10,
11], but these are likely to require many clusters per sequence to reliably
estimate a covariance matrix for the within-period intervention effect estim-
ates. A within-period method has also been suggested for SWTs [12], but
this method made strong assumptions about the correlation of observations
between clusters. The flexible method I have provided is novel in the context
of SWTs. The reduction in power was expected and has been noted by others
[11, 12].
In chapter 9, I describe a Stata command that I developed. The command
has the primary purpose of facilitating the use of the within-period analysis
method described in chapter 8 . The command performs permutation tests
for SWTs by permuting clusters between sequences. It allows specification of
any chosen analysis method for estimating the intervention effect, using cluster
summaries or individual level data, to be run across all periods of the trial [2,
3, 7], or within-periods as I described in chapter 8. Functionality is included
to allow users to test different null hypotheses for the intervention effect in
order to construct confidence intervals.
With the use of this command, the within-period analysis becomes almost as
simple to execute as a mixed-effect model, removing a barrier to the use of this
robust analysis method. Prior to the development of this command, the only
way to conduct a valid permutation test for an SWT was to manually code
the tests oneself. The inbuilt permute command in Stata can only permute
individual observations between intervention conditions. In Chapter 8, R code
is also provided for conducting a within-period analysis and using permutation
tests.
10.1.2 Horizontal and Vertical Comparisons
Chapters 6-8 all contribute to understanding the use of vertical and horizontal
comparisons in SWT analyses.
In chapters 7 and 8, I explored the weight given to vertical and horizontal
comparisons and demonstrate a dependence on the cluster-mean correlation,
which has recently been confirmed by Matthews and Forbes [8].
In chapter 7, the example I used had a large cluster-mean correlation be-
cause the clusters had a geometric-mean size of 1000 observations; this led to
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a cluster-mean correlation of 0.98 for the scenario with lower ICC=0.05 and
common period and intervention effects. In this high cluster-mean correla-
tion scenario with common period effects, model 3.1 retrieved almost all the
intervention effect information from horizontal comparisons.
In chapter 8, I also found that there was a large difference between the power
of the vertical analysis and model 3.1 in scenarios with common period ef-
fects, confirming that model 3.1 obtained a large amount of information from
horizontal comparisons. Again, this paper used scenarios with a high cluster-
mean correlation because of the large cluster sizes (median 200 observations
per cluster); the low ICC scenario had a cluster-mean correlation of 0.80, while
the high ICC scenario had a cluster-mean correlation of 0.95. Even with this
small increase in cluster-mean correlation, there was a clear increase in the
difference in power between the within-period analysis and model 3.1. This
demonstrates that the use of horizontal comparisons depends on the ICC and
cluster size.
This explains why in chapter 6 I found that there was an optimal number of
sequences. The optimal SWT design must balance the precision of the vertical
and horizontal comparisons. In a design with all observations within rollout,
increasing the number of sequences increases the imbalance between the con-
ditions in each period and so reduces the precision of vertical comparisons [9,
13]. Conversely, increasing the number of sequences improves data usage for
horizontal comparisons so increases the precision of horizontal comparisons,
despite increasing the number of period effects estimated by the model.
Previous research found that increasing the number of sequences increased the
power of the standard design [5, 14, 15]. With such a design, the proportion
of observations in the periods outside rollout is determined by the number
of sequences. Therefore, the horizontal precision continues to increase with
sequences, and now the vertical precision increases as well because a larger
proportion of the observations can contribute to these comparisons.
Adding periods outside of the rollout period and increasing the number of
sequences both have the potential to increase the precision of the horizontal
comparisons when the cluster-mean correlation is high. My finding that it is
optimal to have no observations outside rollout suggests that increasing the
number of sequences has a greater benefit to the precision of the horizontal
comparison than introducing periods outside rollout.
This thesis has clarified some of the roles horizontal comparisons play in SWTs.
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They increase precision, but the high dependence on these comparison when
the cluster-mean correlation is high can be the cause of bias and under coverage
of confidence intervals if the incorrect assumptions are made in the analysis.
10.1.3 Utility of the Hussey and Hughes Model
Chapters 7 and 8 both showed that model 3.1 has poor confidence interval
coverage in a range of scenarios. This brings the use of this analysis model
into question without a strong justification for why it is appropriate. The
finding of under coverage when the period effect varies between the clusters
confirms previous research [2, 3, 7], and is consistent with findings from similar
trial designs such as CRXO and CRT with baseline observations [16, 17]. In
chapter 8, I show that the degree under coverage is dependent on the strength
of clustering in the data in line with findings by Wang and DeGruttola [3]. I
demonstrate the novel finding that the under coverage depends on the number
of sequences. Under coverage of confidence intervals also occurred in scen-
arios with only 9 clusters, confirming that mixed effect models are unreliable
with a small number of clusters [9]. In chapter 7, I also showed that model
3.1 produces biased intervention-effect estimates when the intervention effect
varies between clusters. Together, these finding show that model 3.1 is not
appropriate for analysing SWTs in a large range of settings.
This confirms that the results of chapter 6 will not be valid when model 3.1
is misspecified, as suggested by Hooper et al [18]. In particular, the design
effect I derived will underestimate the sample size required to achieve a given
power if the period effects vary between clusters. However, it seems likely that
removing periods before and after rollout will continue to improve efficiency
when this assumption is relaxed, such as in the random-period model, because
less information is obtained from horizontal comparisons. This is supported by
Girling and Hemming [5] who found that the Hybrid design, with some clusters
in the control or intervention conditions for the duration of the trial, is more
efficient than a standard SWT under the assumptions of the less restrictive
model 3.2. Likewise, although the formula for the number of sequences will
not hold exactly, it is likely that the general relationship between the cluster-
mean correlation and the number of sequences will be similar.
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10.1.4 Selecting an Analysis
After identifying that model 3.1 is not a robust analysis method, I have iden-
tified two potential alternatives: the random-period model, and the cluster-
summary method. The choice between these methods will depend on the
setting in which they are being used.
The random-period model will have more power than a within-period analysis.
However, the model may have problems converging if the period effects are
similar in all clusters and this model suffered low confidence interval coverage
when the intervention effect varied between clusters. The model also grows in
complexity as the number of sequences increases.
Alternatively, the cluster-summary method is transparent, robust, and allows
for simple calculation of the risks difference. However, this comes at the cost
of power.
Other alternative analysis models that I have not considered were detailed in
chapter 3.
These include GEE, which have been shown to be robust to misspecification of
correlation structures in other settings [19], and model 3.2. These are methods
which require further research.
Some of my results bring the utility of other alternative methods into question.
In chapter 7, I found that model 3.1 produced biased intervention-effect estim-
ates when the intervention effect varied between clusters. This challenges the
validity of the analysis suggested by Bellan et al [7], Wang and DeGruttola [3]
and Ji et al [2] in this scenario because it uses the estimate from model 3.1.
Greater use of sensitivity analyses would increase readers’ confidence in SWT
results and has been recommended [20]. The within-period analysis would be
particularly useful as a sensitivity analysis because it makes so few assump-
tions.
10.1.5 Issues with Prespecifying an Analysis
The choice of analysis methods has implication from the planning stages of a
trial and so must be prespecified, ideally in an analysis plan. Campbell and
Walters give advice on writing an analysis plan [21]. This allows the design
of the study to reflect the chosen type of analysis, and prevents trialist from
running several analysis models and selecting one based on the results.
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Some analysis methods have more power to detect an effect than others, so
sample size calculations should reflect the analysis choice.
The cluster-summary method will require a larger sample size to achieve the
same power as the random-period model. Moulton et al [13] provide advice on
sample size calculation for a within-period analysis for time to event outcomes
but until further research is conducted, simulations are required to calculate
the sample size of a within-period analysis.
Others provide advice on sample size calculations for methods which incor-
porate the horizontal comparisons (and adjust for period effects) allowing
for random-period effects [5, 18]. These methods require assumptions about
period effects and changes to the correlation over time and there is little guid-
ance available in the literature to guide these assumptions. A conservative
approach is to assume lower than expected correlation between observations
in different periods (auto-correlation) in these formula.
I also found that models with more complex variance structures, such as the
random-period model and random-intervention model, failed to converge when
the variance of the random effects were truly zero; this has been previously
noted for mixed-effect models with binary outcomes [22]. An analysis plan
should specify what action will be taken if this is a problem in the final analysis.
In the discussion in chapter 7, I advised that a simpler model is prespecified in
an analysis plan that can be used if the more complex model fails to converge.
An alternative solution is to identify methods that improve convergence.
10.1.6 Implications for the Sample Size of Stepped-Wedge
Trials
A consequence of using these more robust analysis methods is that SWTs will
need to be larger to achieve the same power than previously thought.
If the cluster-summary method is planned, a CRT will have more power than
an SWT with the same sample size because of the imbalance in the number of
clusters in each condition in each period [13].
If a random-period model analysis is planned, the difference in sample size
compared to a CRT may not be as large as the model 3.1 standard error
suggests. This may have implications for trialists choice of design if sample
size is a primary concern: the additional complications of the SWT design
may outweigh a small reduction (or even increase) in sample size. However,
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implementing my design alterations from chapter 6 may counteract some of
the sample size increases required for the random-period model.
10.1.7 Implications for Reporting
This PhD has raised awareness about the complexity of designing and ana-
lysing SWTs. In addition to the considerations required by all RCTS and by
CRTs, SWTs require that appropriate consideration has been given to period
effects and correlations over time.
In particular, my research has highlighted the high risk of bias from SWT
analysis. In order for readers to assess the validity of trial results, results
must be reported in a way that allows readers to assess the appropriateness
of analysis assumptions. This means that both the assumptions themselves
and an assessment of those assumptions should be clearly reported. Improved
reporting of the observed correlation structure of the data will also help to
inform the planning of future trials in similar settings.
Several reviews have found such reporting to be lacking [23–26]. A lack of
guidance may be responsible as there is currently no CONSORT guidelines
available for SWTs. The development of guidelines are in progress [27], and I
am a member of the expert panel involved in their development. By providing
guidance on reporting before SWTs become commonly used, we hope trialists
will foster good reporting practices. A downside to developing guidelines while
the methodology literature is still developing is that guidelines may lag behind
developments in the methodological literature.
10.2 Dissemination and Increasing Impact
Throughout this PhD, I have placed an emphasis of disseminating findings in a
timely manner to increase their impact. Chapters 6 and 7 have been published
[28, 29], chapter 8 is currently under review at Statistics in Medicine, and
chapter 9 will be submitted to the Stata journal. The research in this thesis
has also been presented at the following conferences and meetings.
In 2014, I presented the aims of this PhD at the London School of Hygiene
& Tropical Medicine research-degree poster day. This received considerable
interest and I was awarded best pre-upgrading poster in my faculty.
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In 2015, at the International Conference for Clinical Trials Methodology in
Glasgow, UK, I gave oral presentations of preliminary findings of chapter 6
and chapter 8. The abstracts from these presentations are published in Trials
[30, 31].
In 2016, I presented the results of chapter 7 as a poster at the First Inter-
national Conference on Stepped-Wedge Trial Design in York, UK; this won a
prize for the best poster and the abstract is published in Trials [32]. In 2017,
I presented this poster again at the School’s research-degree poster day, and
the poster won a prize as one of the best posters in the faculty.
Also in 2016, I presented the examples given in chapter 8 as a demonstration of
the cluster-summary, within-period analysis at the Meeting on Current Devel-
opments in Cluster Randomised Trials and Stepped-Wedge Design in London,
UK.
In 2017, I gave an oral presentation of the final results from chapter 6 as part of
an invited session on SWT design at the International Conference for Clinical
Trials Methodology in Liverpool, UK.
As well as presenting the findings of this thesis at conferences, I have also
become involved in other projects that allow me to influence the future methods
used for SWT designs. I am part of an expert panel involved in developing
CONSORT guidelines for reporting SWTs. The development of the Stata
command in chapter 9 was done with the purpose of improving the uptake
of permutation tests and within-period analyses in SWTs. I am also involved
in a project to create a website providing advice on the design and analysis
of cluster randomised trials and am leading the sections on designing and
analysing SWTs.
10.3 Strengths and Limitations
In this section, I will describe the strengths and limitations of the original work
in this thesis.
The guidance I have provided is practical and simple for trialists to imple-
ment. This should improve the uptake of my suggestions leading to a greater
impact. The design suggestions in chapter 6 are simple adaptations of the
standard SWT design that have a minimal impact on the ease of rolling out
the intervention. The adaptions discussed in the literature involve allowing
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more clusters to be randomised to some sequences than to others [4, 5]: this
could make rollout more difficult where resources for rollout are limited. I also
provided a process for how to choose a trial design. This process acknowledges
that the most efficient design might be infeasible to implement and guides
trialists in choosing the most efficient, practical design given the restraints of
their setting. However, this advice focuses on settings where the data is being
collected for the purpose of the trial. In settings with routinely collected data,
inclusion of baseline data may be possible at no additional cost and will then
be beneficial to reducing the intervention effect variance.
Likewise, chapters 7 and 8 had a pragmatic focus. The simulation studies
focused on realistic scenarios, and I have made practical recommendations for
trial analysis. The Stata command described in chapter 9 was developed in a
way to make it flexible but easy to use, and the help file and journal article give
clear instructions. This command makes my suggested with-period analysis
much simpler to conduct in Stata, and the R code supplied in Chapter 8 makes
the analysis much simpler in R.
Another strength of the work in this thesis is the choice of methods.
The results of chapter 6 were derived algebraically, which means that they
hold wherever the assumptions of the design effect holds. However, these are
strong assumptions.
Chapters 7 and 8 used simulation studies following the advice of Burton et
al [33]. The simulations studies used to assess the analysis methods covered
a range of settings. Across both chapters, the scenarios covered different for-
mulations of between-cluster variability. I studied ICCs ranging from 0.02 to
0.2, different forms of variability in the period effect, and variability in the
intervention effect. Both simulation studies were motivated by real data from
two very different settings. This, along with the findings of previous research,
gives strength to my conclusions that model 3.1 is sensitive to deviations from
the model assumptions across a range of settings.
In developing the Stata command described in chapter 9 I have performed
rigorous testing and incorporated many checks into the code that the user has
correctly specified the command.
However, there are limits to the generalisability of my findings.
Whilst I did consider a range of ICC values, these were all relatively high
for health research where the median ICC is approximately 0.01 [34], and
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the cluster sizes were relatively large (a recent review of SWTs found a median
cluster size of 55 [25]) leading to high cluster-mean correlations in all scenarios.
I have also made several simplifying assumptions. For example, throughout
this thesis I have assumed that the intervention is constant over time, so that
there is no lag or waning of the intervention effect. Assuming a constant effect
when there is really a lag or waning of effect is likely to lead to underestimation
of the intervention effect. This is a topic that requires further research.
Throughout, I have only considered cross-sectional, complete SWT designs.
Although these designs are common in practice [26], my results are not gener-
alisable beyond these designs.
There have also been issues reported with the distributional assumptions of
outcomes. Chapter 6 assumes a normally distributed outcome, which has been
shown to be inappropriate for binary outcomes [35]. Conversely, chapters 7
and 8 focus only on binary outcomes because of their common use in practice
[25]. My simulation studies focused on estimation of log odds ratios because the
logit link transforms probabilities onto the real line. However, interpretation of
odds ratios is made difficult by non-collapsibility. This is an issue in chapter
7, where there are issues of comparability of effects from different analysis
models. The log odds ratio calculated by a cluster summary analyses has
been shown to be biased [36], although I did not find any such issues in the
analyses presented in chapter 8. This discrepancy is because I compared the
estimates to a cluster-specific effect, whereas Ukoumunne et al [36] used a
marginal effect.
A limitation of chapter 6 is the number of assumptions and restraints placed
on the designs that I considered. The results are only valid when model 3.1 is
valid, which later chapters of this thesis show often is not the case. My design
effect required an equal allocation of clusters to each sequence and the same
number of observations in each cluster-period within rollout. Therefore, my
optimised SWT is only optimal within these restraints.
A limitation of my conclusions in chapters 7 and 8 is that both of the analysis
methods I have recommended make the assumption that the intervention effect
is common to all clusters. Chapter 7 shows that the random-period model is
sensitive to this assumption, but I did not explore how sensitive the within-
period method will be. It is not known how common it is for intervention effects
to vary in practice. In CRTs, permutation tests have been shown to be robust
to intervention effect variability when there is the same number of clusters
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in each condition, and are conservative when the assumption is violated [37].
Further research is needed to explore how this relates to the SWT design where
there is overall balance between the number of observations in each condition
but an imbalance in most periods.
10.4 Future Research Directions
The limitations of this work naturally leads on to topics for future research.
The later part of this thesis advises against the use of model 3.1. Instead, I
have suggested the use of the random-period model or the cluster-summary,
within-period analysis. Efficient design when using the random-period model
requires further research. Whilst my findings about the use of vertical and
horizontal comparisons in the random-period model suggest that the general
results of removing the periods before and after rollout and selecting a number
of sequences depending on the cluster-mean correlation are likely to hold, this
needs to be confirmed and the specific relationship needs to be identified. The
design effects provided by Hooper et al [18] and Girling and Hemming [5] may
be able to shed light on this question assuming that the total variance does
not change between period and that there is the same correlation between all
cluster-periods. Alternatively, simulation studies could be used to explore this
topic.
Further research is required to see if there are practically important gains
in efficiency from removing the constraints placed on my optimisation. The
hybrid design shows us that there are gains from allowing an imbalance in
the allocations, but further gains may be possible through allowing all the
periods to vary in length as I did for the periods before and after rollout.
There may be efficiency gains from allowing more observations to be collected
when there is an equal number of clusters in the control and intervention
conditions compared to periods where there is a large imbalance. It should be
possible to explore this concept algebraically using similar methods to those
used in chapter 6. Zhan et al [38] found that such a design reduced the mean-
square error in simulation studies that incorporated no clustering, but no other
research has further explored this issue.
One of my important findings was that the intervention effect estimate from
model 3.1 may be biased if the intervention effect varies between the clusters.
This has not been shown previously and so needs confirming in a variety of
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other scenarios including in data with a lower ICC, smaller clusters, and smaller
variability in the intervention effect to demonstrate when bias may be an issue.
The random-period model is a promising parametric analysis for SWTs. The
form that I suggested in chapter 7 is very flexible: it places no constraints
on how the variability changes over time, or how the periods relate to one
another. A disadvantage of this degree of flexibility is that the model becomes
increasingly complex as the number of periods increases because each addi-
tional period in the study increases the number of variance and covariance
parameters that are estimated by the model. For the majority of scenarios, a
simpler covariance structure may suffice. The model 3.2 is a simpler model re-
commended for CRXO and CRT with baseline observations [16, 17]. It assumes
that the total variability in the data remains the same throughout the trial
and assumes that there is the same relationship between all periods. While
this model performs well for CRXO and CRT with baseline observations, the
larger number of periods in SWTs may make this model less suitable. Future
work must consider if and when this simpler alternative will suffice, and when
a more complex correlation structure is necessary.
Further work is also needed to aid in prespecification of analysis models, such
as improving identification of appropriate correlation structures before a trial
begins. In addition, improved convergence of models in the presence of low
variability between clusters would allow trialists to prespecify a flexible analysis
model when they are uncertain about the correlation structure of their data.
Bayesian hierarchical models may be one method of achieving this [39].
There is little work to date on the number of clusters required for mixed-effect
models to be reliable in the context of SWTs. In CRTs, it is recommended
that there are at least 15 clusters per arm for mixed-effect models [9], but
this may be different for an SWT. The model 3.4 is likely to require more
clusters than model 3.1 to remain reliable because of the additional parameters
being estimated. Simulation studies would be useful to explore the estimates
and error rates of the random-period model when varying the cluster size,
number of clusters, ICC, and number of sequences. The utility of small sample
corrections have been shown to improve the performance of mixed effect models
for CRTs with continuous outcomes [40], so should be explored for SWTs with
different outcome types.
GEE are largely unexplored in SWTs. They are generally thought to give
correct parameter estimates, even when the working correlation structure is
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misspecified [41], and have been shown to give nominal coverage with as few
as 10 clusters if small sample adjustments are applied [42]. However, they
may produce biased estimates in models with time varying covariates [43], so
further research is required to explore this analysis option.
There is also much development possible for the cluster-summary method.
Permutation tests require that the intervention effect is common to all clusters,
but I have not assessed how sensitive the tests are to this assumption in the
context of SWTs. If permutation tests are found to be very sensitive, an
alternative method, such as bootstraps may be required. Whilst bootstraps in
SWTs have been unsuccessful to date [7], this is an area that warrants further
investigation. Future work should also look at ways to improve the power of
the within-period analysis, for example by using different weights or adjusting
of covariates. The methods developed by Wei, Ware, Moulton and Stram
[10, 11, 44] that utilise the covariance matrix for weights (described in section
3.2.7) is worth further consideration, particularly for trials with a large number
of clusters. A benefit of this method over my within-period method is that
confidence intervals and p-values can be calculated from a normal distribution.
There are also possible improvements to be made to the Stata command.
Some SWTs use a constrained randomisation where the randomisation scheme
is selected from the set of schemes that minimise the imbalance of important
baseline covariates [45]. For such a trial to use permutation tests, the set of
permutations would need to be restricted to the set of schemes considered. The
Stata command cannot currently be used for such a design. A future version
of the Stata command would incorporate such functionality.
10.5 Concluding Remarks
In this thesis, I have shown that the most commonly used design is inefficient.
Simple analysis methods make strong, sometimes inappropriate assumptions
about the data. Trialists should give careful thought to how their choice of
design and analysis can affect the power of the study as well as the reliability
of the conclusions.
Designing trials in an efficient way is important to reduce the cost of con-
ducting a trial and I have shown that SWTs can be run more efficiently by
removing the periods before and after rollout and carefully choosing the num-
ber of sequences. A conservative approach to sample size calculations would
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be to assume that there is less correlation between observations in different
periods than expected, as this will reduce the chance of under powering the
study.
Using the correct analysis for a trial is clearly of vital importance; after the
time and energy spent conducting a study, it would be disastrous to draw the
wrong conclusions. Given the results of this thesis, I would discourage the use
of model 3.1 for the analysis of SWTs. Instead, I have suggested two methods
of analysis that will be appropriate in a wider range of settings because they
both make fewer and more realistic assumptions about the data. I recommend
that trialist use either the random-period model if power is of primary concern,
or the within-period analysis with cluster summaries if there is a high degree
of uncertainty about the correlation structure of the data, or few clusters.
The wide adoption of the findings from this thesis would help to overcome some
of the disadvantages of the SWT design as described in chapter 1. When using
an analysis method that utilises horizontal comparisons, removing or shorten-
ing the periods before and after rollout will lead to trials that require fewer ob-
servations, potentially shortening the trials and leading to more timely impact
of trial results. Alternatively, using a within-period analysis with permutation
tests will lead to intervention-effect estimates that are robust to misspecifica-
tion. The results from such an analysis will accurately reflect the uncertainty
around the intervention-effect estimates. Consequently, policy makers will be
better informed about how much weight to place on a particular trial result.
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